close

Medical products

Medical products

Retinal Implants Market Size and Forecast

New Jersey, United States – Comprehensive analyzes of the fastest growing companies Retinal Implants Market provide information that helps stakeholders identify opportunities and challenges. The 2022 markets could be another big year for retinal implants. This report provides an overview of the company’s activities and financial situation (a company profile is required if you want to raise capital or attract investors), recent developments (mergers and acquisitions) and recent SWOT analyses. This report focuses on the Retinal Implants Market over the assessment period 2029. The report also provides an analysis of the growth of the Retinal Implants Market which includes Porter’s Five Factor Analysis and Analysis of the supply chain.

It describes the behavior of the industry. It also outlines a future direction that will help companies and other stakeholders make informed decisions that will ensure strong returns for years to come. The report provides a practical overview of the global market and its changing environment to help readers make informed decisions about market projects. This report focuses on growth opportunities that allow the market to expand its operations in existing markets.

For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/retinal-implants-market-size-and-forecast/

(Use company email id to get higher priority)

The report helps both major players and new entrants to analyze the market in depth. This helps key players determine their business strategy and set goals. The report provides key market insights including niche growth opportunities along with market size, growth rate and forecast in key regions and countries.

The Retinal Implants report contains data based on rigorous studies in elementary and secondary schools using the best research practices. The report contains exhaustive information which will enable you to evaluate each segment of the Retinal Implants market. This report has been prepared considering various aspects of market research and analysis. It includes market size estimates, market dynamics, and company and market best practices. Entry marketing strategy, positioning, segmentation, competitive landscape and economic forecasts. Industry-specific technology solutions, roadmap analysis, alignment to key buying criteria, in-depth vendor product benchmarking

Key Players Mentioned in the Retinal Implants Market Research Report:

Second Sight Medical Products, Centrasight, Retinal Implant, Boston Retinal Implant Project, Nano Retina

Retinal Implants Market Segmentation:

By Product Type, the market is primarily split into:

• Epiretinal implants
• Subretinal implants

By application, this report covers the following segments:

• Retinal degenerative diseases
• Total blindness
• Others

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=481975

Scope of the Retinal Implants Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Geographic segment covered in the report:

The Retinal Implants report provides information on the market area, which is sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and rest of Europe)
• Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
• Latin America (Brazil, Mexico and rest of Latin America)
• Middle East and Africa (GCC and Rest of Middle East and Africa)

Key questions answered in this Retinal Implants Market report

  1. How much revenue will the Retinal Implants market generate by the end of the forecast period?
  2. Which market segment is expected to have the maximum market share?
  3. What are the influencing factors and their impact on the Retinal Implants market?
  4. Which regions are currently contributing the maximum share of the overall Retinal Implants market?
  5. Which indicators are likely to drive the Retinal Implants market?
  6. What are the key strategies of the major Retinal Implants market players to expand their geographical presence?
  7. What are the key advancements in the Retinal Implants market?
  8. How are regulatory standards affecting the retinal implant market?

Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=481975

Visualize Retinal Implants Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and findings with an integrated presentation feature that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D and development of products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Retinal Implant Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

Most Popular Reports

Global Ultrasonic Bone Densitometer Market Size and Forecast

Global Bioremediation Technology Market Size and Forecast

Global Hip Reconstruction Devices Market Size and Forecast

Global Energy-Based Hyperhidrosis Devices Market Size and Forecast

Global Sick Bed Market Size and Forecast

Global Neonatal Monitoring Devices Market Size and Forecast

Global External Pacemaker Market Size and Forecast

Global Retinal Implants Market Size and Forecast

Global Adaptive Self-Injection System Market Size and Forecast

Global Animal Pharmaceuticals Market Size and Forecast

About Us: Verified Market Reports

Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website: – https://www.verifiedmarketreports.com/

read more
Medical products

Insider Selling: Utah Medical Products, Inc. (NASDAQ: UTMD) Director Sells 2,000 Shares


Utah Medical Products, Inc. (NASDAQ:UTMDGet a rating) Director Barbara A. Payne sold 2,000 shares of Utah Medical Products in a trade dated Wednesday, May 11. The shares were sold at an average price of $85.20, for a total value of $170,400.00. Following the sale, the director now owns 5,338 shares of the company, valued at approximately $454,797.60. The sale was disclosed in an SEC filing, available at this hyperlink.

NASDAQ:UTMD opened at $85.05 on Thursday. The company has a 50-day moving average of $87.51 and a 200-day moving average of $95.57. The company has a market capitalization of $310.86 million, a price-earnings ratio of 20.35 and a beta of 0.25. Utah Medical Products, Inc. has a 1-year low of $81.01 and a 1-year high of $133.87.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 6. Investors of record on Friday, June 17 will receive a dividend of $0.29. The ex-dividend date is Thursday, June 16. This represents a dividend of $1.16 on an annualized basis and a yield of 1.36%. Utah Medical Products’ payout ratio is 27.75%.

Separately, StockNews.com began covering Utah Medical Products in a research report on Thursday, March 31. They established a “Strong Buy” rating for the company.

A number of large investors have recently increased or reduced their stakes in UTMD. HealthInvest Partners AB increased its position in Utah Medical Products by 40.0% in Q1. HealthInvest Partners AB now owns 56,000 shares of the medical device supplier worth $5,032,000 after buying an additional 16,000 shares in the last quarter. JPMorgan Chase & Co. increased its position in Utah Medical Products by 16.9% in the 1st quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying 14,693 additional shares in the last quarter. FMR LLC increased its position in Utah Medical Products by 2.4% in the 1st quarter. FMR LLC now owns 488,255 shares of the medical device supplier worth $43,089,000 after purchasing an additional 11,248 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in Utah Medical Products in Q4 for approximately $1,086,000. Finally, James Investment Research Inc. acquired a new stake in Utah Medical Products in Q1 for a value of approximately $384,000. Institutional investors hold 71.44% of the company’s shares.

Utah Medical Products Company Profile (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Recommended Stories



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

Utah Medical Products, Inc. Declares Quarterly Dividend of $0.29 (NASDAQ: UTMD)


Utah Medical Products, Inc. (NASDAQ:UTMDGet a rating) declared a quarterly dividend on Tuesday, May 10, Zacks reports. Shareholders of record on Friday, June 17 will receive a dividend of 0.29 per share from the medical device supplier on Wednesday, July 6. This represents a dividend of $1.16 on an annualized basis and a yield of 1.37%. The ex-dividend date is Thursday, June 16.

Utah Medical Products has increased its dividend payout by an average of 38.1% per year over the past three years and has increased its dividend each year for the past 1 consecutive years.

NASDAQ UTMD traded down $0.06 during Wednesday’s trading, hitting $84.66. The stock had a trading volume of 9 shares, compared to an average volume of 13,666 shares. The company’s 50-day moving average is $87.58. The company has a market capitalization of $309.43 million, a P/E ratio of 20.24 and a beta of 0.25. Utah Medical Products has a 12-month low of $81.01 and a 12-month high of $133.87.

Separately, StockNews.com began covering Utah Medical Products in a research report on Thursday, March 31. They issued a “Strong Buy” rating on the stock.

A number of large investors have recently increased or reduced their stakes in UTMD. JPMorgan Chase & Co. increased its stake in Utah Medical Products shares by 16.9% in the first quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying 14,693 additional shares in the last quarter. Barclays PLC increased its holdings of Utah Medical Products shares by 196.3% in the fourth quarter. Barclays PLC now owns 4,157 shares of the medical device supplier worth $415,000 after buying an additional 2,754 shares in the last quarter. BlackRock Inc. increased its holdings of Utah Medical Products shares by 0.3% in the fourth quarter. BlackRock Inc. now owns 217,007 shares of the medical device supplier worth $21,700,000 after purchasing an additional 748 shares in the last quarter. Citadel Advisors LLC purchased a new stake in Utah Medical Products stock in Q4 for approximately $233,000. Finally, State Street Corp increased its stake in Utah Medical Products shares by 2.4% in the 4th quarter. State Street Corp now owns 68,934 shares of the medical device supplier worth $6,893,000 after buying an additional 1,599 shares in the last quarter. 71.44% of the shares are currently held by institutional investors.

About Utah Medical Products (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Read more

Dividend history for Utah Medical Products (NASDAQ:UTMD)



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

read more
Medical products

Innovative Electrocardiogram Electrodes Market Strategy by 2030 | 3M, Shandong Intco Medical Products Corporation Ltd.

Global Electrocardiogram electrodes The market report is an objective and in-depth study of the current state aimed at the main drivers, strategies of the Electrocardiogram Electrodes market and the growth of the key Electrocardiogram Electrodes players. The Electrocardiogram Electrodes study also involves the significant achievements of the Electrocardiogram Electrodes market, the research and development of the Electrocardiogram Electrodes, the launch of the new product of the Electrocardiogram Electrodes, the responses of the Electrocardiogram Electrodes products Electrocardiogram Electrodes and the regional growth of the Electrocardiogram Electrodes industry of the major competitors operating in the market on a universal and local basis. scale. The structured analysis contains a graphical and schematic representation of the global Electrocardiogram Electrodes market with its specific geographical regions.

[Duetothepandemi[email protected][Enraisondelapandémienousavonsinclusunesectionspécialesurl’impactpré[email protected][Duetothepandemi[email protected]Market that would mention how Covid-19 affects EKG electrodes

Get Sample Copy of EKG Leads Report @ jcmarketresearch.com/report-details/1411744/sample

** Values ​​marked with an XX are confidential data. To learn more about the Electrocardiogram Electrodes industry CAGR figures, fill in your information so that our JCMR Business Development Manager can contact you.

Global Electrocardiogram Electrodes Market (Thousand Units) and Revenue (USD Million) Breakdown by Coverage:-

By Type – Fabric Materials – Foam Materials – Tape Materials By Application – Hospital – Clinic – Others

The Electrocardiogram Electrodes research study is segmented by Application such as Laboratory, Electrocardiogram Electrodes Industrial Use, Electrocardiogram Electrodes Utilities and Others with historical and projected market share and a compound annual growth rate.
Global Electrocardiogram Electrodes by Region (2022-2030)

Electrocardiogram Electrodes Market Segmentation By Regions 2015 2017 2019 2020 CAGR (%) (2022-2030)
North America xx xx xx xx% xx%
Europe xx xx xx xx% xx%
AEM xx xx xx xx% xx%
APAC and rest of the world xx xx xx xx% xx%
Total xx xx xx xx% xx%

Geographically, this Electrocardiogram Electrodes report is segmented into several key Regions, with production, consumption, revenue (Million USD) and Electrocardiogram Electrodes market share and growth rate of Electrocardiogram Electrodes electrocardiogram in these regions, from 2015 to 2030 (forecast) covering.

Additionally, EKG electrode export and import policies can have an immediate impact on EKG electrodes. This Electrocardiogram Electrodes study contains a chapter related to EXIM* on Electrocardiogram Electrodes Market and all its associated companies with their profiles, which provides valuable data regarding their prospects in terms of Electrodes industry finances electrocardiogram, electrocardiogram electrodes product portfolios, electrocardiogram electrodes investment plans, and electrocardiogram electrodes marketing and electrocardiogram electrodes business strategies. The Electrocardiogram Electrodes report is an important document for all market enthusiasts, decision makers, investors, and players.

Answers to Key Questions in this Electrocardiogram Electrodes Industry Report – 2030 Data Survey Report

What will be the size of the EKG market in 2030 and what will be its growth rate?
What are the key trends in the Electrocardiogram Electrodes market?
What drives the electrocardiogram electrodes?
What are the growth challenges of the Electrocardiogram Electrodes market?
Who are the main suppliers of electrocardiogram electrodes in space?
What are the key market trends impacting the growth of Electrocardiogram Electrodes?
What are the main results of the analysis of the five forces of electrocardiogram electrodes?

Get Attractive Discount on Electrocardiogram Electrodes Report with Additional Customization @ jcmarketresearch.com/report-details/1411744/discount

There are 15 chapters to display the electrocardiogram electrodes.

Chapter 1, to describe Definition, Specification and Classification of Electrocardiogram Electrodes, Applications of Electrocardiogram Electrodes, Market Segment by Regions;

Chapter 2, to analyze Electrocardiogram Electrodes manufacturing cost structure, Electrocardiogram Electrodes raw materials and suppliers, Electrocardiogram Electrodes manufacturing process, Electrodes industry chain structure electrocardiogram;

Chapter 3, to view the Technical Data and Manufacturing Plants Analysis of Electrocardiogram electrodesEKG electrodes commercial production capacity and date, EKG electrodes manufacturing plant distribution, EKG electrodes R&D status and technology source, EKG electrodes raw material source analysis;

Chapter 4, to show the Global Electrocardiogram Electrodes Market Analysis, Capacity Analysis of Electrocardiogram Electrodes (Company Segment), Electrocardiogram Electrodes Sales Analysis (Company Segment), Company), Electrocardiogram Electrode Sales Price Analysis (Company Segment);

Chapter 5 and 6, to show the Regional Electrocardiogram Electrodes Market Analysis that includes North America, Europe, Asia-Pacific etc, the Electrocardiogram Electrodes Segment Market Analysis electrocardiogram by various segments;

Chapter 7 and 8, to analyze the Electrocardiogram Electrodes Segment Market Analysis (by Application) Major Manufacturers Analysis of Electrocardiogram Electrodes;

Chapter 9, Electrocardiogram Electrodes Market Trend Analysis, Regional Market Trend, Market Trend by Product Types, Market Trend by Applications;

Chapter 10, Electrocardiogram Electrodes Regional Marketing Type Analysis, Electrocardiogram Electrodes International Trade Type Analysis, Electrocardiogram Electrodes Supply Chain Analysis;

Chapter 11, to analyze the Consumers Analysis of Electrocardiogram Electrodes;

Chapter 12, to describe Electrocardiogram Electrodes Research Findings and Conclusion, Appendix, methodology and data source;

Chapter 13, 14 and 15, to describe sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Buy Instant Copy of Full Electrocardiogram Electrodes Research Report: @ jcmarketresearch.com/checkout/1411744

Find more research reports on Electrocardiogram electrode industry. By JC Market Research.

Thank you for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About the Author:
JCMR’s global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities, but also to empower and inspire you to create visionary growth strategies for the future, through our extraordinary depth and breadth of thought leadership, research, tools, events and experience. that help you make goals a reality. Our understanding of the interplay between industry convergence, megatrends, technologies and market trends provides our clients with new business models and opportunities for expansion. We are focused on identifying the “Accurate Forecast” in each industry we cover so that our clients can reap the benefits of being early market entrants and can achieve their “Goals and Objectives”.

Contact us:
JCMARKETRESEARCH
Mark Baxter (Business Development Manager)
Call:
+1 (925) 478-7203
Email: [email protected]

Connect with us at – LinkedIn

read more
Medical products

Allied Corp. enters into a sales agreement with a Brazilian distributor of medical products

Canadian cannabis producer Allied company. (OTCQB: ALID) added another list of sales contract recipients for its BC-grown pot.

On Wednesday, the Kelowna-based company announced that under the purchase agreement, US$147,000 of its products would go each month to an unnamed Brazilian distributor who would deliver medical products to Israelita Albert Einstein Hospital in São Paulo.

Cannabis products are intended for thousands of Brazilians undergoing cancer treatment. The sales agreement took four months to approve due to product review, manufacturing specifications and testing.

The company plans to send the first monthly shipments under the contract starting in May this year.

Shares of the company fell 8.3% on Wednesday to US$0.78 on the OTC market.

Albert Einstein Hospital in São Paulo. Photo by Lukaaz–Marcelo via Wikimedia Commons

Read more: Allied Corp. exports dried flowers grown in Colombia to Australia and the United States

Read more: Allied Corp. will send 1 million euros worth of cannabis to its Australian partner

The Israelita Albert Einstein Hospital in São Paulo was founded in 1971 with the mission of providing quality health care, generating knowledge and promoting social responsibility. He specializes in providing complex treatments in oncology and neurology.

According to Forbes, it is among the top 20 hospitals in the world.

The hospital’s research and education institute has already trained around 130,000 professionals and conducts hundreds of studies each year.

Allied’s products will be offered specifically to patients undergoing cancer and neurological treatments.

“With over 200 million people, Brazil is an obvious market for us at Allied. Quality, flavor profiles and supply chain integrity were all considered in bringing the Brazilian partner and Allied together under this agreement,” said Allied CEO Calum. Hughes, in a statement.

“The rigorous review process that Allied underwent in order to meet the standard for a customer of this caliber again demonstrates our manufacturing competence and knowledge of international regulatory compliance,” he said, adding that the revenue this generates will only fuel their future growth. .

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

[email protected]

read more
Medical products

Veress Needle Market Size, Scope and Outlook

New Jersey, United States – The study is a professional and comprehensive assessment of the Veress needle market with an emphasis on in-depth analysis of market data. The purpose of the study is to provide a quick understanding of the business along with a comprehensive categorization of the Veress Needles market by type, activity, end-use, and region. The study provides specific market statistics for major manufacturers and distributors, as well as an analysis of the outlook for the industry in general. The study examines the global Veress Needles market by considering supply and demand and identifies the variables that will influence the Veress Needles market in each region during the projection period. On the consumer side, market trends, limitations and opportunities as well as an assessment of consumer development are examined.

The study discusses the elements driving the global Veress needles market. Traders and investors can use this data to strategize to increase their market share, and newcomers can use it to locate opportunities and grow in the business. There are also some restrictions on expanding this market. The Veress Needle Market study also provides company biographies, SWOT analysis and business strategies for key industry players. Additionally, the research focuses on major industry players, providing details such as company descriptions, skills, current finances, and company advancements.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

Market factors could use prospect information to attract informed prospects in underdeveloped countries. The analysis covers sales, revenue, annual growth and market share of Veress Needle in the global market for the past and future years. Figures for the past year and subsequent years show the sales, revenue, growth rate and customer base of each industry. Veress Needle Market Research has published a report that examines the key physical and chemical growth methodologies employed by companies in the Veress Needle market. Product launches, product endorsements, and intellectual property strategies were among the most common tactics for sustained growth. Partnerships, collaborations and alliances were among the most important tactics for business expansion. Veress Needle Market participants were able to increase their business through these actions.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and findings with an integrated presentation feature that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D and development of products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Benefits of medical products shares on April 28: TMO, BIO and more

The first quarter earnings season for the Medical sector started last week. The last Revenue overview reflects a strong year-over-year improvement in quarterly performance so far in this reporting cycle. According to the industry scorecard, 7% of companies in the medical sector, constituting nearly 27.6% of the sector’s market capitalization, reported profits through April 22. Of these, 100% beat earnings estimates and 75% beat the same for revenue. Profits rose 8.4% year over year on the back of revenue up 13.5%.

This dashboard reflects the current stability in the United States on the continued economic reopening. However, a number of MedTech players faced severe staff shortages and supply chain vagaries in the first quarter, thanks to the emergence of new COVID variants.

Overall, first-quarter medical profits are expected to rise 10.3% on a 13.3% increase in sales. That compares to reported earnings growth of 27.8% and revenue growth of 14.3% in the fourth quarter. It is worth mentioning that the medical sector is expected to be one of the nine sectors that are expected to register profit growth in the first quarter of 2022.

Quarterly summary of medical products

An integral part of the broader medical industry, Zacks’ definition Medical products Collective growth in business activity is expected to have improved compared to last year, with a significant increase in the vaccination campaign and a reduction in COVID-related deaths in the United States and other developed countries. The dynamic nature of the COVID-19 crisis has been a roller coaster ride for the medical products industry over the past few months.

In the recent past, companies in this space had experienced a sharp decline in their core business. However, results for the majority of medical product stocks have so far shown accelerated growth in non-COVID business in the first quarter months compared to 2020 on a reduction in the severity of COVID-19 despite the emergence new virus variants. Overall, the recovery of the companies’ legacy core business during the first quarter months was impressive. Medical product companies like Thermo Fisher Scientific OMT, Bio-Rad Laboratories ORGANIC, LabCorp HL and ResMed RMD is likely to have been impacted by these factors in the first quarter.

It should be mentioned here that disruptions in the form of the emergence of more contagious COVID-19 variants like Delta, Omicron and XE are still evident in many developed countries. A number of MedTech players faced severe staffing shortages and supply chain uncertainties during the first quarter months. As a result, many industry players have witnessed a decline in their business performance on a sequential basis.

In addition, first-quarter results from diagnostic testing companies showed lower demand for testing so far, due to declining cases, which has dampened business growth for many companies.

Let’s take a look at four Medical Products players who are due to announce their results on April 28th.

Thermo Fisher Scientific: During the first quarter months, Thermo Fisher’s analytical instruments segment should have generated strong sales thanks to the flourishing electron microscopy, chromatography and mass spectrometry businesses. The company is expected to record growth driven by a favorable business mix and a strong increase in volumes and productivity enabled by the PPI trading system. (Read more: Thermo Fisher to Release First Quarter Results: What’s in Store?)

Zacks’ consensus estimate for total revenue of $10.63 billion for the first quarter suggests a 7.3% increase over the reported figure for the year-ago quarter. The consensus mark for Thermo Fisher’s earnings of $6.17 per share indicates a decline of 14.4% from the reported figure for the year-ago quarter.

According to our proven model, a title with the combination of a positive effect ESP Earnings and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating the estimates. However, this is not the case as you can see below.

TMO has an ESP on earnings of -1.20% and carries a Zacks rank #3. You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

Thermo Fisher Scientific Inc. Prize and EPS Surprise

Thermo Fisher Scientific Inc. price-eps-surprise | Quote from Thermo Fisher Scientific Inc.

You can see the full list of today’s Zacks #1 Rank stocks here.

Bio-Rad Laboratories: Bio-Rad’s life sciences segment has seen robust revenue growth in recent quarters. We expect this growth momentum to continue in the first quarter thanks to continued sales growth in the Polymerase Chain Reaction (PCR), Droplet Digital PCR (dPCR), Process Media and Western Blot businesses. The company also saw strong growth in the biopharmaceutical market for the Droplet Digital PCR platform, which is expected to have made a significant contribution to first quarter revenue. (Read more: Bio-Rad to Report First Quarter Results: What’s in the Charts?)

Zacks’ consensus estimate for Bio-Rad’s first-quarter revenue is set at $678 million, implying a 6.7% decline from the prior year’s figure. The consensus estimate for earnings per share is set at $2.80, suggesting a decline of 46.3% from the figure reported the previous year.

BIO has a Gain ESP of 0.00% and a Zacks Rank #3.

BioRad Laboratories, Inc. EPS Awards and Surprise

BioRad Laboratories, Inc. EPS Awards and Surprise

BioRad Laboratories, Inc. price-eps-surprise | BioRad Laboratories, Inc. Quote

LabCorp: LabCorp recorded a continued rebound in sales in the core business for the Diagnostics and Drug Development segments. However, as the effects of the pandemic fade, we expect demand for COVID-19 testing services to gradually decline, which will impact first quarter sales performance. In the fourth quarter of 2021, the company reported higher adjusted operating income and improved margins within the core business, given organic growth and LaunchPad savings. According to the fourth quarter earnings call, the company has implemented a new LaunchPad business process improvement initiative, which is expected to generate $350 million in savings over the next three years. The new initiative is expected to have helped the company’s margin in the first quarter. (Read more: LabCorp to Report First Quarter Results: What’s in the Cards?)

Zacks’ consensus estimate for first-quarter earnings of $5.88 a share implies a 33.1% drop from the figure reported a year ago. The consensus revenue estimate is set at $4.04 billion, suggesting a 2.9% drop from the figure reported the previous year.

LH has an ESP on Earnings of -0.22% and a #3 Zacks Rank.

Laboratory Corporation of America Holdings award and EPS surprise

Laboratory Corporation of America Holdings award and EPS surprise

Laboratory Corporation of America Holdings price-eps-surprise | Quote from Laboratory Corporation of America Holdings

ResMed: ResMed is expected to have benefited in the third quarter of fiscal 2022 from increased demand for sleep and respiratory care devices thanks to the steady recovery of markets following the impacts of COVID-19 and the recall of products from a competitor. The growth of home medical equipment and home care facilities should have contributed to the revenue growth of the SaaS business. Continued robust adoption of ResMed’s AirSense 10 and AirSense 11 platforms reinforces optimism for the company. These developments likely contributed to the company’s revenue in the upcoming quarter.

Zacks consensus estimate for its fiscal third quarter earnings per share is set at $1.44. Revenue is expected to be $908.7 million.

RMD has an ESP of 0.00% and Zacks Rank #3.

ResMed Inc. Award and EPS Surprise

ResMed Inc. Award and EPS Surprise

ResMed Inc. price-eps-surprise | Quote ResMed Inc.

Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

Laboratory Corporation of America Holdings (LH): Free Stock Analysis Report

Thermo Fisher Scientific Inc. (TMO): Free Inventory Analysis Report

ResMed Inc. (RMD): Free Stock Analysis Report

BioRad Laboratories, Inc. (BIO): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Medical products

Personal Mobility Devices Market Size, Scope and Outlook

New Jersey, United States – The study is a professional and comprehensive assessment of the personal mobility device market with an emphasis on in-depth analysis of market data. The aim of the study is to provide a quick understanding of the business along with a comprehensive categorization of the Personal Mobility Devices market by type, activity, end-use, and region. The study provides specific market statistics for major manufacturers and distributors, as well as an analysis of the outlook for the industry in general. The study examines the global personal mobility device market considering supply and demand and identifies the variables that will influence the personal mobility device market in each region during the projection period. On the consumer side, market trends, limitations and opportunities as well as an assessment of consumer development are examined.

The study discusses the elements driving the global personal mobility device market. Traders and investors can use this data to strategize to increase their market share, and newcomers can use it to locate opportunities and grow in the business. There are also some restrictions on expanding this market. The Personal Mobility Devices market study also provides company biographies, SWOT analysis and business strategies for key industry players. Additionally, the research focuses on major industry players, providing details such as company descriptions, skills, current finances, and company advancements.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

Market factors could use prospect information to attract informed prospects in underdeveloped countries. The analysis covers sales, revenue, annual growth and market share of personal mobility devices in the global market for the past and future years. Figures for the past year and subsequent years show the sales, revenue, growth rate and customer base of each industry. Personal Mobility Devices Market research has published a report that examines the key physical and chemical growth methodologies employed by companies in the Personal Mobility Devices market. Product launches, product endorsements, and intellectual property strategies were among the most common tactics for sustained growth. Partnerships, collaborations and alliances were among the most important tactics for business expansion. Participants in the personal mobility device market have been able to increase their business due to these actions.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape with respect to region, country, and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Life Wear Technologies donates over 62,000 units of supporting medical products to House of Ukraine

POMPANO BEACH, Florida–(BUSINESS WIRE)–Life Wear Technologies, a leading provider of private label and branded sports medicine products, is pleased to announce a charitable contribution to the House of Ukraine, Inc. a cultural museum in San Diego providing information to the public about the country of Ukraine.

The donation consisted of more than 62,000 medical product units including knee, ankle and wrist braces, back support, elastic bandages, heat, cold packs and more. Regularly reporting on cultural aspects of Ukraine including art, history, traditions and language, House of Ukraine is also currently accepting product donations including military supplies and aid kits to donate to local Ukrainians in kyiv and to refugees.

“As a mass producer in the first aid and pharmacy market, we didn’t hesitate to find a way to support Ukraine with the supplies we have,” said Bradley Waugh, president and CEO of the management of Life Wear Technologies. “We are grateful to be able to offer our products as a useful medical aid, and hope they will even bring a glimmer of relief to those in need.”

the House of Ukraine, Inc. is a member of the House of Pacific Relations International Cottages, Inc, (HPR), Balboa Park, San Diego, California, founded in 1935 and is a nonprofit community organization dedicated to fostering cooperation and understanding among national groups in United States .

Learn more about the House of Ukraine, as well as Life wear technologies can be found at their corresponding links.

About Life Wear Technologies:

Life Wear Technologies, LLC was established in 1974 as one of the first manufacturers of sports medicine products. The company began selling its products to athletic trainers, institutions, sporting goods retailers and professional teams throughout the US market.

After gaining notoriety as a leading sporting goods innovator, the company moved into the growing first aid and pharmacy market. In addition to health supports, Life Wear began manufacturing elastic bandages, athletic bands and eventually hot and cold therapy products to become the first single-source solution for private label sports medicine products.

Today, Life Wear Technologies, LLC is a leading supplier of private label and branded sports medicine products sold through the drug, food and mass merchant distribution chains.

read more
Medical products

Personal Mobility Devices Market Size and Forecast

New Jersey, United States – personal mobility device market Research Report provides you with detailed and accurate analysis to strengthen your position in the market. It provides the latest updates and powerful insights on the Personal Mobility Devices industry to help you improve your business strategy and ensure strong revenue growth for years to come. It elucidates the current and future market scenarios and lets you understand the competitive dynamics of the Personal Mobility Devices market. The market segmentation analysis provided in the research report shows the performance of different product segments, applications, and regions in the Personal Mobility Devices market.

The report includes validated and revalidated market data such as CAGR, gross margin, revenue, price, production growth rate, volume, value, market share and year-on-year growth on the other. We use the latest primary as well as secondary research techniques to compile this comprehensive Personal Mobility Devices Market report. As part of the regional analysis, we studied key markets such as North America, Europe, India, China, Japan and MEA. Profiles of leading companies are based on various factors including markets served, production, revenue, market share, recent developments, and gross profit margins. A section dedicated to market dynamics with in-depth analysis of drivers, restraints, opportunities, influencers, challenges and trends.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

The report gives a good overview of the main macroeconomic factors that have a significant impact on the growth of the Personal Mobility Devices market. It also provides absolute dollar opportunity analysis which is essential for identifying opportunities for revenue generation and increasing sales in the Personal Mobility Devices market. Market players can use the qualitative and quantitative analysis provided in the report to fully understand the Personal Mobility Devices market and make great strides in the industry in terms of growth. The overall size of the Personal Mobility Devices market and the overall size of each segment studied in the report are precisely calculated based on various factors.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The report is the best compilation of different types of segmental analyzes of the Personal Mobility Devices Market performed from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Personal Mobility Devices research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Women’s Health Rehabilitation Products Market Size and Forecast

New Jersey, United States – Women’s Health Rehabilitation Products Market Research Report provides you with detailed and accurate analysis to strengthen your position in the market. It provides the latest updates and powerful insights on the Women’s Health Rehabilitation Products industry to help you improve your business strategy and ensure strong revenue growth for years to come. It elucidates the current and future market scenarios and allows you to understand the competitive dynamics of the Women’s Health Rehabilitation Products market. The market segmentation analysis provided in the research report shows the performance of different product segments, applications, and regions in the Women’s Health Rehabilitation Products market.

The report includes validated and revalidated market data such as CAGR, gross margin, revenue, price, production growth rate, volume, value, market share and year-on-year growth on the other. We use the latest primary as well as secondary research techniques to compile this comprehensive Women’s Health Rehabilitation Products Market report. As part of the regional analysis, we studied key markets such as North America, Europe, India, China, Japan and MEA. Profiles of leading companies are based on various factors including markets served, production, revenue, market share, recent developments, and gross profit margins. A section dedicated to market dynamics with in-depth analysis of drivers, restraints, opportunities, influencers, challenges and trends.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=22158

Key Players Mentioned in the Women’s Health Rehabilitation Products Market Research Report:

Accord Medical Products, BSN medical, Carib Rehab, Cornerstone Chiropractic, DeRoyal, EMS Physio, GE Healthcare, GPC Medical, Meyer Physical Therapy, Midtown Chiropractic, PROSPINE Health and Injury Center, Pelvic Health and Rehabilitation, Pure Health Chiropractic, Sportstek, Win Health Medical, Zynex

The report gives a good overview of the main macroeconomic factors that have a significant impact on the growth of the Women’s Health Rehabilitation Products market. It also provides absolute dollar opportunity analysis which is essential for identifying opportunities to generate revenue and increase sales in the Women’s Health Rehabilitation Products market. Market players can use the qualitative and quantitative analysis provided in the report to fully understand the Women’s Health Rehabilitation Products market and make great strides in the industry in terms of growth. The overall size of the Women’s Health Rehabilitation Products market and the overall size of each segment studied in the report are precisely calculated based on various factors.

Women’s Health Rehabilitation Products Market Segmentation:

Women’s Health Rehabilitation Products Market by Product

• Orthopedic care
• Urinary incontinence
• Breast cancer care
• Pregnancy and postpartum care

Women’s Health Rehabilitation Products Market By Application

• Hospitals
• Clinics

The report is the best compilation of different types of Women’s Health Rehabilitation Products market segmental analysis done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting their market sizes makes the Women’s Health Rehabilitation Products research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=22158

Scope of the Women’s Health Rehabilitation Products Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Women’s Health Rehabilitation Products Market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Women’s Health Rehabilitation Products Market?

2. How will the women’s health rehabilitation products market develop in the next five years?

3. Which product and application will occupy the lion’s share of the women’s health rehabilitation products market?

4. What are the drivers and restraints of the Women’s Health Rehabilitation Products Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Women’s Health Rehabilitation Products market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/women-health-rehabilitation-products-market/

Visualize Women’s Health Rehabilitation Products Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Women’s Health Rehabilitation Products Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

India capitulates to EU over TRIPS waiver for Covid-19 medical products

The compromise reached puts all the odds on its side against the poorest countries. Additionally, eligibility is limited to developing WTO countries that exported less than 10% of global vaccines in 2021. This would exclude Brazil, China, and non-WTO countries such as Kosovo, Palestine, Iran, Serbia and Syria.

Chronology of negotiations

In October 2020, India and South Africa submitted a proposal which called for the relinquishment of patents, but also of industrial designs, copyrights and trade secrets which are protected by the agreement of WTO on TRIPS.

In May 2021, a revised proposal was tabled which specified that the TRIPS waiver would only apply to vaccines, diagnostics, therapeutics, medical devices and personal protective equipment related to COVID-19 and would remain in effect for at least three years. .

In December 2021, the WTO Secretariat convened a meeting between the four parties – South Africa, India, the US and the EU – but it was held in two formats. For one meeting, only quad trade and trade ministers met and in the other meeting, only negotiators from these four countries met. Indian Commerce Minister Piyush Goyal attended these meetings. Normally, negotiators and ministers attend meetings together. In the next round of online meetings, India met the US and South Africa met the EU.

On March 11, 2022, there was a meeting of the four ministers only where the compromise was agreed. This is after EU officials sent a note to their member countries on the compromise reached.

The United States Trade Representative (USTR) released a statement on March 16 indicating that a compromise had been reached but countries had yet to agree on the final test. A little after, WTO Director General, Ngozi Okonjo-Iweala said the details of the deal were not yet settled.

However, India remained silent on the issue after the compromise was reached. In November 2021, a senior Commerce Ministry official had reiterated that India would continue to demand waiver of intellectual property rights for COVID-19 vaccines and supplies. India had affirmed that it would ensure that the interests of developing nations were not compromised.

read more
Medical products

Free offers of medical products – No violation of the prohibition on promotional gifts under Hwg 7(1) when the purchase price is refunded in full

In the case at issue, the plaintiff, on the basis of Sections 8, 3, 3a of the German Unfair Competition Act (UWG) in conjunction with Section 7(1) Nr. 1 of the German Health Advertising Act (HeilmittelwerbegesetzHWG), sought an injunction against defendant’s promotional offer “Incontinence Pants – FREE TRIAL” which was challenged as in violation of competition law.

Specifically, the defendant had affixed a folded sticker containing the words “FREE TRYon the packaging of its medical product. The inside of the sticker contained instructions on how to obtain a refund of the purchase price after purchasing the product by uploading to the defendant’s website a photo of the payment receipt and the promotional package and providing the name, address and bank details, after which the purchase price would be refunded within 14 days.

The Higher Regional Court of Cologne (judgment of 17 December 2021, file no. 6 U 91/51) upheld the decision of the Regional Court of Cologne (judgment of 25 May 2021, file no. 33 O 60/20) to reject the action and dismissed the appeal against said decision.

In his appeal, the plaintiff argued that the defendant could not rely on the exceptions provided for in § 7, paragraph 1, no. 1 of the HWG, because the limit of the lower value is exceeded when the purchase price exceeds at least eight euros. The other exception in Section 7(1) No. 2(a) of the HWG was irrelevant because the public would not view reimbursement of the purchase price as a gift, but rather as acquiring the product. Furthermore, a full refund of the purchase price is not covered by this provision.

The Higher Regional Court, on the other hand, found no violation of Section 7 (1) HWG. According to this provision, it is in principle inadmissible to offer, advertise or grant advantages and other promotional gifts (goods or services). The term “promotional gift” should be interpreted broadly and includes any free gift in connection with the purchase of a product or service. In the opinion of the Tribunal de Grande Instance, the reimbursement of the purchase price described above constitutes such a free gift. However, the the exception under Section 7 (1) No. 2 (a) HWG applies here, whereby the benefit or promotional gift is permitted if granted for a specific amount of money or for an amount of money calculated in a certain way.

In this case, the Cologne courts therefore did not consider the product itself as the gift, but rather the purchase price reimbursed under the conditions described. Therefore, the exception for low value items under Section 7(1) No. 1 HWG was not relevant.

The decisive factor in this respect is that the product must first be fully paid for by the consumer. The consumer therefore does not understand the message on the sticker to mean that the product is given away free of charge. Also, the consumer is informed of similar promotions, so he will take into account the additional information on the reimbursement conditions appearing inside the sticker. In addition, the refund relates to the total purchase price of the product and therefore to a “specified sum of money or for a sum of money calculated in a certain way”. The fact that the full purchase price is refunded is also not in contradiction with this, since the wording of Article 7(1)(2) (a) of the HWG does not provide for any relative or absolute limitation on the amount of the donation. Accordingly, in the opinion of the Higher Regional Court, the except for Section 7 (1) No. 2 (a) HWG does not to fail due to lower limit value of Section 7 (1) No. 1 HWG nor is it in conflict with this provision.

The Higher Regional Court of Cologne thus follows the decision of the Higher Regional Court of Hamburg, which had previously rejected a previous request for an injunction (judgment of 20 June 2019, file no. 3 U 137/18).

The decision concerns an interesting and finely drawn line between the two exceptions to the fundamental prohibition on promotional gifts under Section 7(1) HWG and illustrates the complexity surrounding the legal assessment of promotional activities for drugs and products. medical, in particular in the planning of such promotional activities. It is strongly recommended to seek legal advice here.

This judgment is one of many decisions which raise the bar for the promotion by pharmaceutical companies of corresponding products. Particular attention should always be paid to the prohibition of promotional gifts under Section 7 HWG discussed here. See also the articles “Mandatory information in pharmaceutical advertising” of the September 7, 2021and “Provision of Complimentary Samples to Pharmacies Pursuant to Section 7 HWG” of April 14, 2021.

read more
Medical products

Brazil’s Viveo to Acquire 3 Medical Products Companies in Expansion Spurt

SAO PAULO, April 12 (Reuters)Brazilian distributor of medicines and medical products Viveo VVEO3.SA has reached an agreement to acquire three companies for a total of 365.5 million reais ($77.86 million) as it pushes for expansion, it said in a securities filing on Tuesday.

The deal includes parenteral nutrition company FAMAP, a supplier of sterile solutions and a distributor of hospital PHD products, Viveo – formerly known as CM Hospitalar SA – said.

Life and FAMAP combined accounted for 58 million reais of earnings before interest, taxes, depreciation and amortization (EBITDA), while PHD is expected to add 17.5 million reais of EBITDA, Viveo added.

Life and PHD are based in the southern city of Porto Alegre, and FAMAP is headquartered in Belo Horizonte. The deal still requires approval from Brazilian antitrust watchdog CADE.

The move comes less than a year after Viveo and its shareholders raised R$2.32 billion in an initial public offering (IPO) that valued the company at R$5.7 billion at the time.

($1 = 4.6944 reais)

(Reporting by Gabriel Araujo; editing by Jason Neely)

(([email protected]; +55 11 5644 7745;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Medical products

Veress Needle Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of Veress needle market with holistic information about important factors and aspects impacting the future growth of the market. The Veress Needles Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain thorough understanding of the Veress Needles Market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Veress Needle market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Veress Needle Market report have made a brilliant attempt to study the key developments, pricing and business-related tactics as well as the future plans of the major companies. Along with the Players Veress Needle Market performance in terms of revenue and revenue, analysts shed light on their production, areas served, gross margin, and other important factors. Moreover, Veress Needle report helps players to gain an upper hand in market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

The report is the best compilation of different types of segmental analyzes of the Veress Needle market done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Veress Needle study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be used by all participants of the Veress Needle market as it covers all the major and minor aspects of the current and future competition in the market. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to make a foray into the Veress Needle market can get useful insights and effective guides from the report. On the other hand, established companies can use the Veress Needle report to keep themselves informed about current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and which application will take the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Women’s Health Rehabilitation Products Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of Women’s Health Rehabilitation Products Market with holistic information about important factors and aspects impacting the future growth of the market. The Women’s Health Rehabilitation Products Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain thorough understanding of the Women’s Health Rehabilitation Products market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Women’s Health Rehabilitation Products market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Women’s Health Rehabilitation Products market report have made a brilliant attempt to study the key developments, pricing and business tactics as well as the future plans of major companies. . Along with the Players Women Health Rehabilitation Products market performance in terms of revenue and revenue, the analysts shed light on their production, areas served, gross margin, and other important factors. Moreover, the Women’s Health Rehabilitation Products report helps players to gain an upper hand in the market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=22158

Key Players Mentioned in the Women’s Health Rehabilitation Products Market Research Report:

Accord Medical Products, BSN medical, Carib Rehab, Cornerstone Chiropractic, DeRoyal, EMS Physio, GE Healthcare, GPC Medical, Meyer Physical Therapy, Midtown Chiropractic, PROSPINE Health and Injury Center, Pelvic Health and Rehabilitation, Pure Health Chiropractic, Sportstek, Win Health Medical, Zynex

Women’s Health Rehabilitation Products Market Segmentation:

Women’s Health Rehabilitation Products Market by Product

• Orthopedic care
• Urinary incontinence
• Breast cancer care
• Pregnancy and postpartum care

Women’s Health Rehabilitation Products Market By Application

• Hospitals
• Clinics

The report is the best compilation of different types of Women’s Health Rehabilitation Products market segmental analysis done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting their market sizes makes the Women’s Health Rehabilitation Products research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be utilized by all participants of the Women’s Health Rehabilitation Products market as it covers all the major and minor aspects of the current and future market competition. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to foray into the Women’s Health Rehabilitation Products market can get helpful insights and efficient guides from the report. On the other hand, established businesses can use the Women’s Health Rehabilitation Products report to keep themselves informed with current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=22158

Scope of the Women’s Health Rehabilitation Products Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Women’s Health Rehabilitation Products Market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Women’s Health Rehabilitation Products Market?

2. How will the women’s health rehabilitation products market develop in the next five years?

3. Which product and application will occupy the lion’s share of the women’s health rehabilitation products market?

4. What are the drivers and restraints of the Women’s Health Rehabilitation Products Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Women’s Health Rehabilitation Products market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/women-health-rehabilitation-products-market/

Visualize Women’s Health Rehabilitation Products Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Women’s Health Rehabilitation Products Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Personal Mobility Devices Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of personal mobility device market with holistic information about important factors and aspects impacting the future growth of the market. The Personal Mobility Devices Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain a thorough understanding of the Personal Mobility Devices market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Personal Mobility Devices market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Personal Mobility Devices market report have made a brilliant attempt to study the key developments, pricing and business-related tactics as well as the future plans of leading companies. Along with Players Personal Mobility Devices market performance in terms of revenue and revenue, analysts shed light on their production, areas served, gross margin and other important factors. Moreover, the Personal Mobility Devices report helps players to gain an upper hand in the market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The report is the best compilation of different types of segmental analyzes of the Personal Mobility Devices Market performed from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Personal Mobility Devices research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be used by all participants of the Personal Mobility Devices market as it covers all the major and minor aspects of the current and future competition in the market. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to make a foray into the Personal Mobility Devices market can get useful insights and effective guides from the report. On the other hand, established businesses can use the Personal Mobility Devices report to keep themselves informed with current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

FDA Releases Draft MDUFA V 2023 – Medical Product Supply Chain Week in Review | Alston and bird

Over the past few weeks, the FDA has continued to focus its attention on supply chain issues. The agency has released draft guidance on the expectations of its supply chain business partner verification system for prescription drugs and a draft of what manufacturers can expect in changes to drug fees. Device Use (MDUFA V) 2023. The Center for Devices and Radiological Health (CDRH) has released a fact sheet to inform the public of its plans to prevent future medical device shortages. The FDA has submitted its 2023 budget to Congress. In a similar vein, the FDA updated its device shortage and discontinuation list and sent a letter to medical personnel detailing retention strategies. Representatives Mike Gallagher (R-WI) and Mark Pocan (D-WI) introduced a bill in an effort to strengthen the supply chain for medical products. In other developments, investments continue to be made in cold chain monitoring as consumer lifestyles and habits change. Please see details of these and other supply chain developments below:

  • On March 10, the FDA published draft guidance on agency expectations of drug supply chain business partners, “Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs.” These follow-up guidelines clarify the expectations of manufacturers, repackers, wholesale distributors and dispensers to prepare for the implementation of Section 202 of the Security of the Medicines Supply Chain Act of 2013. Specifically, the draft guidance focuses on expectations of system requirements and what system activities it expects to see from each supply chain trading partner. Emphasis is placed on what is necessary to ensure adequate assessment processes for suspect and illegitimate products to either release them to market or safely remove them from the supply chain to prevent future distribution.
  • On March 17, the FDA published a fact sheet, “Mitigate and Prevent Medical Device Shortages and Prioritize Public Health,” designed to inform the public of the steps CDRH is taking to prevent future device shortages. Under the authority granted by the CARES Act, the FDA worked with manufacturers and other entities to expedite the review of device submissions and address supply chain vulnerabilities. Going forward, the FDA is seeking legislation requiring manufacturers to notify the agency of impending shortages, whether or not a public health emergency exists.
  • On March 21, the FDA added 0.9% sodium chloride IV lock/flush prefilled syringes (product code NGT – saline, vascular access flush) to the appliance shortage list and the device abandon list. The FDA has issued a Letter to health personnel provide recommendations, including storage strategies, for syringes. The FDA has also added certain discontinued surgical garments (product codes FME, FXP, FYF, LYU, and OEA) to the device discontinuation list.
  • On March 23, the FDA published the draft MDUFA V 2023, which outlines the responsibilities FDA commits to for manufacturers of medical products that require oversight. The agency plans to hire additional staff to facilitate compliance. Timelines attempt to manage expectations of increased submissions by providing timelines in which the agency will respond with the appropriate next step. The shared results objectives are:
    • Average total decision time for premarket approval submissions and panel pathway supplements of 290 and 285 calendar days for fiscal year 2023-2024 and for years 2025-2027, respectively.
    • For 510(k) submissions, the shared outcome targets are total decision time of 118 days for fiscal year 2023, 124 days for fiscal year 2024, and 112 days for years 2025-2027.
    • The FDA will also continue the Q-Submission program, which allows for pre-submission meetings with the agency for feedback. The FDA commits to a maximum response time of 15 calendar days for acceptability and 70 calendar days (or five before a meeting) for written comments.

    The terms of the agreement ask the FDA to commit to 90% timeliness for pre-submissions for FY2023 if the cohort is below 3,585 and 75% if the cohort is above (up to 4,300). For fiscal year 2024, the commitment is 90% for less than 4,060 and 80% for more (up to 4,300). For the years 2025 to 2027, the engagement target is 90% for a maximum of 4,300 pre-submissions. The specific objectives of the agency are stated in the letter.

  • On March 24, Rep. Mike Gallagher (R-WI), with Rep. Mark Pocan (D-WI) as co-sponsor, presented HR 7208, the Medical Supply Chain Security Act, which would amend federal food, drug and cosmetic law. As submitted, this bipartisan bill would require manufacturers to provide additional reporting on the supply and composition of drugs and medical devices and potential and impending shortages and allow expedited review of devices that traditionally require approval. prior to marketing. Manufacturers may be concerned about additional requirements that may increase the regulatory burden; however, the potential trade-off is the ability to more effectively market potential products considered life-saving. The bill was referred to the Energy and Commerce Committee.
  • On March 28, the FDA released its 2023 budget ask Congress. The application’s priorities indicate that the agency wants to increase its oversight power and is looking for ways to become more effective. Specifically, the FDA wants to require manufacturers to participate in remote interactive assessments and wants greater oversight to implement cybersecurity measures on devices, remove products from the market when no confirmatory data has been produced, removing barriers to competing generic drug approvals, overseeing dietary supplement ingredient lists, extending expiry dates for pharmaceutical products in the event of shortages, and ordering the destruction of imported products and payment for the action of destruction by manufacturers. The request also includes some elements relating to drug shortages. The agency is asking for the ability to require companies to report when a shortage of medical devices is expected and also to require companies to conduct risk assessments of their supply chain. It is expected that not all applications will be approved; however, they could be included in future legislation.
  • The FDA published its FY 2021 Medical Countermeasures Initiative (MCMi) program update. The objective of the program is to promote “the development of and access to safe and effective MCMs”. For fiscal year 2021, approximately 470 EUAs were issued for approximately 750 products. The agency has also approved, licensed, or cleared more than 1,000 generic drugs and about 500 PPE products. Additionally, in a signal that it intends to vigorously exercise its oversight authority, the FDA has identified approximately 1,500 fraudulent products. As a result, 260 warning letters were sent and 393 fraudulent test kits were reported. For this effort, the agency advises its partners in fiscal year 2021 that it has exercised its authority to “advance the FDA’s capabilities to monitor the MCM supply chain to identify product shortages and distribution of mislabelled/counterfeit products”.
  • Companies have been execution their own solutions for disruptions in the pharmaceutical supply chain. Three companies, Swoop Aero, Skyports and BD Rowa, have joined efforts to develop drone delivery systems for pharmaceuticals using healthcare technology solutions. Drone companies, Swoop Aero and Skyports, will provide the drone infrastructure. Swoop Aero has extensive mapping and video technology, and Skyports is developing vertiports for drone activities. BD Rowa will bring its automated technology to healthcare. The hope is that this joint venture can help eliminate touch points in the supply chain and improve efficiency and access to pharmaceuticals.
  • Consumption and consumer needs, including pharmaceuticals and farm-to-fork food trends, are driving demand for global monitoring of the cold chain, which encompasses the use of software and hardware to monitor refrigeration. It is estimated that by 2026, the market will reach $10.9 billion, driven largely by the United States and China, as companies invest in facilities and emerging technologies for their products. Growth is also visible in the Asia-Pacific region. With the expected growth, this is a business opportunity for manufacturers of software applications and hardware devices to grow and expand to meet incoming needs worldwide.

[View source.]

read more
Medical products

Veress Needle Market Size, Growth and Forecast

New Jersey, United States – This Veress needle market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Veress Needle Market report explores new developments, trends, and prospects, and forecasts the current status and future prospects of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations. The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses charts to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Veress Needle market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

This Veress Needle Market report also assesses the economic landscapes of the organization to better understand market dynamics at the international as well as regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Veress Needle market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also discussed in Veress Needle market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Veress Needle market report also shows how dead inventory affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and which application will take the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Swabs Market Size, Growth and Forecast

New Jersey, United States – This swab market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Swab Market report explores new developments, trends, and outlook, and forecasts the current status and future outlook of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations. The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses charts to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Swab market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=23805

Key Players Mentioned in the Swabs Market Research Report:

Puritan Medical Products, Sarstedt, MWE, SARSTEDT AG & Co, Lab M Limited., Clean Cross Co. Ltd., GPC medical ltd., Citotest Labware Manufacturing Co., Ltd. and Q-TIPS, ELMEX.

This Swabs Market report also assesses the economic landscapes of the organization to better understand the market dynamics at the international as well as regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Swab Market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Swabs Market Segmentation:

Swabs Market, By Application

• Pharmaceutical
• Microbiological
• Laboratory
• Others

Swab market, by well

• Aluminum
• Polypropylene
• Others

Swabs Market, By Test Type

• DNA test
• Urine test
• Saliva test
• Others

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also discussed in the Swabs market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Swabs market report also shows how dead inventory affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23805

Scope of Swabs Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the swabs market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the Top Five Swab Market Players?

2. How will the swab market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the swab market?

4. What are the Swab Market drivers and restraints?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Swab market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/swab-market/

Visualize the swab market using verified market intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Personal Mobility Devices Market Size, Growth and Forecast

New Jersey, United States – This personal mobility device market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Personal Mobility Devices Market report explores the new developments, trends and prospects, and forecasts the current status and future prospects of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations . The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses graphics to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Personal Mobility Devices market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

This Personal Mobility Devices Market report also assesses the economic landscapes of the organization to better understand market dynamics at international and regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Personal Mobility Devices market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also covered in the Personal Mobility Devices market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Personal Mobility Devices market report also shows how dead stock affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Surgical Swabs Market Impact and Recovery Analysis Puritan Medical Products, 3M, Dynarex, Copan Diagnostics, BD – Business Merseyside

The research report on Surgical Swabs Market is a professional asset that provides dynamic and statistical insights into the regional and global markets. It includes an in-depth study of the current scenario to safeguard market trends and prospects. Surgical swab research reports also keep track of future technologies and developments. Detailed information about new products, regional and market investments are provided in the report. This surgical swab research report also examines all the elements businesses need to gain unbiased data to help them understand the threats and challenges facing their business. The Healthcare Industry report further includes market gaps, stability, growth drivers, restraining factors, and opportunities over the forecast period.

Get a sample report with table and charts: www.a2zmarketresearch.com/sample?reportId=529762

“Surgical Swab is growing at a good CAGR over the forecast period. The growing interest of individuals in the healthcare industry is one of the main reasons for the expansion of this market. »

Major Companies in this report are: Puritan Medical Products, 3M, Dynarex, Copan Diagnostics, BD, Advacare Pharma, DLS Medical, FL MEDICAL srl

Presentation of the report:

* The report analyzes regional growth trends and future opportunities.

* Detailed analysis of each segment provides relevant information.

* The data collected in the report is researched and verified by analysts.

* This report provides realistic information on supply, demand and future forecasts.

Surgical Swabs Market Overview:

This systematic research study provides an in-depth assessment of the Surgical Swabs market while offering significant fragments of knowledge, chronic information, and measurably maintained industry-approved healthcare market conjecture. Additionally, a controlled and formal set of assumptions and strategies were used to construct this in-depth review.

Segmentation

The report offers an in-depth assessment of the Surgical Swabs market strategies, geographic and business segments of major market players.

Type

Cotton swabs, foam swabs, non-woven swabs, others

Application

Hospitals and clinics, laboratories and diagnostic centers, research institutes

During the crafting of this Surgical Swabs research report, the driving factors of the market are studied. It also provides information on market constraints to help clients build successful businesses. The report also discusses key opportunities.

Get a discount: www.a2zmarketresearch.com/discount/529762

This report provides an in-depth and broad understanding of the surgical swab. With precise data covering all the key characteristics of the current market, the report offers detailed data from key players. An audit of the state of the market is mentioned as accurate historical data for each segment is available during the forecast period. The driving force, restraints, and opportunities are provided to help provide an improved picture of this investment in the market over the forecast period 2022-2027.

Some Key Objectives of the Surgical Swabs Market Research Report:

oh Vital developments: The Custom Survey provides the critical Surgical Swabs Market improvements including R&D, shipment of new items, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working on the global and regional healthcare market.

oh Market characteristics: The report contains Surgical Swabs Market Highlights, Revenue, Boundary, Boundary Utilization Rate, Value, Net, Creation Rate, Generation, Utilization, Import, Trade, supply, demand, cost, part of the industry in general, CAGR and gross margin. Likewise, the market report offers an exhaustive investigation of the most recent elements and their patterns, as well as fragments and sub-sections of the Healthcare market.

oh Survey tools: This market report incorporates the precisely considered and assessed information about the major established players and their extension in the Surgical Swabs market by methods. Systematic tools and methodologies for example Porter’s Five Powers Survey, Possibility Study, and many other statistical survey methods have been used to analyze the development of major players working in the Surgical Swabs market .

oh Convincingly, the Surgical Swabs report will give you an unequivocal perspective on every market reality without the need to allude to any other research report or information source. This report will provide you all with the realities of the past, present and future fate of the healthcare market.

Buy exclusive reports: www.a2zmarketresearch.com/buy?reportId=529762

If you have any special requirements, please let us know and we will offer you the report you want.

Contact us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[email protected]

+1 775 237 4147

Related reports:

Patent and Trademark Renewal Services Market Share Forecast Global Impact of Competitors

Global Industrial Analytics Market Research Forecast Impact

Global Cleanroom Robots Market Research Forecast Impact

Emulsion Explosives Market Impact, Share Discount Industry Competitors Globally | Orica, IPL, MAXAM, AEL

Emulsion Explosives Market 2022: Business Development, Size, Share and Opportunities 2026

Targeted Therapeutics Market 2022

Reabastecimiento de combustible aire-aire Market 2022: Desarrollo de Negocios, Tamaño, Participación y Oportunidades 2026 Omega Air Refueling Services, Eaton Corporation, Airbus SAS

Spatial Augmented Reality (SAR) Market 2022: Business Development, Size, Share and Opportunities 2026 Intermap Technologies, Autodesk, Cybercity 3D

Dispositivos de oncología interventionista Market 2022: Desarrollo de Negocios, Tamaño, Participación y Oportunidades 2026 Cook Medical, Merit Medical Systems, Boston Scientific Corporation

read more
Medical products

Laser manufacturing of high precision medical products

By Matthew Nipper, Spectrum Plastics Group, Director of Engineering

Laser micromachining is one of the highest precision processes used in the manufacturing of medical devices. In fact, lasers are often the only option capable of producing certain delicate features, especially in thin or sensitive materials. Lasers can quickly cut micron-sized features to sub-micron tolerances without defects, thereby reducing or eliminating secondary finishing processes, shortening cycle times and accelerating time to market. Because of these advantages, lasers are quickly becoming the preferred method for micro-machining miniaturized and/or complex parts and products for medical devices, in virtually any shape or pattern.

Innovative product designs that require microscopic features are often best produced using laser machining, for example, catheters, medical balloons, and devices for neurovascular, cardiovascular, and diagnostic procedures. Features produced in polymers can be as small as 10 microns in width, with tolerances as tight as 1-2 microns.

Polymers are the material of choice for many medical devices. These materials are mechanically robust, bioinert and have excellent insulating properties. Polymers can be engineered to exhibit specific mechanical and chemical characteristics, to improve biocompatibility and performance, and can be extruded, injection molded or additively manufactured. Virtually any thermoplastic or thermoset polymer material can be laser processed with high precision, including polycarbonate, polyurethanes, ABS, FEP, polyamides, polyimides, PEEK, PTFE, PMMA, polyester , nylon, PE and acrylics.

laser methods

As products become smaller and more complex, engineers must use their technical skills, materials knowledge, and experience to design processes that can create tiny, high-precision features that enhance product functionality, which can ultimately improving or saving the lives of patients.

Here are examples of commonly used high-precision laser methods:

laser removal

Lasers can be programmed to remove or “vaporize” material from surfaces with sub-micron precision. Ablation selectively removes substrate or coating layers from the surface of fabricated parts, with little or no negative thermal or structural impacts on the surrounding material.

Laser cut

Laser cutting is ideal for manufacturing/industrial applications that require a powerful, highly precise cutting tool that creates sharp features on a microscopic scale. As products become smaller, with more functionality, complexity and tight tolerances, laser cutting is often the only method that can produce the high precision features these devices require.

Laser drilling

Many manufactured parts today require microscopic features that can only be created with laser drilling. This highly adaptable, versatile and reliable microfabrication process is used in a wide range of industries. Laser fabrication and post-laser processing can be customized to meet unique drilling needs, optimizing applications such as micro-holes, hole arrays, blind holes and specialty portals. Micron-scale holes can be laser drilled in a variety of patterns with the utmost precision, with no burrs or residual material to clog the holes.

wire stripping

Wire stripping removes sections of insulation or shielding from wires and cables to provide electrical contact points for termination. Conventional stripping methods make physical contact with the conductor, which can damage the wire and slow processing speed. Laser wire stripping is much faster, offers excellent accuracy and process control, and eliminates wire contact, allowing the processing of gauges as small as 46 AWG (0.0015 inches in diameter).

Ultra-fast lasers

Ultra-fast lasers are in high demand due to their speed, accuracy, and lack of thermal or structural damage to the material being processed. With an average pulse width of 150 femtoseconds (150 quadrillionths of 1 second), there is virtually no heat transfer beyond the dimensions of the cut, making it a “cold” process. Therefore, secondary processing is usually not required to remove burrs from cutters or improve edge quality, saving time and money.

Components and laser technology

Precision laser processing can be used for extruded medical tubing, catheters and drug delivery products, medical balloons, injection molding and flexible films. For example:

  • Extruded medical tube. Lasers are high-precision machining instruments that cut micron-scale features in extruded tubing that enable specific medical applications, such as intravascular delivery of drugs or stents. Extruded medical tubing is a commonly used component in medical devices. It is made from a variety of materials and in a wide range of shapes and sizes. Important chemical and mechanical properties include heat and chemical resistance, lubricity, flexibility, kink resistance, and drug eluting capabilities.
  • Catheter technologies. The lasers, which offer high speeds, incredible precision and the ability to process without thermally altering the surrounding material, are ideal for removing material by ablation or drilling a variety of micron-sized features in tubing. catheter and other materials. As medical catheters become smaller and more complex, lasers are often the only manufacturing technology capable of providing the precision needed.
  • Medical balloons. Lasers play a vital role in creating detailed, high-precision medicine ball features that no other method can replicate, including; texturing, grooving and section thinning. With the latest laser technologies, tools, and materials, medicine balloons can be fabricated with microscale features, from a wide variety of materials, for neurovascular, cardiovascular, gastrointestinal, urology, and catheterization procedures. increasingly innovative.
  • Injection molding. For injection molded products, lasers can be used to create micron-sized features in molds, process molded ophthalmic implants, and improve osseointegration of injection molded bioresorbable implants. Because ultra-fast lasers cause no thermal damage, they are ideal for treating sensitive implantable and bioresorbable materials.
  • Flexible films. Laser processing can be used for a variety of film applications. For example, lasers can be used to create surface micro-texture patterns on thin films increasing adhesion in delicate bonding applications. Lasers are also ideal for drilling small features, such as dense arrays of holes in filters or spargers. These are often made from thermoplastic materials, which are very heat sensitive.

Spectrum laser processing

As a full-service laser solutions provider, Spectrum can manufacture high-precision parts to exact specifications in the most efficient and cost-effective manner. Spectrum excels at turning even seemingly impossible designs into high-value products that exceed customer expectations.

Not only is Spectrum a contract manufacturer of high precision laser products, but we also supply ready made laser die tubes and laser cut marking tapes online at online store.spectrumplastics.com, which can be used to speed up the development phase of your next project. For more information on Spectrum’s services and laser processing capabilities, visit www.spectrumplastics.com or call 404-564-8560.

Content sponsored by Spectrum Plastics Group

read more
Medical products

Counterfeit medical products increased by 47% between 2020 and 2021, report says

Fueled by the COVID-19 pandemic, incidents of substandard and falsified (SF) medical products increased nearly 47% between 2020 and 2021, according to a report by the Association of Authentication Solution Providers ( ASPA), a non-profit organization that deals with anti-counterfeiting awareness.

The report said the incidents found were mostly related to medical products related to COVID-19, including vaccines, drugs, COVID test kits, antibiotics, face masks and disinfectants. During the peak of COVID-19, incidents of SF medical products were seen in 23 out of 29 states and 7 union territories of India.

“Criminals have seen the pandemic crisis as an opportunity to sell more and more substandard and falsified medical products, taking advantage of the vulnerability of people in need. The huge negative impact of the huge increase in circulation counterfeit medicines and essential medical products on the The fight against the COVID-19 pandemic has gone almost unnoticed.It is unfortunate that criminals manufacture ineffective or harmful products in packages that appear identical to the genuine products, which makes them difficult to detect,” said Nakul Pasricha, ASPA President.

“The circulation and use of these SF medical products violates the right to health and slows down the pace of providing the quality health services that people deserve. It is high time to act firmly to stem this threat. If preventive measures are taken now, we will be in a better position to provide effective healthcare to patients,” Pasricha added.

Despite the guidelines, the circulation of SF medical products has been an under/under-treated problem in India. The government has recently taken the decision to make QR codes on Active Pharmaceutical Ingredients (APIs) mandatory. APIs are the main raw materials used in the manufacture of medicines – capsules, tablets, syrups and others.

National authentication and traceability projects have seen an international trend in recent years, with China, Brazil, Turkey, the United States and the EU being the pioneers in this field. It has helped these countries reduce the parallel market in various industries, improve tax collection, and significantly reduce business losses from counterfeit products and illegal trade. India should also implement these measures in other sectors to join the league of advanced digital economies, observes the report.

Despite the Union government’s efforts to deliver real coronavirus vaccines through transparent procurement and procurement systems and the technology-backed CoWin administration platform, the global monitoring and surveillance system The World Health Organization (WHO) control for substandard and counterfeit medical products in August 2021 had also identified fake versions of the COVID-19 Covishield vaccine in India and Uganda. The apex global public health agency also this month reported the circulation of a fake drug Remdisvir used for the management of COVID-19.

Also read: CBI has made ‘substantial progress’ in investigation of NSE collocation cases: FM Sitharaman

Also Read: PE/VC Investors Raise a Record $41.3 Billion Through Exits in 2021

read more
Medical products

Hot Extrusion Medical Products Market Trend, Impact of COVID-19, Current Industry Figures with Demand by Countries and Future Growth 2026

The latest economic intelligence report on Hot Extrusion Medical Products Market elaborates on the factors responsible for the growth of the industry such as key growth enablers, restraints, and opportunities. Moreover, it expands past years data and current business scenario to infer the performance of the industry over the period 2020-2025.

To calculate the size of the industry on a global level, an exhaustive analysis of how this business sphere operates on a regional and national level is incorporated into the report. Going further, the research literature scrutinizes the dominant players and assesses the strategies adopted by them to stay in the competitive arena. Additionally, the current and projected impact of the Covid-19 pandemic was taken into consideration with a focus on revenue generation prospects and methodologies to deal with the changing landscape.

Main highlights of the table of contents:

Request a sample copy of this report @ https://www.runningafrica.com/request-sample/2952

Product land

  • Product range: Films, taste masking, drug eluting devices and others
  • Forecasts of the growth rate of each product type over the forecast period.
  • Returns earned and market share held by each product category.

Scope

  • Application spectrum: Research laboratory, contract manufacturing organization and pharmaceutical companies
  • Estimates of product demand and market share for each type of application.
  • Annual growth rate of each application segment over the forecasted schedule.

Regional outlook

  • Geographic bifurcation: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.
  • Figures relating to total sales and net income accumulated by each regional market.
  • Annual growth rate of each region over the forecast period.

Competitive landscape

  • Main contenders: AbbVie Formex BASF Pharma Omipa Biogrund Lubrizol
  • Assessment of the market concentration ratio.
  • Portfolio of products and services of listed companies.
  • Manufacturing units of key players in operating regions.
  • Financial attributes such as pricing model, sales, profit margins, and market share for each company.
  • Updates on the latest mergers, acquisitions and expansion proposals.

To summarize, the report authors have inspected the Hot Melt Extrusion Medical Devices market through several segmentations followed by in-depth discussion on industry supply and sales channel including upstream basics and downstream to help companies effectively deploy their products and solutions to market. .

The Hot Extrusion Medical Products market report is summarized as follows:

Industry with market definition, key elements such as market restraints, drivers, potential opportunities, challenges, Medical Hot Melt Extrusion Products market trends, etc.

Hot Extrusion Medical Products Market Segmentation Based on Product, Application, Geographic Region and Competitive Market Share

Hot Extrusion Medical Products Market Size, Approximations, Forecast for the said Period

Hot Melt Extrusion Medical Products Market Distribution Channel Assessment

Competitive analysis of crucial Hot Melt Extrusion Medical Products Market manufacturers, trends, company profiles, strategies, etc.

Factors responsible for the growth of the hot extrusion medical products market

The in-depth geographic market assessment of the leading hot melt extrusion medical products market

Customization request on this report @ https://www.runningafrica.com/request-for-customization/2952

read more
Medical products

Swabs Market Size and Forecast

New Jersey, United States,- The latest research report provides a comprehensive assessment of the swab market for the forecast year 2022-2029, which is beneficial for businesses regardless of their size and revenue. This survey report covers key market insights and industry approach related to COVID-19 (Omicron) in the coming years. The Swab market report provides data and information on investment structure development, technological enhancements, market trends and developments, abilities, and in-depth information about major Swab market players. The market strategies followed globally with respect to the current and future scenario of the industry have also been detailed in the study.

The report begins with a brief introduction and overview of the Swabs market, current market landscape, market trends, major market players, product type, application, and region. It also covers the impact of COVID-19 (Omicron) on Swabs Market trends, future forecasts, growth opportunities, end-user industries, and market players. It also provides historical data, current market scenarios and future information on the Swab Market. This study provides a comprehensive understanding of the market value with product price, demand, gross margin, and supply of the Swabs market. The Competitive Perspective section of the report provides a clear insight into the market share analysis of key industry players.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=23805

Key Players Mentioned in the Swabs Market Research Report:

Puritan Medical Products, Sarstedt, MWE, SARSTEDT AG & Co, Lab M Limited., Clean Cross Co. Ltd., GPC medical ltd., Citotest Labware Manufacturing Co., Ltd. and Q-TIPS, ELMEX.

Swabs market is segmented by Product and Type. All of these segments were examined individually. The detailed study helps to evaluate the factors affecting the Swabs market. Experts analyzed the nature of development, investments in research and development, changing consumption patterns and the growing number of applications. In addition, analysts have also assessed the development of the economy around the Swab market, which is likely to impact its price.

Swabs Market Segmentation:

Swabs Market, By Application

• Pharmaceutical
• Microbiological
• Laboratory
• Others

Swab market, by well

• Aluminum
• Polypropylene
• Others

Swabs Market, By Test Type

• DNA test
• Urine test
• Saliva test
• Others

The regional analysis section of the report allows players to focus on high growth regions and countries that could help them expand their presence in the swabs market. Besides expanding their presence in the swabs market, regional analysis helps players increase their sales while gaining a better understanding of customer behavior in specific regions and countries. The report provides CAGR, revenue, production, consumption and other important statistics and figures in global and regional markets. It shows how different types, applications, and regional segments of the Swabs market are progressing in terms of growth.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23805

Scope of Swabs Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the swabs market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five Swab market players?

2. How will the swab market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the Swab market?

4. What are the Swab Market drivers and restraints?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Swab market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/swab-market/

Visualize the swab market using verified market intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Scoliosis Management Market 2022-2030, by Top Key Players – Aspen Medical Products, Boston Orthotics & Prosthetics, LA Brace, Charleston Bending Brace, Spinal Technology

The Scoliosis Management Market report is a perfect basis for people who are looking for comprehensive study and analysis of the Scoliosis Management Market. This report contains study and miscellaneous information which will help you to understand your niche and focus major market channels in the regional and global Scoliosis Management market. To understand the competition and take action based on your key strengths, market size, current and future years demand, supply chain information, business concerns, competitive analysis and prices as well as supplier information will be presented to you. The report also includes information about the major market players, Scoliosis Management applications, its type, trends and overall market share.

To put your business plan into action based on our detailed report, you will also receive comprehensive and accurate forecasts and projected figures for the future. This will provide an overview of the market and help design solutions to leverage key profitable elements and gain market clarity to develop strategic plans. The data present in the report comes from different publications in our archives as well as many reputable paid databases. Moreover, the data is gathered with the help of dealers, raw material suppliers, and customers to ensure that the end result covers every minute detail regarding the Scoliosis Management market, making it a perfect tool for serious buyers of this study.

Scoliosis Management Market: Competition Landscape

The Scoliosis Management Market report includes information on product launches, sustainability, and outlook from key vendors including: (Aspen Medical Products, Boston Orthotics & Prosthetics, LA Brace, Charleston Bending Brace, Spinal Technology, Inc., Optec USA, Inc., Pro-Tech Orthopedics, DJO Global, UNYQ, Lawall Prosthetics and Orthotics, Chaneco, Trulife, Össur, Ortholutions GmbH & Co. KG, Ottobock)

Click the link for a free sample report @ https://crediblemarkets.com/sample-request/scoliosis-management-market-385291?utm_source=Amruta&utm_medium=SatPR

Scoliosis Management Market: Segmentation

By types

Thoraco-lumbo-sacral orthosis (TLSO)
Sacral Lumbar Thoracic Cervical Orthosis (CTLSO)
Lumbosacral orthosis (OSL)
Scoliosis brace
Others

By apps

Online pharmacies
Hospitals & Clinics
Retail pharmacies

Scoliosis Management Market: Regional Analysis

The whole regional segmentation has been studied based on recent and future trends, and the market is forecast through the forecast period. The countries covered in the regional analysis of the Global Scoliosis Management Market report are USA, Canada & Mexico North America, Germany, France, UK, Russia , Italy, Spain, Turkey, Netherlands, Switzerland, Belgium and the rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia Pacific (APAC) in Asia Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of the Middle East and Africa (MEA), and Argentina, Brazil and the rest of South America as part of South America.

Key benefits of the report:

  • This study presents the analytical representation of the global Scoliosis Management industry together with current trends and future estimations to determine impending pockets of investment.
  • The report presents information related to key drivers, restraints, and opportunities, along with a detailed analysis of the global Scoliosis Management market share.
  • Current market is quantitatively analyzed from 2021 to 2028 to highlight the growth scenario of the global Scoliosis Management market.
  • Porter’s five forces analysis illustrates the power of buyers and suppliers in the marketplace.
  • The report provides a detailed analysis of the Global Scoliosis Management Market based on the competitive intensity and how the competition will shape in the coming years.

Directly buy this market research report now @ https://crediblemarkets.com/reports/purchase/scoliosis-management-market-385291?license_type=single_user;utm_source=Amruta&utm_medium=SatPR

Main points covered in the table of contents:

Market overview: It includes six sections, research scope, key manufacturers covered, market fragments by type, Scoliosis Management market shares by application, study objectives and years considered.

Market landscape:Here, the global Scoliosis Management market opposition is dissected, by value, revenue, transactions, and pie slice by organization, market rate, fierce circumstances Latest landscape and patterns, consolidation, development, obtaining and parts of the entire industry from top organizations.

Manufacturer Profiles: Here, the driving players of the global Scoliosis Management market are considered dependent on region of deals, key elements, net benefit, revenue, cost, and creation.

Market Status and Outlook by Region: In this segment, the report examines net benefit, transactions, revenue, creation, global industry share, CAGR and market size by region. Here, the Global Scoliosis Management Market is thoroughly examined based on regions and countries like North America, Europe, China, India, Japan, and MEA.

Application or end user: This segment of the exploration study demonstrates how extraordinary end-customer/application sections are added in the global Scoliosis Management market.

Market forecast: Production side : In this part of the report, the creators focused on the conjecture of creation and creation esteem, the gauge of the main manufacturers and the estimation of the creation and creation esteem by type .

Research results and conclusion: This is one of the last segments of the report where the findings of the investigators and the end of the exploratory study are given.

Answers to key questions in the report:

  • What will be the market development pace of the Scoliosis Management market?
  • What are the key factors driving the Global Scoliosis Management Market?
  • Who are the main manufacturers on the market?
  • What are the market openings, market risks and market outline?
  • – What are sales volume, revenue, and price analysis of top manufacturers of Scoliosis Management market?
  • Who are the distributors, traders and dealers of Scoliosis Management Market?
  • What are the Scoliosis Management market opportunities and threats faced by the vendors in the global Scoliosis Management Industries?
  • What are the deals, revenue, and value review by market types and uses?
  • What are the transactions, revenue and value review by business areas?

About Us

Credible Markets is a new era market research company with a firm grip on the pulse of global markets. Credible Markets has become a trusted source for business market research needs in a short period of time. We’ve partnered with leading market intelligence publishers and our report pool coverage spans all key industry verticals and thousands of micro-markets. The massive repository allows our clients to choose from recently released reports from a range of publishers who also provide in-depth analysis by region and country. Moreover, pre-booked research reports are among our best offers.

The collection of market intelligence reports is regularly updated to provide visitors with quick access to the latest market information. We provide round-the-clock support to help you reuse search parameters and benefit from a full range of reserved reports. After all, it’s about helping you make an informed strategic decision on purchasing the right report that meets all your market research demands.

Contact us

Credible market analyzes
99 Wall Street 2124 New York, NY 10005
E-mail: [email protected]

read more
Medical products

South Korea to deliver non-lethal military medical products to Ukraine

On the 15th, the South Korean government said it would provide non-lethal military supplies to Ukraine, which is fighting the Russian incursion. “The government has agreed to deliver non-lethal military supplies to Ukraine,” Boo Seung-chan, spokesman for the Ministry of National Defense, said during a regular briefing. “As for details, including transportation and other matters, conversations are ongoing,” spokesman Boo said. A total of 20 goods will be sent to Ukraine. Military supplies include combat helmets, blankets, emergency snacks and military folding beds, which total 12 items. Medical supplies are among the other items. The total amount of supplies provided to Ukraine is estimated at around 1 billion won.

Military supplies should be shipped by air. From this week or next week at least, the supplies will be sent to Ukraine. Meanwhile, the Ministry of National Defense announced on the 15th that a direct communication channel with the Russian Navy and Air Force would be opened. Spokesman Boo said: “We were informed earlier this year that the Russian communication network has been installed. The official opening is expected to take place after a test call between the two countries.

Summary of news:

  • South Korea to deliver non-lethal military medical products to Ukraine
  • Check out all the news and articles from the latest global news updates.
Disclaimer: If you need to update/edit this article, please visit our Help Center. For the latest updates, follow us on gohohgIand News
read more
Medical products

The Definitive Guide 2021 – Second Sight Medical Products LLC, Nano Retina Ltd., Nidek Co. Ltd., MetaModal LLC, Bionic Vision Technologies, Biomedical Technologies SL – The Bollywood Post

The Global bionic eye market report focused on the comprehensive analysis of the current and future outlook of the Bionic Eye industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics and forecasts for various segments and sub-segments considering macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements of the Bionic Eye market has been performed to calculate the growth rates of each segment and sub-segments.

The influence of the latest government directives is also analyzed in detail in the report. It studies the Bionic Eyes market’s trajectory between forecast periods. The cost analysis of the Global Bionic Eyes Market has been done while considering manufacturing expense, labor cost, and raw materials along with their market concentration rate, suppliers, and price trend.

Sample Free Report + All Related Charts & Graphs @ https://www.adroitmarketresearch.com/contacts/request-sample/1651?utm_source=PT14

Major Bionic Eyes Market Players Including:

Second Sight Medical Products LLC, Nano Retina Ltd., Nidek Co. Ltd., MetaModal LLC, Bionic Vision Technologies, Biomedical Technologies SL, Monash Vision Group and Pixium Vision

This report in this research study provides the current economic state of the Bionic Eye industry in both local and . The market study is a valuable source of information for market players including policy makers, professionals, R&D experts, academics, suppliers, manufacturers and all market players interested in the Eye Care market bionic. The strongest single-level segments of the Bionic Eye market are highlighted in the report, representing their market share, market size, annual sales, revenue in terms of Million US$ and future scope of these markets.

In addition, new technologies incorporated into these segments to increase productivity and efficiency are studied in detail. Different standard methodologies are applied to collect the data and measure the current status and development of the Eye Bionics Market. The specific objective of data collection is to analyze the most innovative and productive sectors of the Bionic Eye market. The research is supplemented with data from various surveys and industry associations. The report presents all important market information such as business scenarios, cost structure, cost benchmarking, top performing application and product segments and those about to experience growth quick. The report estimates the revenue generated by these products and their contribution to market output.

The report discusses the segments and its products or services that are dominating the market and have immense growth potential in the market. Also, the production cost, competition, and which companies are investing significant funds to make the product or service more attractive are detailed in the report. Data and product or service distribution and market response are included in the report. Price patterns, target markets for the same product and reasons for price fluctuations for the same product or service in different markets are discussed in the report.

Bionic Eyes Market Segment By Type:

By technology (electronic, mechanical) Type (external eye, implanted eye) End use (hospitals, eye clinics, other)

Bionic Eyes Market Segment By Application:

N / A

Why B2B companies around the world rely on us to grow and maintain revenue:

• Obtain a clear understanding of the Bionic Eye market, how it works and the different stages of the value chain.
• Understand the current market situation and future growth potential of the Eye Bionics Market throughout the forecast period.
• Develop marketing strategies, market entry, market expansion and other business plans by understanding the factors influencing market growth and buyer purchasing decisions.
• Understand your competitors’ business structures, strategies and prospects and react accordingly.
• Make more informed business decisions using insightful primary and secondary research sources.

This report provides:

A detailed overview of the global Bionic Eye Market.
Assessment of global industry trends, historical data from 2011, projections for the coming years and anticipation of compound annual growth rates (CAGR) by the end of the forecast period.
Discoveries of new market insights and targeted marketing methodologies for Global Bionic Eye
Discussion on R&D and demand for new product launches and applications.
Varied company profiles of major industry players.
The composition of the market, in terms of dynamic molecule types and targets, highlighting the key industry resources and players.
The growth of patient epidemiology and market revenue for the global market and among key players and market segments.
Study the market in terms of generic and premium product revenues.
Determine business opportunities in the market sales scenario by analyzing trends in licensing and co-development agreements.

Contents:

1 Scope of the report
1.1 Market Overview
1.2 Research objectives
1.3 Years considered
1.4 Market research methodology
1.5 Economic indicators
1.6 Currency considered
2 Executive Summary
3 Global Bionic Eye by Players
4 Bionic Eye by Regions
4.1 Bionic Eyes Market Size by Regions
4.2 Americas Bionic Eyes Market Size Growth
4.3 APAC Bionic Eyes Market Size Growth
4.4 Europe Bionic Eyes Market Size Growth
4.5 Middle East & Africa Bionic Eyes Market Size Growth
5 Americas
6 APACs
7Europe
8 Middle East and Africa
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market trends
10 Global Bionic Eyes Market Forecast
Analysis of the 11 key players
12 Research findings and conclusion

Do you have a specific question or requirement? Ask our industry expert @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1651?utm_source=PT14

ABOUT US:

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of businesses, manufacturing companies, product/technology development institutions and industry associations who need to understand market size, key trends, participants and future prospects of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help them create opportunities that increase their revenue. We follow a code – Explore, learn and transform. At our core, we are curious people who enjoy identifying and understanding industry patterns, creating insightful study around our findings, and crafting lucrative roadmaps.

CONTACT US:

ryan johnson
Global Account Manager
3131 McKinney Ave Ste 600, Dallas,
TX 75204, USA
Phone number: USA: +1.210.667.2421/ +91 9665341414

read more
Medical products

Hot Extrusion Medical Products Market Trends by 2026 with Major Key Players – BASF Pharma, Formex, Omipa, Biogrund, AbbVie and Lubrizol

This global Hot Extrusion Medical Products Market is an attempt to analyze the global opportunities in the field of the global industry, its current capabilities and the potential of selected countries and regions in the market. The report to businesses and companies provides a better understanding of their ability to invest in the market. The report provides the most business-critical issues of the leading organizations in the Global Hot Melt Extrusion Medical Devices Market globally. The report aims to explain to market players the business outlook, key developments and drivers of the global hot melt extrusion medical products market.

The challenges and opportunities of the Hot Melt Extrusion Medical Products market are presented in the report. The report highlights critical value chain destinations of the global hot extrusion medical products market. The report also highlights issues and concerns of local and foreign market players and provides recommendations for policy makers and actions for industrials to grow in the global Medical Hot Melt Extrusion Products market. The report makes projections based on the current global economic scenario. The uncertainties and difficulties faced by the Hot Extrusion Medical Devices market players are included.

Request a sample report: https://www.orbisresearch.com/contacts/request-sample/6239962?utm_source=Sgir

Major Players of Global Hot Extrusion Medical Products Market:

AbbVie
Formex
BASF Pharmaceuticals
omipa
Biogrund
Lubrizol

Points covered in the Hot Melt Extrusion Medical Products Market report:

• Overview of the global hot melt extrusion medical products market by studying different segments.
• The employment contribution of the global hot melt extrusion medical products market to economies around the world.
• The economic contribution of the global hot melt extrusion medical products market to economies around the world.
• Key players’ marketing approaches to attract foreign markets for hot extrusion medical products.
• Domestic and global regulatory constraints faced by the Hot Extrusion Medical Products market players.
• Global and/or regional trends in the medical hot melt extrusion industry in selected countries.
• Financial information and capital market information of hot melt extrusion medical products are provided in the report.

Type of hot extrusion medical products industry includes:

Movies
Taste masking
Drug eluting devices
Others

Hot extrusion medical products industry applications consist of:

Research Laboratory
Contract manufacturing organization
Pharmaceutical companies

This report analyzes the recent Hot Melt Extrusion Medical Devices industry trends along with the production chain, consumption patterns, regional and international level business activities and other industry related fields. The report emphasizes the potential of the global hot extrusion medical products market in developed countries. The data used to study all the factors of the global hot extrusion medical products market uses data from 2010 to 2020 also considering the latest year for performing the analysis. The report compares the growth rates of the strongest segments and consumption and production patterns. The report provides a detailed study of the performance of major Hot Melt Extrusion Medical Products market on the domestic and global fronts. Additionally, the report highlights the countries with the greatest potential for future growth.

Investigate before accessing the report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/6239962?utm_source=Sgir

Why Buy This Hot Melt Extrusion Medical Products Market Report?

• This report helps the Hot Melt Extrusion Medical Products market players to strengthen their market position, improve their business, reach markets and gain competitive advantages.
• The Hot Melt Extrusion Medical Products report focuses on the strategies implemented by manufacturers in their operations, purchasing, and supply chain management.
• The report leverages the capabilities of Hot Melt Extrusion Medical Devices market players to seize new opportunities.
• The report offers supply chain visibility to enable improvisation for Hot Melt Extrusion Medical Devices market players who wish to expand their business into new international markets.
• The Hot Melt Extrusion Medical Products report compares the growth rates of the strongest segments and consumption and production patterns.
• The supply chain visibility provided in this report aids in understanding the drivers of the Global Hot Melt Extrusion Medical Devices Market and helps them maintain their leading position in the Global Hot Melt Extrusion Medical Devices Market over the course of years of forecasting.

About Us:

Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

Contact us:

Hector Costello
Senior Manager – Client Engagements
Central Highway 4144N,
Suite 600, Dallas,
Texas – 75204, USA
Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155
Email ID: [email protected]

Buy the full report at: https://www.orbisresearch.com/contact/purchase-single-user/6239962?utm_source=Sgir

read more
Medical products

This week’s big story: Stop banning medical product exports, report says

A new report from the National Academies of Sciences, Engineering and Medicine in the United States calls for an international treaty to prevent countries from banning exports of medical products, in a bid to prevent supply shortages.

The paper, called Strengthen the resilience of the country’s medical product supply chains, cites the restrictions that a number of countries have imposed on the export of medical products during the pandemic. Many of these still remain, as according to the World Trade Organization (WTO), 45 countries still had more than 70 restrictions in place in 2021, many of which applied to medical products.

The authors of the article go on to warn that export restrictions “can be dangerously counterproductive. What makes sense in an isolated emergency can be seriously detrimental in a global crisis.”

Globalization and the pharmaceutical industry

The pandemic has highlighted how dependent countries have become on imports to ensure they can meet domestic drug demand. China produces most of the active pharmaceutical ingredients (APIs) needed to manufacture common drugs such as penicillin and acetaminophen. India, in turn, relies heavily on imports from China to manufacture drugs for the US market, where it is the largest supplier of generic drugs.

The Russian invasion of Ukraine also raises fears that global supply chains could be disrupted. Russia signed an executive order this week banning exports of medical products from a list of countries it has deemed “unfriendly”, including the UK, EU, Canada, New Zealand, US States, Switzerland and Japan. This ban will apply to products stored in warehouses in Russia, or which pass through customs controls.

The need for collaboration

In the paper, the authors urge the US federal government to consider a multilateral agreement with major exporters of medical products that would be overseen by the World Trade Organization (WTO). They also suggest that the WTO could impose sanctions on countries that have not joined the agreement.

The 336-page document calls for greater international cooperation to prevent supply chain disruptions. It also contains detailed recommendations to prevent national shortages, such as pharmacy teams working with hospitals to inform them of a potential shortage and suggest alternative forms of treatment.

Earlier this year, the US Food and Drug Administration (FDA) made permanent its guidance to prevent supply shortages in the wake of the Covid-19 pandemic. This included requiring manufacturers to submit a notification at least six months before a product is permanently discontinued.

Also in the news:

google launched a new campaign featuring women entrepreneurs in Africa, including the story of Vivian Nwakah who launched Medsaf, a pharmaceutical supply chain solution to help Nigerians access quality pharmaceutical healthcare.
Pharmaceutical Logistics IQ has launched a new survey with SkyCell to get your perspective on the issues facing pharmaceutical supply chains today and the role hybrid container solutions could play. Share your thoughts with us and enter our draw to win a $100 Amazon gift card.

Get exclusive access to articles, reports, videos, interviews, webinars and other members-only premium content from industry experts and thought leaders by signing up for Pharma Logistics IQ here.

read more
Medical products

“Shortage” of medical products in Ukraine – WHO

There is a “shortage” of essential medical supplies in Ukraine, health officials have warned in condemning at least 16 attacks on health services in the country.

The World Health Organization (WHO) said there had been 16 attacks on health services, including damage to facilities and hospitals, as well as the commandeering of ambulances and the hijacking of ambulances from ’emergency.

These attacks left nine dead and 16 injured, according to the WHO.

The European branch of the global health body also said there was a shortage of essential supplies in Ukraine, including oxygen, insulin, surgical supplies and blood.

(PA graphics)

(PA graphics)

Experts have also warned that Covid deaths will rise due to a lack of oxygen supply in the region – with 731 deaths reported last week.

Meanwhile, health officials have raised concerns about cases of hypothermia – where a person’s body temperature becomes dangerously low – among refugees in cold weather.

They also highlighted fears over maternity care for pregnant Ukrainian women, with around 80,000 women expected to give birth in the country in the next three months.

During a press briefing on the humanitarian crisis that resulted from the conflict, Dr Hans Henri Kluge, WHO Regional Director for Europe, said: “It is now 13 days since the military offensive began in Ukraine, and today in the country, we see a healthcare system under great pressure, and beyond its borders, the fastest growing refugee crisis in Europe for more than 75 years.

“Life-saving essential medicines, such as oxygen and insulin, personal protective equipment, surgical supplies, anesthetics and safe blood products, are in short supply.”

He said 76 tons of trauma and emergency health supplies are in transit in Ukraine, with more on the way.

WHO is also working to ensure that refugees crossing the border have access to health care and that those who remain in the country also receive support.

Dr Kluge added: “It should not be necessary to say that health workers, hospitals and other medical establishments should never be a target at any time, including during crises and conflicts. To date, we have 16 confirmed reports of health incidents in Ukraine, with more being verified.



We know from previous conflicts that when more doors close, health diplomacy becomes key

Dr Hans Henri Kluge, WHO Regional Director for Europe

“WHO strongly condemns these attacks on health services.”

Dr Catherine Smallwood, WHO Europe Incident Manager for Covid-19, said: “We have documented or verified 16 attacks with varying levels of certainty.

“These have, to our knowledge, caused at least nine deaths and 16 injuries, and they have occurred in various major cities and around conflict zones.

“This includes direct attacks on health facilities or hospitals that have been damaged.

“It also includes the appropriation of health infrastructure such as ambulances, it includes the diversion of ambulances and their use for purposes not directly related to the provision of health care.”

Dr Kluge praised Ukrainian health officials for continuing to monitor the spread of Covid-19, but added that “731 Covid-19 deaths were reported to WHO from Ukraine last week, and unfortunately, that number will increase as oxygen shortages continue.”

He said: “Older people will be disproportionately affected because their access to healthcare is disrupted and because only a third of those over 60 are fully protected with a full course of vaccines.”

Asked about the humanitarian corridors, Dr Kluge said: “Time is running out, so in that sense, willy-nilly, we need to get whatever we can to the affected areas.

(PA graphics)

(PA graphics)

“We know from previous conflicts that when more doors close, health diplomacy becomes key.

“Our principle is health for all and our top priority is to get life-saving humanitarian medical supplies to people in need.”

On maternity care, Dr Isabel Yordi Aguirre, WHO Europe Technical Officer for Gender and Human Rights, said: “The estimate from UNFPA (United Nations Population Fund ) that 80,000 women will give birth in the next three months in Ukraine means that these women may have gone from a life-changing experience to a life-threatening experience.

“The UNHCR (UN Refugee Agency) predicts that by July this year we will have four million refugees, which will mean around 1,000 births per week that will be anticipated.

“That’s why we must ensure that sexual and reproductive health services are at the heart of our assistance to women – refugees crossing borders and women left behind.”

Tarik Jasarevic, WHO Field Representative in Ukraine, said at the briefing: “It is heartbreaking to see hundreds, if not thousands, of people on the border between Ukraine and Poland – mainly women and children seeking treatment and seeking safety.



Health facilities need supplies, they need electricity, they need water

Tarik Jasarevic, WHO representative in Ukraine

He added: “In the east, hundreds of health facilities are either areas that have changed control or are along the battle lines or within 10 kilometers of them.

“Health facilities need supplies, they need electricity, they need water.

“I have just spoken to a doctor who is in contact with his colleagues in the most affected areas in the East and she was telling me that people cannot access health centers and hospitals because of security and the structural damage.

“And this is not just the case for patients but also for health workers who risk their lives to get to their place of work.”

read more
Medical products

Stereotactic Biopsy Table Market Size 2022-2029

New Jersey, United States,-Global Stereotactic Biopsy Table Market Size, Status and Forecast 2022-2028. This research report covers key aspects of the Stereotactic Biopsy Table market including drivers, limitations, past and current trends, regulatory scenarios, and technological developments. An in-depth study of industry’s role in the COVID-19 outbreak. A comprehensive risk assessment and industry recommendations have been made for market research reports and industry analysis over a specific period of time. The report compares the market before Corona 19 and after Corona 19. The impact of COVID-19 on the local economy is also considered in the study.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=448109

The term Based Stereotactic Biopsy Table market study provides helpful insights such as studying the effects on significant aspects, alternatives, and restraints. Graphical analysis of the Emotion Detection and Recognition demand forecasts for the predicted periods can demonstrate the financial requirements of the global Emotion Detection and Recognition industry. Likewise, the study highlights features which limit demand growth, adequately predict Stereotactic Biopsy Table Market quantities, and have long term effects over the predicted period.

The impact of the Corona 19 outbreak on the global Emotion Sensing and Awareness industry, growth rates, correct supply chain analysis, scale in various scenarios, and responses Corporate critiques of the outbreak are all examined in research on emotion sensing and sensitization. The research focuses on emotion detection and recognition in global markets, particularly in North America, Europe and the Asia-Pacific region, as well as South America, the Middle East and Africa. The study divides the market into four parts: manufacturer, region, type and application.

Major Players Covered in Stereotactic Biopsy Tables Markets:

  • MPI Medical
  • Devicor medical products
  • Siemens
  • Aurora imaging technology
  • Hological
  • Planmeca
  • Metaltronics

Stereotactic Biopsy Tables Market Split By Type:

  • Mechanically operated stereotactic biopsy table
  • Electronically controlled stereotactic biopsy table

Stereotactic Biopsy Tables Market Split By Applications:

  • Hospital
  • diagnostic center
  • Others

The Stereotactic Biopsy Table market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Stereotactic Biopsy Tables Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Stereotactic Biopsy Tables market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=448109

Scope of the Stereotactic Biopsy Tables Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Market Analysis Stereotaxic Biopsy Chart can be represented as follows:

Each regional Stereotaxic Biopsy Table sector is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global stereotaxic biopsy table market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-stereotactic-biopsy-table-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Dale Medical Products, Inc. Becomes 100% Employee-Owned

John Brezak commented on Dale’s story; “Since our founding in 1961 and as Chairman since 1997, my philosophy has been to empower our people to make our products and to work with our suppliers and customers as if they were direct Dale stakeholders. I am extremely pleased that my vision has become fully realized. Our employees can now have an added level of confidence that Dale is here to meet the needs of its customers over a much longer horizon. I am thrilled to sell the business to our employees themselves, so they can continue our Dale brand, our vision and our unity as a unique company and culture.”

Bob SimpsonDale’s new President and CEO comments “As an employee-owned company, we will uphold Dale’s heritage of providing highly reliable medical products to help caregivers and patients around the world. Our employees have always been extremely proud of the positive impact we have on patient care, and now they can benefit even more as stakeholders in our business.”

Dale Medical Products, Inc. was founded in 1961, in Sharon, MA. From humble beginnings, the company has become an industry leader in the market niches it serves around the world. Today, Dale is headquartered in Franklin, Mass. where their headquarters and manufacturing facilities are located. Dale Medical Products, Inc. is an ISO 13485 registered company.

For more information, please see www.dalemed.com or call 800-343-3980.

SOURCEDale Medical Products, Inc.

read more
Medical products

Summit Medical Products, Taizhou Pinqing – business philosophy

The updated Analgesic Infusion Pumps Market report gives an accurate analysis of the value chain assessment for the review period of 2022 to 2027. The research includes comprehensive administration assessment of major companies market and their revenue-generating business strategies adopted by to conduct sustainable business. The Services industry report further lists market gaps, stability, growth drivers, restraining factors, opportunities for the projected period.

Get a sample report with the latest industry trend analysis:

https://www.a2zmarketresearch.com/sample-request/313749

Leading companies in this report include: Summit Medical Products, Taizhou Pinqing, B. Braun, KD Scientific, Smiths Medical, Medtronic, Woo Young Medical, Hospira, Terumo, CareFusion (BD), Baxter, Fresenius Kabi.

The global analgesic infusion pump market is expected to register a notable expansion in the market of XX% during the considered period due to the highest market value in 2022. The market research provides measure of product effectiveness, real-time Analgesic Infusion Pumps market scenario, along with customized facility . The study further offers market analysis, strategies and planning, R&D landscape, target audience management, market potential, due diligence and competitive landscape.

Report Scope:

An in-depth statistical analysis of current and emerging trends offers insights into the Analgesic Infusion Pump market dynamics. The report includes Porter’s five forces to analyze the importance of various characteristics such as understanding suppliers and customers, risks posed by various agents, strength of competition and promising emerging businessmen to understand a resource precious. Additionally, the report covers research data on Analgesic Infusion Pumps of various companies, benefits, gross margin, strategic decision of the global market, and more through tables, graphs, and infographics.

The Analgesic Infusion Pumps report highlights an all-encompassing assessment of the revenue generated from different segments across different regions for the forecast period, 2022 to 2027. To leverage business owners gain an in-depth understanding of the In its current momentum, analgesic infusion pump research is harnessing hard-to-find data on aspects such as, but not limited to, demand and supply, distribution channel, and technology upgrades. Primarily, the determination of stringent government policies and regulations and government initiatives enhancing the growth of the Analgesic Infusion Pump market offers knowledge of what awaits business owners in the coming years.

Global Analgesic Infusion Pumps Market Segmentation:

Market Segmentation: By Type

Self-controlled analgesic pumps, uncontrolled analgesic pumps

Market Segmentation: By Application

Hospitals, Clinics, Others

Get an exclusive discount on this report:

https://www.a2zmarketresearch.com/discount/313749

COVID-19 Impact Analysis

The COVID-19 pandemic has emerged in lockdown across regions, line limitations and collapsing transport organizations. Furthermore, the financial vulnerability of the Analgesic Infusion Pumps market is much higher than past outbreaks like Extreme Severe Respiratory Disease (SARS), Bird Flu, Swine Flu, Avian Influenza, and Ebola, inferred from the increasing number of individuals infected and vulnerability to the end of the crisis. With the rapid increase in cases, the global analgesic infusion pump refresh market is influenced from multiple perspectives.

Labor accessibility is evidently disrupting the inventory network of the global Analgesic Infusion Pump Drinks market as lockdown and spread of infection pushes individuals to stay indoors. Analgesic Infusion Pump manufacturers overview and product transportation are related. If the assembly movement is stopped, the transport and, likewise, the store network additionally stop. Stacking and dumping of elements, i.e. raw materials and results (fasteners), which require a ton of labor, are also heavily affected by the pandemic. From the entrance of the assembly plant to the warehouse or distribution center to the end customers, that is, the application companies, the entire network of inventory of analgesic infusion pumps is seriously compromised because of the episode.

The research provides answers to the following key questions:

  • What is the projected size of the analgesic infusion pump market by 2027?
  • What will be the normal share of the whole industry for the coming years?
  • What is the prominent development driving the components and restraints of the Global Analgesic Infusion Pump Market across different geographies?
  • Who are the top sellers expected to lead the market for the assessment period 2022 to 2027?
  • What are the moving and emerging advancements expected to influence the advancement of the Global Analgesic Infusion Pumps Market?

What are the development techniques received by the important sellers of the market to stay on the lookout?

Buy an exclusive report on:

https://www.a2zmarketresearch.com/checkout

If you have any special requirements, please let us know and we will offer you the report you want. you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About A2Z Market Research:

The A2Z Market Research Library provides market research syndication reports from around the world. Buy-ready syndication Market research will help you find the most relevant business intelligence.

Our research analyst provides business insights and market research reports for large and small businesses.

The company helps its clients to develop business policies and grow in this market. A2Z Market Research is interested not only in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F&B , media, etc., but also your company data, country profiles, trends, information. and analysis on the sector that interests you.

Contact us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[email protected]

+1 775 237 4147

read more
Medical products

Medicom donates over $250,000 in medical products

In order to support ongoing humanitarian efforts in UkraineMedicom will send $250,000 value of medical products North America and Europe. In addition, the company is launching a fundraiser among its nearly 2,000 employees and will match every dollar donated. The funds raised will be donated to Médecins Sans Frontières and used mainly to improve access to healthcare and medicines.

“For the past few days, our thoughts have been with our colleagues from Kyiv and with the Ukrainian people. In line with our mission to protect, we have decided to help caregivers involved in humanitarian efforts and their patients,” said Guillaume LaverdureChief Operating Officer of Medicom.

Medicom customers and partners who wish to support humanitarian medical aid operations in Ukraine can visit the Médecins Sans Frontières website at https://www.msf.org.

About Medicom Group

The Medicom Group is one of the world’s leading manufacturers and distributors of high quality, single-use, infection prevention and control products for the medical, dental, industrial, animal health, laboratory, retail, retail and health and wellness. Medicom was named one of from Canada Best Managed Companies for 2021 and received a Mercure Award at Mercuriades 2021.

Medicom distributes infection control products under the Medicom, Ritmed, Kolmi, Hopen, Ocean Pacific and Hedy brands. Medicom subsidiaries include Kolmi-Hopen in FranceMedicom Asia in hong kongUnited Medical Enterprise in the United StatesKHM Engineering at Singapore and Medicom HealthPro Limited in the UK

Medicom has extensive experience in meeting the demand for personal protective equipment in the event of a pandemic. Medicom was founded in 1988 in response to the urgent need for medical gloves for healthcare professionals during the global HIV crisis. Since then, the company has been a reliable provider of infection control solutions during multiple epidemics, including Avian Flu, SARS, H1N1 and Ebola, as well as the COVID-19 pandemic.

For more information about Medicom and the company’s full portfolio of infection control solutions, including an extensive line of medical masks, please visit Medicom.comfollow us on Twitter @MedicomGlobal or visit our pages on Facebook Where LinkedIn.

SOURCEAMD Medicom Inc.

read more
Medical products

Metal Fiduciary Marks Market Analysis by 2030

New Jersey, United States,-The Metal Fiduciary Marks Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

Metal Fiduciary Marks Market Overview:

The research report on global “Metal Fiduciary Marks Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Metal Fiduciary Marks market study provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

This Metal Fiduciary Marks Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=245961

The report includes a detailed segmentation study of the global Metal Fiduciary Brands market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Metal Fiduciary Marks Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Metal Fiduciary Marks Market.

Key Players Covered in Metal Fiduciary Marks Markets:

  • CIVCO Radiotherapy
  • IZI medical products
  • Naslund Medical AB
  • IBA
  • Boston Scientific Society
  • Medtronic

Metal Fiduciary Marks Market Split By Type:

  • pure gold
  • Gold alloys
  • Other metal-based markers

Metal Fiduciary Marks Market Split By Application:

  • Hospitals and outpatient facilities
  • Independent radiotherapy centers
  • Cancer research centers

The Metal Fiduciary Marks Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Metal Fiduciary Brands Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Metal Fiduciary Marks market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=245961

Scope of the Metal Fiduciary Marks Market Report

Report attribute Details
Market size available for years 2022 – 2029
Reference year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Metal Fiducial Marks Market analysis can be represented as follows:

Each regional Metal Fiduciary Brands industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global metal fiat brands market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-metal-fiducial-marks-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Tongue Depressor Market Forecast 2022 by 2029

New Jersey, United States,-The Tongue Depressor Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

Overview of the Tongue Depressor market:

The research report on “Global Tongue Depressor Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Tongue Depressor market study provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

This Tongue Depressor Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=208333

The report includes a detailed segmentation study of the global Tongue Depressor market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Tongue Depressor Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Tongue Depressor Market.

Major Players Covered in Tongue Depressor Market:

  • Puritan Medical Products
  • Agaplastic
  • medical dtr
  • Fazzini
  • Fl Medical
  • FASA Group
  • Francois Mensch
  • Parburch Medical Developments
  • Plasti Lab
  • Dental Shufa
  • timesco
  • We Ophthalmic
  • A. Algeo
  • Dental Asa

Tongue Depressor Market Split By Type:

  • wooden tongue depressor
  • Metal tongue depressor
  • plastic tongue depressor

Tongue Depressor Market Split By Application:

  • Hospitals
  • Clinics
  • Academic research institutes

The Tongue Depressor Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Tongue Depressor Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Tongue Depressor market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=208333

Scope of the Tongue Depressor Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Tongue Depressor Market Analysis can be represented as follows:

Each regional Tongue Depressor industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global Tongue Depressor market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/%ef%bb%bftongue-depressors-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Laryngeal Stents Sales Market Outlook Forecast by 2029

New Jersey, United States,-The Laryngeal Stents Sales Market report contains a detailed overview of the industry along with gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, the actual value, overall size, share and future development factors.

Laryngeal Stent Sales Market Overview:

The research report on the global “Laryngeal Stents Sales Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification . The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Laryngeal Stents Sales market research provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

This Laryngeal Stents Sales Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=524591

The report includes a detailed segmentation study of the global Laryngeal Stents sales market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets in the global Laryngeal Stents Sales Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Laryngeal Stents Sales market.

Key Players Covered in Laryngeal Stents Sales Markets:

  • Boston Medical Products (bess AG)
  • Hood Laboratories
  • Stening S.r.l.

Laryngeal Stents Sales Market Split By Type:

  • Hooded laryngeal stent
  • Laryngeal Tubular Stent Segment by Users
  • Child
  • Competitive landscape for adults: factors such as cost analysis
  • marketing strategy
  • factor analysis
  • distributors
  • sourcing strategy
  • and industrial chain

Laryngeal Stents Sales Market Split By Application:

The Laryngeal Stents Sales Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Laryngeal Stents Sales Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Laryngeal Stents sales market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=524591

Scope of the Laryngeal Stents Sales Market Report

Report attribute Details
Market size available for years 2022 – 2029
Reference year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Laryngeal Stents Market Analysis Sales can be represented as follows:

Each regional Laryngeal Stents Sales Industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global laryngeal stent sales market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/laryngeal-stents-sales-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Thermoplastic Orthotics Market Size 2031

New Jersey, United States,-The Orthopedic Thermoplastics market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service delivery, value actual, overall size, share and future development factors.

Orthopedic Thermoplastics Market Outlook:

The research report on the global “Orthopedic Thermoplastics Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, orthopedic thermoplastics market research provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

This Thermoplastic Orthotics Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=520938

The report includes a detailed segmentation study of the global orthopedic thermoplastics market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about the profitable revenue pockets of the global orthopedic thermoplastics market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus on the right areas of the global orthopedic thermoplastics market.

Major Players Covered by Orthopedic Thermoplastics Markets:

  • Medical clarity
  • Performance Health
  • Chesapeake Medical Products
  • Orfit Industries
  • T-Tape Company
  • Allard International
  • Breg
  • North

Orthopedic Thermoplastics Market Split By Type:

  • Minimum stretch resistance
  • Moderate resistance to stretching
  • Maximum stretch resistance

Orthopedic Thermoplastics Market Split By Application:

  • hand and arm
  • Foot and Knee

The Thermoplastic Orthotics Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global orthopedic thermoplastics market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Orthopedic Thermoplastics market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=520938

Scope of the Orthopedic Thermoplastics Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Orthopedic Thermoplastics Market Analysis can be represented as follows:

Each regional Orthopedic Thermoplastics industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global thermoplastic orthotics market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/orthotic-thermoplastics-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Pneumatic Compression Devices for Lymphedema Consumption Market Size 2031

New Jersey, United States,-Pneumatic Compression Devices for Lymphedema Consumption 2022 Industry Outlook Analysis: Pneumatic Compression Devices for Lymphedema Consumption Market 2022 is expected to be profitable. As the trends rise, investors, research methodologies, CEOs, traders, vendors, directors, presidents, research and media, and a better understanding of the Consumer Pneumatic Compression Devices market of lymphedema.

The report specifically focuses on the Virtual Reality Cardboards in North America, Europe, Asia-Pacific, South America, Middle East and Africa, and global market. The report categorizes the market based on manufacturer, region, type and application. QYResearch market research analysts believe factors such as low cost of VR headsets to drive the market growth over the next five years. The assembly parts used to make the VR cartons are cost effective and do not require heavy machinery or huge manufacturing plants to produce these VR cartons. This low cost of VR cardboard is a prediction period for pneumatic compression devices for consumption of lymphedema. a new GIR (Global Information Research) study, of XX million US $ in 2017.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=429826

The report includes a detailed segmentation study of the global Pneumatic Compression Devices for Lymphedema Consumption market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets of the global Pneumatic Compression Devices for Lymphedema Consumption Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Pneumatic Compression Devices for Lymphedema Consumption market.

Key Players Covered in Pneumatic Compression Devices for Lymphedema Consumer Markets:

  • Devon Medical Products
  • Medical Touch
  • ArjoHuntleigh (Getinge AB)
  • LymphaPress?
  • Global DJO
  • Inc.
  • XIAMEN SENYANG CO.
  • LTD
  • Medline Industries
  • Inc.
  • Biocompression systems
  • Inc.
  • B?sl Medizintechnik

Pneumatic Compression Devices for Lymphedema Consumption Market Split By Type:

  • Pneumatic compression pump
  • Pneumatic compression garments

Pneumatic Compression Devices for Lymphedema Consumption Market Split By Application:

The Pneumatic Compression Devices for Lymphedema Consumption Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Pneumatic Compression Devices for Lymphedema Consumption market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Pneumatic Compression Devices for Lymphedema Consumptions market and its growth potential in coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=429826

Scope of Pneumatic Compression Devices for Lymphedema Consumption Market Report














Report attribute Details
Market size available for years 2021 – 2028
Base year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

The regional analysis of Pneumatic Compression Devices for Lymphedema Consumption Market can be represented as follows:

Each regional Pneumatic Compression Devices for Lymphedema Consumption industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global Pneumatic Compression Devices for Lymphedema Consumption market has been segmented as follows:

    • North America includes the United States, Canada and Mexico

    • Europe includes Germany, France, UK, Italy, Spain

    • South America includes Colombia, Argentina, Nigeria and Chile

    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-pneumatic-compression-devices-for-lymphedema-consumption-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Smith+Nephew appoints new CEO as medical device maker navigates pandemic

Feb 22 (Reuters) – Smith+Nephew (SN.L) on Tuesday appointed Deepak Nath of Siemens Healthineers AG (SHLG.DE) as chief executive to succeed Roland Diggelmann after the medical device maker narrowly missed the analysts’ estimate of annual profit.

Diggelmann was recruited by Smith+Nephew after his former boss left his salary at the end of 2019, and the British company was counting on his more than 20 years of experience in the orthopedic and diagnostic sectors to accelerate the growth of its income.

However, the pandemic hit soon after, forcing hospitals to delay surgeries and elective services to accommodate COVID-19 patients, and slumping demand for hip and knee replacement surgeries. business, while supply chain issues have also weighed it down.

Join now for FREE unlimited access to Reuters.com

Register

The UK company’s revenue rose 10.3% to $5.21 billion in the 12 months to December 31 on an underlying basis, recovering steadily from 2020, while trading profit was $936 million, compared to $683 million the previous year.

Healthcare networks around the world are once again under pressure from the novel coronavirus variant Omicron, and the company is targeting underlying revenue growth in the range of 4.0% to 5.0% for 2022.

“(Deepak Nath) joins us at an inflection point for the business and will bring his drive, experience and expertise to lead the team as we execute on our rapid growth strategy,” said Chairman Roberto. Quarter in a press release.

Analysts had expected a profit of $945 million in 2021 on sales of $5.22 billion at the median, a consensus provided by the company show.

Join now for FREE unlimited access to Reuters.com

Register

Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu

Our standards: The Thomson Reuters Trust Principles.

read more
Medical products

Disposable Pressure Transducers Market Outlook by 2030

New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global disposable pressure transducers market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global disposable pressure sensors market, analysts have segmented the market based on applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Disposable Pressure Transducers market.

Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the assessment of these vendors’ financial outlook, Disposable Pressure Sensors market growth strategy and expansion plan during the forecast period. All the information presented in the Global Disposable Pressure Sensors Market research report has been certified by market experts.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=403765

The report includes a detailed segmentation study of the global Disposable Pressure Sensors market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Disposable Pressure Transducers Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Disposable Pressure Transducers market.

Key Players Covered in Disposable Pressure Transducers Market:

  • Edwards life sciences
  • Utah Medical Products
  • Smith’s Medical
  • Elcam Medical
  • Medical intensive care
  • Argon Medical
  • Biosensors International
  • Medical Merit Systems
  • Shenzhen Antmed
  • B. Braun
  • Cook Regentec
  • PendoTECH
  • SCW Medicath
  • George Phillips
  • DeRoyal Industries
  • Lepu Medical
  • copper medical technology
  • medical ace
  • Biometrix B.V.
  • Metko Ltd.
  • Guangdong Baihe Medical
  • Tianck Medical

Disposable Pressure Transducers Market Split By Type:

  • Single channel transducers
  • Dual channel transducers
  • Three-channel transducers

Disposable Pressure Transducers Market Split By Application:

The Disposable Pressure Transducers Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Disposable Pressure Transducers Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Disposable Pressure Sensors market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=403765

Scope of the Disposable Pressure Transducers Market Report

Report attribute Details
Market size available for years 2021 – 2028
Base year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Disposable Pressure Transducers Market Analysis can be represented as follows:

Each regional Disposable Pressure Sensors industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global disposable pressure sensors market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-disposable-pressure-transducers-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Himachal Pradesh government plans to deliver agricultural and medical products by drones and strikes a deal

Explore the use of drone in various departments, Himachal Pradesh state government reached an agreement with Drone delivery service company skye air. Under the agreement, the company will deliver medicines and agricultural products by drones.

As part of this strategic partnership, Skye Air has launched a 3-day BVLOS trial in the Chamba district of Himachal Pradesh to connect over 6 PHCs/CHCs and hospitals in the region via multiple point-to-point flights covering an air distance of 170 km throughout the trial. The drone delivery technology company will use advanced drones and technology to provide real-time deliveries of vaccines and drugs within a specified temperature range of 2 to 8 degrees Celsius. There will be several reverse logistics flights that will also be conducted to aid in the adoption of drone technology to enable cost effective deliveries in the state.

In the trial run. the drone flights, equipped with shipments of medical supplies, hovered at an altitude of 400 feet above the ground in a designated green area in Chamba district. The flights took place in 3 air corridors – Chaned, Tissa and Mehla.

Commenting on the development, Mukesh Repaswal, Director, Information Technology Department, Government. of Himachal Pradesh said, “The demonstration in Chamba will help determine the benefits of using drones in drug delivery and the benefits of drone governance. We look forward to the success of the BVLOS trials in Chamba and the expansion of the drone delivery ecosystem in Himachal Pradesh to medical and agri-food deliveries.

Commenting on the deal, Swapnik Jakkampundi, co-founder of Skye Air, said: “To begin with, we will operate around 25 flights during the trial phase overcoming the challenges of harsh weather and terrain. In the coming months, as we look forward to enabling commercial flights in the district, we will be able to directly benefit over 5.19 lakh people through improved accessibility to healthcare and local job creation. in the drone delivery ecosystem.

Skye Air recently made headlines for delivering India’s first agri-food product via drones to Meghalaya, enabling 1st mile logistics for farmers.

read more
Medical products

2021 Enforcement Review: FDA Regulated Medical Products – Food, Drug, Healthcare, Life Science


United States: 2021 Enforcement Review: FDA Regulated Medical Products

To print this article, all you need to do is be registered or log in to Mondaq.com.

Although the continuing public health emergency related to COVID-19 remained an obstacle to many Food and Drug Administration (“FDA”) inspections in 2021, the pandemic did not prevent criminal and civil actions. related to major violations of FDA regulations, particularly matters that have been under investigation since before the pandemic. The Department of Justice (“DOJ”) has announced numerous indictments, civil and criminal settlements, and criminal convictions involving individuals accused of violating the Federal Food, Drug, and Cosmetic Act (“FDCA”) ) and other laws related to product schemes. COVID-19 fraud remained a top priority, as did cases involving opioids and clinical trial fraud.

This app review of 2021 covers major criminal and civil actions against life sciences companies, starting with those related to the ongoing COVID-19 pandemic. It then discusses actions involving the illicit distribution of opioids, which continue to be a DOJ priority, and then focuses on a new area of ​​interest for law enforcement: clinical trial fraud. The article then examines other enforcement actions brought under the FDCA and related criminal statutes, as well as civil misrepresentation law, which are based on a somewhat broader variety of alleged violations of the FDA regulations. The article ends by looking forward to what FDA-regulated companies can expect on the enforcement horizon in 2022.

The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

read more
Medical products

Analysis of investments in the axillary crutches market

A new research study from JCMR with the title Global Axillary crutches Market Research Report 2021 provides an in-depth assessment of Armpit Crutches, including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies and strategies. Research Study Provides Predictions For Axillary Crutches investments until 2029.

The report includes the latest post-pandemic market research on the Axillary Crutches market.

Competitive Analysis: Cardinal Health, Home Medical Products Inc, New York Millennium Pharmaceutical, AMG Medical, BREG, Chinesport, Dr. Med, Mikirad, Ossenberg GmbH,

Request Free Sample PDF Report @: jcmarketresearch.com/report-details/97013/sample

Frequently Asked Questions:

  • How fast is the market expected to grow

Year-over-year growth for 2021 is estimated at XX% and additional growth for Armpit Crutches market is estimated to be USD xxx million.

Get Up To 40% Off Corporate Copy & Customization available for the following regions and countries: North America, South and Central America, Middle East and Africa, Europe, Asia-Pacific

  • Who are the key players in the Axillary Crutches market?

Cardinal Health, Home Medical Products Inc, New York Millennium Pharmaceutical, AMG Medical, BREG, Chinesport, Dr. Med, Mikirad, Ossenberg GmbH,

  • What are the key drivers and challenges for the Axillary Crutches Market?

The demand for ASW capacity building is one of the major factors driving the axillary crutches market.

  • What is the size of the armpit crutches market in North America?

The North America region will contribute XX% of the Axillary crutches market share

Survey for Axillary Crutches Segment [email protected]/report-details/97013/enquiry
This customized Arm Crutches report will also help clients track new product launches in the direct and indirect markets related to COVID-19, upcoming vaccines and pipeline analysis, and significant developments in the operations of the suppliers and government regulations.

Geographical analysis of axillary crutches:

• Axillary crutches industry North America: United States, Canada and Mexico.

• Axillary crutches industry South and Central America: Argentina, Chile and Brazil.

• Axillary crutches industry Middle East and Africa: Saudi Arabia, United Arab Emirates, Turkey, Egypt and South Africa.

• Armpit crutches industry Europe: United Kingdom, France, Italy, Germany, Spain and Russia.

• Asia-Pacific armpit crutches industry: India, China, Japan, South Korea, Indonesia, Singapore and Australia.

Market Analysis by Types & The market analysis by applications is as follows:

[Segments]

Some of the Points Covered in the Global Axillary Crutches Market Research Report are:

Chapter 1: Global Axillary Crutches Market Overview (2013-2025)
• Definition of axillary crutches
• Specifications of axillary crutches
• Classification of axillary crutches
• Applications of axillary crutches
• Axillary crutches regions

Chapter 2: Axillary Crutches Market competition by players/suppliers 2013 and 2018
• Axillary Crutches Manufacturing Cost Structure
• Raw material and suppliers of axillary crutches
• Axillary crutches manufacturing process
• Industry Chain Structure of Armpit Crutches

Chapter 3: Axillary Crutches Sales (Volume) and Revenue (Value) by Region (2013-2021)
• Sales of axillary crutches
• Axillary crutches revenue and market share

Chapter 4, 5 and 6: Global Axillary Crutches Market by Type, Application and Player/Supplier Profiles (2013-2021)
• Armpit Crutches Market Share by Type and Application
• Growth rate of Underarm Crutches by type and application
• Factors and opportunities of axillary crutches
• Basic information about axillary crutches company

Continue……………

Note: Please share your budget by call/mail. We will try to meet your needs. @ Call: +1 (925) 478-7203 / E-mail: [email protected]
Find more research reports on Axillary crutches industry. By JC Market Research.

Thank you for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About the Author:

JCMR’s global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities, but also to empower and inspire you to create visionary growth strategies for the future, through our extraordinary depth and breadth of thought leadership, research, tools, events and experience. that help you turn your goals into reality. Our understanding of the interplay between industry convergence, megatrends, technologies and market trends provides our clients with new business models and opportunities for expansion. We are focused on identifying the “Accurate Forecast” in each industry we cover so that our clients can reap the benefits of being early market entrants and can achieve their “Goals and Objectives”.

Contact us: https://jcmarketresearch.com/contact us

JCMARKETRESEARCH

Mark Baxter (Business Development Manager)

Call: +1 (925) 478-7203

E-mail: [email protected]

Connect with us at – LinkedIn

read more
Medical products

Tetra Bio-Pharma partners with Avicanna to bring medical cannabinoid products to LATAM

Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) is teaming up with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to bring Tetra’s products to Latin America.

On Monday, the Ottawa-based cannabinoid drug developer revealed a non-binding terms sheet with Avicanna consisting of three strategic areas.

The first involves the registration and marketing of Tetra’s prescription cannabinoid products through Avicanna’s sales channels in Latin America. The second provides co-development and support for Avicanna’s pharmaceutical pipeline through level clinical development and registration with Canadian regulatory authorities.

The partnership also involves a supply of active pharmaceutical ingredients (APIs) from Avicanna for Tetra’s pharmaceutical pipeline.

In a statement, Tetra’s chief commercial officer, Steeve Neron, said his company will need multiple reliable API vendors to support operations related to its painkiller QIXLEEF, which has a fixed ratio of THC and CBD that complies with regulations. cGMP from the United States.

“QIXLEEF is Tetra’s proprietary investigational new drug and is currently being evaluated in two US FDA-cleared clinical trials,” says Neron.

Avicanna’s established distribution channels in Latin America could help advance the commercialization of Tetra’s products in certain jurisdictions, he adds.

Other Tetra products slated for commercialization include anti-nausea, cannabinoid drug REDUVO, bio-delivery technology AdVersa and painkiller CAUMZ.

Read more: Avicanna Reports Record Sales of $1 Million

Read more: Avicanna subsidiary obtains GACP certification in Colombia

Avicanna CEO Aras Azadian said Tetra has proven to be a pioneer in cannabinoid-based pharmaceuticals.

“As the global industry continues to mature and focus on evidence-based medicines, the two companies are well positioned to work synergistically on multiple projects and leverage their leadership position to achieve successful business outcomes. “

Under the Aureus brand, Avicanna sells raw materials in 12 countries and offers seeds, flowers, full-spectrum extracts and other isolated cannabinoids like CBD.

The products come from its majority-owned Colombian subsidiary Santa Marta Golden Hemp SAS, which is GACP-certified and has USDA National Organic Program certification for its hemp cultivar.

The company also has patent-pending drug candidates that are in various stages of clinical development and commercialization.

Its RHO Phyto brand includes medical and wellness products with different ratios of CBD and THC in different forms such as creams, pills and transdermal patches.

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

[email protected]

read more
Medical products

Proctology Table Market Size and Forecast by 2029

New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global Proctology Table Market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global proctology table market, analysts have segmented the market on the basis of applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Proctology Table market.

Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the evaluation of these vendors’ financial outlook, proctology table market growth strategy and expansion plan during the forecast period. All information presented in the Global Proctology Table Market research report has been certified by market experts.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=308775

The report includes a detailed segmentation study of the global Proctology Table market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the Global Proctology Table Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Proctology Table Market.

Major Players Covered in Proctology Table Markets:

  • AR-EL MEDICAL PRODUCTS
  • promotional
  • INDUSTRIAL ECHOME
  • SCHMITZ and. Sohne
  • B?Çakc?lar
  • NQR
  • Wardray premise

Proctology Table Market Split By Type:

  • Adjustable Proctology Table
  • Non-Adjustable Proctology Table

Proctology Table Market Split By Application:

  • Hospital
  • Clinical
  • Ambulatory surgery centers

The Proctology Table Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Proctology Tables market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Proctology Tables market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=308775

Scope of the Proctology Tables Market Report

Report attribute Details
Market size available for years 2021 – 2028
Reference year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

The Regional Proctological Table Market Analysis can be represented as follows:

Each regional sector of the Proctological Table is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

On the basis of geography, the global Proctology Table market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-proctologic-table-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Global Nasal Splints Market Forecast 2029 | Network Medical Products, Summit Medical, Surgiform, Mentor – Sox Sphere

A Global Market Study nasal splints market examines the performance of the nasal splints market in 2022. It contains an in-depth analysis of the nasal splints market status and competitive landscape globally. Global Nasal Splints Market can be obtained through market details such as growth drivers, latest developments, Nasal Splints Market business strategies, regional study and future market status. The report also covers information, including the latest opportunities and challenges in the nasal splints industry, as well as historical and future trends in the nasal splints market. It focuses on the market dynamics which are constantly changing due to technological advancements and socio-economic status.

Recent market research on the Nasal Splints market analyzes the crucial factors of the Nasal Splints market based on the current industry situation, market demands, business strategies adopted by the Nasal Splints market players, and their growth scenario. This report isolates the Nasal Splints market based on key players, type, application, and region. First of all, the Nasal Splints Market report will offer in-depth knowledge of the company profile, its core products and specifications, revenue generated, production cost, who to contact. The report covers forecast and analysis of the Nasal Splints market on a global and regional level.

Get a Free Copy of the Nasal Splints Market Report 2022: https://calibreresearch.com/report/global-nasal-splints-market-253116#request-sample

COVID-19 impact analysis:

In this report, the pre and post COVID impact on market growth and development is well described for better understanding of the Nasal Splints market on the basis of financial and industry analysis. The COVID-19 pandemic has affected a number of markets and the global nasal splints market is no exception. However, the dominant players in the global nasal splints market are determined to adopt new strategies and seek new funding resources to overcome the growing hurdles for market growth.

Key Players Studied in the Nasal Splints Market Report:

Networked medical products
Medical Summit
Surgical
Mentor
DTR Medical
Boston Medical Product Inc.

Product Types uploaded in the Nasal Splints Market are:

Malleable nose splints
Airway Nasal Splints
Bivalve nasal splints

The main applications of this report are:

Plastic surgery
rhinological operations
ENT surgery

Point COVERED DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR From 2017 to 2021
VALUE (USD million/billion)
SECTORS COVERED Competitors, types, applications, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE The report can be customized to your needs when purchasing. Any additional requirements (regional breakdown of data, addition/removal of top players) will be incorporated into the final report.

Nasal Splints report provides past, present and future Nasal Splints industry size, trends, and forecast information related to expected Nasal Splints revenue, growth, demand and supply scenario nasal splints. In addition, the opportunities and threats to the development of the Nasal Splints market forecast period from 2022 to 2029 are also covered extensively in this research document.

Get a full report for better understanding : https://calibreresearch.com/report/global-nasal-splints-market-253116

In addition, the Nasal Splints report gives insights into the company profile, market share, and contact information along with an analysis of the Nasal Splints industry value chain, industry rules and methodologies. Nasal Splints industry, circumstances driving market growth and restraints blocking growth. The scope of the nasal splints market development and various business strategies are also mentioned in this report.

read more
Medical products

Swab Market Size and Growth

New Jersey, United States,- This swab market The report includes an in-depth competitive analysis with the aim of estimating financial growth and maximizing the company’s profit potential. It helps in making reasonable investment decisions based on consumer needs. It also forecasts the overall growth of the market over the years 2022-2029. It displays objective data useful for professional industry analysis, as well as consumer buying habits. This Swab market research also makes it easy to know the likes and dislikes of different customers, which helps the company generate significant revenue. It serves as a comprehensive reference guide for key new businesses to learn about industry variables and business methodologies that will help them grow their business in the market. New participants will gain a solid understanding of how to run a successful business by executing tactics such as acquisitions, partnerships and new product launches. The market growth statistics presented here are backed by hard facts and figures. The data collected here at a granular level is very useful for predicting productivity.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=32528

This Swabs Market report study examines the sales in depth. It is also a useful tool for participants, suppliers and players. Market research assessment constantly attempts to conduct surveys to provide accurate market insights. It explains how COVID-19 has impacted key market segments. It also explains how COVID-19 will impact each industry for years to come. Business owners can make the right decisions to stand out from their competitors with the help of such unique and excellent market analysis. The scope of this Swabs market report also helps in identifying the best opportunities to earn big profit. When launching a new product or entering the market as a beginner, it’s usually a good idea to check out a solid market report. It also describes how these industries are trying to recover from their dire situation. This Swabs Market report helps companies to increase sales and maintain reputation by providing up-to-date marketing data.

Key Players Mentioned in the Swabs Market Research Report:

Puritan Medical Products, Sarstedt, MWE, SARSTEDT, Clean Cross, GPC Medical, Citotest Labware Manufacturing, Q-TIPS, ELMEX

Swabs Market Segmentation:

By Product Type, the market is primarily split into:

• Absorbent cotton
• Non-absorbent cotton

By application, this report covers the following segments:

• Pharmaceutical
• Microbiological
• Laboratory
• Others

Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=32528

Scope of Swabs Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Geographic segment covered in the report:

The Swab report provides information on the market area, which is further sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and rest of Europe)
• Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
• Latin America (Brazil, Mexico and rest of Latin America)
• Middle East and Africa (GCC and Rest of Middle East and Africa)

Answers to key questions in the report:

1. Who are the top five Swab market players?

2. How will the swab market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the Swab market?

4. What are the Swab Market drivers and restraints?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Swab market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/global-swab-market-size-and-forecast-to-2025/

Visualize the swab market using verified market intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

Most Popular Reports

Global Wearable Skin Patches Market Size and Forecast

Global Fetal Monitoring Market Size and Forecast

Global dental consumables market size and forecast

Global Automated Hospital Bed Market Size and Forecast

Global Urinalysis Testing Market Size and Forecast

Global Swabs Market Size and Forecast

Global Lichen Nitidus Treatment Market Size and Forecast

Global Wolff Parkinson White Syndrome Market Size and Forecast

Global Hammertoe Market Size and Forecast

Global Hydronephrosis Market Size and Forecast

About Us: Verified Market Reports

Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website: – https://www.verifiedmarketreports.com/

read more
Medical products

Protek Medical Products in Iowa City will close, eliminating 53 jobs

Protek Medical Products in Iowa City last month announced it would be closing effective April 29.

The closure will affect 53 employees, who will be made redundant when the business closes.

News of the impending closure came on January 26, when Protek filed a required worker accommodation and retraining notification.

Protek Medical Products is a Coralville-based manufacturer of medical supplies. The company manufactures probe covers and needle guides for ultrasound used in tissue biopsies, fluid aspiration and vascular access procedures, as well as protective covers for medical equipment and instruments. It was founded in 1996 by Rick Pruter.

In November 2020, Aspen Surgical Products acquired Protek for an undisclosed amount. Aspen has also secured the rights to Protek’s patented Pull-Up probe technology, which claims to help produce efficacy in clinical settings. Based in Caledonia Michigan, Aspen hoped to boost its medical, patient and staff safety product profile with the acquisition.

Messages to Protek’s Coralville office on Monday were not returned.

This article originally appeared on Iowa City Press-Citizen: Protek Medical Products in Iowa City to close, costing 53 jobs

read more
Medical products

3 medical products stocks poised to beat this earnings season

Despite the resurgences of COVID-19, so far the fourth quarter reporting cycle has shown improvement for the Medical products companies in the wider medical sector. It should be mentioned that the Medical is expected to be one of the seven fastest growing sectors in earnings in the fourth quarter.

By the last Earnings overview, 33.9% of companies in the medical sector, accounting for nearly 53.7% of the market capitalization of the sector, reported profits through February 2. Profits improved 10% year over year on revenue up 12.1%. A total of 36.8% of corporate earnings and revenue beat Zacks’ consensus estimate.

This dashboard highlights stability in the United States, thanks to the continued economic reopening amid the resurgence of COVID-19 cases. However, this resurgence has led to supply chain disruptions that persist. Additionally, several of the international markets affected by COVID are still suffering due to lower cash flow and difficult economic conditions.

Companies in the medical products sector saw a sequential decline in collective business versus legacy core business in the third quarter. On a positive note, the fourth quarter reporting cycle so far has shown a recovery in these activities despite the resurgence of COVID-19. The substantial increase in vaccination campaigns has helped people gradually return to pre-pandemic normality. This, in turn, has likely resulted in some recovery in hospital visits and core hospital activities in the current reporting cycle, which in turn may have boosted non-COVID legacy activities and electives in the medical sector. Although companies are seeing a sequential recovery in their core business, the improvement in the overall trend is still below pre-COVID levels.

Meanwhile, due to the resurgence of COVID-19 and rising case numbers, manufacturers of tests, vaccines and therapeutics have witnessed massive market uptake of their products and services. of COVID-related healthcare support in the fourth quarter. Diagnostic test stocks have so far seen phenomenal growth, driven by an increase in demand for COVID-19 tests, in line with industry trends. For example, in the fourth trimester, Abbott Laboratories‘ABT’s underlying legacy diagnostic activity continued to improve. This was due to strong sales of ABT’s COVID-19 tests thanks to strong demand for the BinaxNOW, Panbio and ID NOW rapid test platforms. Sales of Abbott’s rapid diagnostics and point-of-care diagnostics both grew organically.

Stocks set to beat fourth-quarter earnings estimates

Given the high degree of diversity in the medical products industry, finding the right stocks with the potential to beat estimates could be quite a task.

However, our proprietary Zacks methodology makes this quite simple.

We focus on actions that combine a positive effect ESP Earnings and a Zacks rank #1 (strong buy), 2 (buy) or 3 (hold). You can see the full list of today’s Zacks #1 Rank stocks here.

Our research shows that for stocks with this combination, the chance of a positive earnings surprise is as high as 70%.

The ESP of earnings provides the percentage difference between the most accurate estimate and the Zacks consensus estimate. You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

Here we feature three stocks that are expected to top earnings estimates in this reporting cycle.

Baxter International, Inc. BAX: Increased demand for acute therapy products due to the COVID-19 pandemic, and continuous renal replacement therapy (CRRT), related devices and consumables are likely to have boosted Acute business performance Baxter’s Therapies in Q4 2021. BAX’s strong product pipeline and expected launch of therapies and products may be reflected in Q4 revenue.

The combination of Baxter’s ESP gains of +3.50% and a Zacks #2 ranking raises the possibility of an earnings surprise in the quarter to report.

The company is expected to release its fourth quarter results on Feb. 17, before the market opens.

Baxter International Inc. Awards and EPS Surprise

Baxter International Inc. price-eps-surprise | Baxter International Inc. Quote

Henry Schein, Inc. HSIC: According to the third quarter 2021 earnings call, the company has seen stronger demand in the global dental and medical markets as practices gradually reopen and global patient traffic has stabilized over the past few months. months, even in countries with stricter lockdown rules. . This recovery trend is expected to have continued through the fourth quarter, boosting the company’s revenue.

HSIC is expected to release its fourth quarter 2021 results on February 15.

Henry Schein has a +1.94% Earnings ESP and a #2 Zacks rank.

Henry Schein, Inc. Awards and EPS Surprise

Henry Schein, Inc. Awards and EPS Surprise

Henry Schein, Inc. price-eps-surprise | Quote from Henry Schein, Inc.

DENTSPLY SIRONA Inc. XRAY: DENTSPLY SIRONA’s Consumables segment is expected to have seen improved revenue in the fourth quarter. The rebound in sales of all product categories may have contributed to the increase. The Technology & Equipment segment may have shown growth in the reportable quarter, driven by recovery across all product categories.

XRAY is expected to report its fourth quarter 2021 results on February 28.

DENTSPLY SIRONA has a Gain ESP of +1.06% and a Zacks Rank #3.

DENTSPLY SIRONA Inc. Price and EPS Surprise

DENTSPLY SIRONA Inc. Price and EPS Surprise

DENTSPLY SIRONA Inc. price-eps-surprise | Quote DENTSPLY SIRONA Inc.

Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

Just Released: Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know our top 10 buy and hold tickers for all of 2022?

Last year 2021 Zacks Top 10 Stocks the portfolio generated gains as high as +147.7%. Now, a brand new portfolio has been selected from over 4,000 companies covered by the Zacks ranking. Don’t miss your chance to participate in this long term shopping

Access the Top 10 Zacks Stocks for 2022 today >>

Click to get this free report

Abbott Laboratories (ABT): Free Inventory Analysis Report

Baxter International Inc. (BAX): Free Stock Analysis Report

DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report

Henry Schein, Inc. (HSIC): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Medical products

Hot Melt Extrusion Medical Products Market Growth Analysis 2022, Industry Dynamics 2026

The global Hot Melt Extrusion Medical Devices industry market study provides important insights that can help companies to set priorities, better position their businesses, devise well-thought-out business strategies and make business decisions. investment for the future. The report mainly includes the current status of the Hot Melt Extrusion Medical Products market, products, materials, services and other key aspects of the market. In this research, the report explores the status of the Hot Melt Extrusion Medical Products market in key regions. It includes an overview of how the Hot Extrusion Medical Devices industry fits into the global market landscape, key trends influencing market companies and consumers, and information about what players in the hot extrusion medical products market might want to focus to support and be competitive in the market. Marlet. The report studies the segments that are major contributors to the market and are expected to dominate the hot melt extrusion medical products market in the coming years.

Request a sample report: https://www.orbisresearch.com/contacts/request-sample/6249201?utm_source=SLP

Hot Extrusion Medical Products Market Key Players

AbbVie
Formex
BASF Pharmaceuticals
omipa
Biogrund
Lubrizol

The report studies key parameters of the Medical Hot Melt Extrusion Products industry, including the macroeconomic situation, current status, research and development initiatives, and ongoing merger and acquisition activities. The report studies key indicators of the Hot Melt Extrusion Medical Devices industry defining the current economic situation and financial performance of the market. The major ongoing developments in the industry such as mergers and acquisitions and research and developments locally and globally are highlighted in the report.

Hot Extrusion Medical Products Industry Different product categories include:

Movies
Taste masking
Drug eluting devices
Others

The global hot extrusion medical products industry has a number of end-user applications, including:

Research Laboratory
Contract manufacturing organization
Pharmaceutical companies

The above mentioned activities from 2019 to 2021 are covered in the report with an assessment of pandemic effect on Medical Hot Melt Extrusion Products industry. Additionally, the changes that the pandemic brings to the market, new business models, supply and demand scenario, regulatory framework, technological innovations shaping the market. Then, the report focuses on the key developments that the hot melt extrusion medical products market will witness in 2021 and the developments that occurred in 2020 due to the pandemic. The hot melt extrusion medical products market drivers evident in the market in recent years are studied in the report. This detailed information presented in the report enables market players to make informed decisions and design innovative and sustainable business models.

Investigate before accessing the report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/6249201?utm_source=SLP

What does the Hot Extrusion Medical Products Market report include?

– Factors that may affect future business ventures.
– The future growth rate and expected growth of the Medical Extruders industry and your business.
– The business models and business strategies executed by players of the Hot Melt Extrusion Medical Products market.
– Market, financial and other risks related to local and international commercial activities of hot melt extrusion medical products.
– Global hot extrusion medical products market industry-related revenue.
– The report highlights the opportunities arising from the pandemic for the hot melt extrusion medical products market players over the current and upcoming years.
– The report includes details of revenue and market share losses suffered during the pandemic.
– The report recognizes the drivers of change in the Hot Melt Extrusion Medical Devices industry ahead of 2020.
– The risks and uncertainties that may arise in the Hot Melt Extrusion Medical Devices market are discussed in the report.
– Segments or regions that have extreme growth potential and are expected to witness huge growth in the Hot Melt Extrusion Medical Devices market in the future are detailed in the report.
– The report provides a neutral perspective of the global hot extrusion medical products market and its performance.
– The report explains how players in the hot extrusion medical products market can adapt to the changing market.
– Detailed details of supply chain operations by segment.
– Financial and economic conditions of the Hot Extrusion Medical Products industry market.
– Analysis of revenue growth of all business segments.

About Us:

Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

Contact us:

Hector Costello
Senior Manager – Client Engagements
Central Highway 4144N,
Suite 600, Dallas,
Texas – 75204, USA
Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155
Email ID: [email protected]

Click here to see the full table of contents: https://www.orbisresearch.com/contact/purchase-single-user/6249201?utm_source=SLP



read more
Medical products

Foreign medical products attract medical travel to Hainan, China

Lecheng International Medical Tourism Zone in eastern Hainan Island, says it is three years ahead of schedule for the registration of foreign medical products, with the authorization of more than 200 medical devices and drugs requiring a special license for use. With the advanced foreign medical technology in the area, the local authority says Chinese citizens and foreigners have the opportunity to seek treatment on the island without having to travel to other countries where these drugs and equipment are produced. . They also note that treatment costs have come down and claim that corneal transplants in Hainan will now cost seven times less than in the United States.

By the end of 2021, the Zone had registered more than 200 imported medical devices and medicines. The list of reimbursable drugs covered by its insurance system includes 100 types of special medical products, 75% of which are produced by foreign pharmaceutical companies.

39 of these devices and drugs are designed to treat cancer, 38 help in the rehabilitation of patients after injuries and illnesses, 31 are used in the field of ophthalmology and 28 are used in cardiology.

The minimum “Lecheng” national insurance package for the purchase of pharmaceuticals is 39 yuan per year (6 US dollars) and 29 yuan (5 US dollars) for residents of Hainan. Over 1.7 million people bought it in 2020.

The number of patients using them in Hainan has increased by 454 percent according to the Lecheng area administration, reaching its goal not in 2025, but three years earlier.

Authorities remain vague on actual numbers for 2021 but the 2025 target is 250,000 medical tourists. Almost all come from mainland China.

Hainan reported 19,000 medical tourists in 2017, 32,000 in 2018, 68,000 in 2019, and 83,900 in 2020. An increase of 83,900 by 454% is 382,630. If the five years are added together, that’s about 250,000 .

read more
Medical products

Medical Products Stock Earnings Feb. 2: BSX, TMO and More

The last Revenue overview reflects a considerably strong quarterly performance for the Medical sector so far this reporting cycle. According to the sector scorecard, 8.9% of companies in the medical sector, constituting nearly 29.2% of the sector’s market capitalization, reported profits through January 26. Of these, 80% beat earnings estimates and 60% beat the same for revenue. Profits were up 27% year over year on revenue up 12.2%.

This dashboard reflects stability in the United States on continued economic reopening amid the resurgence of COVID-19 cases. However, supply chain disruptions are still significant, thanks to the emergence of the Omicron variant. Additionally, many parts of the COVID-affected international market are still suffering due to lower cash flow and tough economic conditions.

Overall, fourth-quarter profits for the medical sector are expected to rise 18.4% on a 12.2% increase in sales. That compares to reported earnings growth of 29.7% and revenue growth of 15.7% in the third quarter. It is worth mentioning that the medical sector is expected to be one of the seven sectors with the strongest earnings growth in the fourth quarter.

Quarterly summary of medical products

The dynamic nature of the COVID-19 crisis is rapidly transforming the landscape of the medical products industry. Medical products Corporate collective activities (within the broader medical sector) showed a sequential decline in terms of legacy core activity in the third quarter. So far, the fourth quarter reporting cycle has shown a sequential rebound in terms of the companies’ legacy core business despite the emergence of the new Omicron variant. This rebound can be attributed to the fiscal and monetary stimulus measures and the mass vaccination campaign at home and abroad. Although companies are seeing a sequential recovery in basic activity, the improvement in the overall trend is still below the pre-COVID level.

It should be mentioned here that disruptions in the form of the emergence of newer, more infectious variants of COVID-19 have again begun to delay non-COVID-19 elective hospital admissions and procedures. Meanwhile, with resurgences of COVID-19 and rising case numbers, manufacturers of tests, vaccines and therapeutics have witnessed massive market uptake of their products and support services. COVID-related health care in the fourth quarter.

Specifically, fourth-quarter diagnostic test inventory results have so far shown considerable growth, driven by an increase in demand for COVID-19 tests, which had seen a slowdown in demand in the third quarter, a report said. gained momentum in the fourth quarter, in line with industry trends.

Let’s take a look at four Medical Products players who are due to announce their results on February 2.

Boston Scientific Society BSX: In the fourth quarter, within the Urology/Pelvic Health division of Boston Scientific, sales of the Stone, Prostate Health and Pelvic Health franchises are expected to have recorded strong growth. The acquisition of Lumenis (closed in September) should have contributed a full quarter to the company’s sales. The LithoVue, SpaceOAR and Rezum product lines should have performed well. The company continues to expect urology/pelvic health to have one of the fastest potential recovery curves, aided by a higher in-office ASE mix for most elective procedures. (Read more: What do Boston Scientific’s fourth quarter results have in store for us?)

Zacks’ consensus estimate for fourth-quarter earnings per share is pegged at 44 cents and revenue at $3.10 billion.

Boston Scientific Corporation Award and EPS Surprise

Boston Scientific Corporation price-eps-surprise | Boston Scientific Corporation Quote

Boston Scientific doesn’t have the right combination of the two key ingredients – a silver lining ESP Earnings and a Zacks Rank #3 (Hold) or better. BSX has an ESP on gains of 0.00% and carries a Zacks rank of #4 (sell). You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

You can see the full list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Thermo Fisher Scientific Inc. TMO: Thermo Fisher’s Life-Science Solutions segment is expected to have seen strong revenue contributions driven by growing demand for COVID-19 testing with the emergence of the Omicron variant during the fourth quarter. Additionally, vaccine and therapeutics production supplies (recognized in the BioProduction and Biosciences businesses) are expected to have contributed strongly to the company’s growth in the fourth quarter. Thermo Fisher is expected to have seen robust growth in the areas of genetic sciences, biosciences and biomanufacturing thanks to the surge in economic activity globally and the company’s response to the pandemic. (Read more: Increase in COVID testing to boost Thermo Fisher Q4 revenue)

Zacks’ consensus estimate for its fourth-quarter earnings per share is set at $5.22. Revenue is expected to be $9.03 billion.

Thermo Fisher Scientific Inc. Prize and EPS Surprise

Thermo Fisher Scientific Inc. Prize and EPS Surprise

Thermo Fisher Scientific Inc. price-eps-surprise | Quote from Thermo Fisher Scientific Inc.

TMO has a +12.77% win ESP and a #3 Zacks rank.

Hologic, Inc. HOLX: Hologic’s diagnostics business likely experienced robust growth in the first quarter of fiscal 2022 due to increased demand for COVID-19 testing. With that in mind, in November 2021, the company confirmed that its three SARS-CoV-2 tests detect the recently emerged Omicron variant of the coronavirus. This development should have boosted Hologic’s diagnostics revenue in the first fiscal quarter. The same month, Hologic launched the Novodiag system for on-demand molecular testing in Europe. This should have witnessed strong market uptake in the fiscal first quarter as it capitalized on the surge in coronavirus cases induced by the Omicron variant, thus adding to revenue. (Read more: Hologic to Report First Quarter Results: What’s in the Cards?)

Zacks’ consensus estimate for its first-quarter earnings per share is set at $1.21. Revenue is expected to be $1.12 billion.

Hologic, Inc. Price and EPS Surprise

Hologic, Inc. Price and EPS Surprise

Hologic, Inc. price-eps-surprise | Hologic, Inc. Quote

The company has an ESP on Earnings of -1.65% and a #2 Zacks Rank (Buy).

McKesson Corporation MCK: The company’s US pharmaceutical and specialty solutions segment likely acted as a key growth driver in the third quarter of fiscal 2022. The segment should have benefited from market growth and higher volumes of specialties during the quarter to appear. However, brand-to-generic conversions may have weighed on segment performance. The growing demand for COVID-19 testing (due to the resurgence of COVID-19) and improved primary care patient visits have likely positively impacted the company’s medical-surgical solutions segment. (Read more: McKesson to Report Third Quarter Results: What’s in the Cards?).

Zacks’ consensus estimate for its third-quarter earnings per share is set at $5.38. Revenue is expected to be $66.13 billion.

McKesson Corporation and EPS Surprise Award

McKesson Corporation and EPS Surprise Award

McKesson Corporation price-eps-surprise | Quote from McKesson Corporation

MCK has a +1.86% earnings ESP and a #3 Zacks rank.

Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

7 best stocks for the next 30 days

Just Released: Experts distill 7 elite stocks from the current Zacks No. 1 Ranking 220 Strong Buys list. They consider these tickers “most likely for early price increases.”

Since 1988, the full list has beaten the market more than 2 times with an average gain of +25.3% per year. So be sure to give your immediate attention to these 7 handpicked ones.

Discover them now >>

Click to get this free report

Boston Scientific Corporation (BSX): Free Stock Analysis Report

Thermo Fisher Scientific Inc. (TMO): Free Inventory Analysis Report

McKesson Corporation (MCK): Free Stock Analysis Report

Hologic, Inc. (HOLX): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Medical products

These Are The Top 10 Competitive Medical Products And Equipment…

(MENAFN-ValueWalk) Bru-nO / Pixabay

The medical products and equipment industry has experienced remarkable growth over the past decade. This industry consists of businesses that sell instruments, devices, or machines used in the prevention, diagnosis, or treatment of disease or ailment. The medical products and equipment industry, in turn, depends on many other industries to maintain its competitive edge, including telecommunications, software development, biotechnology and more. Let’s take a look at the top ten medical product and equipment companies.

Get the complete Henry Singleton series in PDF

Get the complete 4-part series on Henry Singleton in PDF. Save it to your desktop, read it on your tablet, or email it to co-workers

Q4 2021 Hedge Fund Letters, Talks & More

This fund focused on the financial sector has performed well in 2021

The Arbiter Global Financials fund generated an estimated return of 26%, compared to its benchmark, the MSCI ACWI Financials Index, which generated a return of 25.1%. In their year-end letter, which was obtained by ValueWalk, Arbiter’s Matthew Hankin and Ross Levin said they believe their portfolio is well positioned in the current environment. Q4 2021 Hedge Fund Letters, Conferences and Read More

Contents Pin up

  • 1. Ten largest medical products and equipment companies

  • 2. Dentsply Sirona (>$4 billion)

  • 3. Edwards Lifesciences (>$4.3 billion)

  • 4. Intuitive surgery (>$4.4 billion)

  • 5. Zimmer Biomet Holdings (>$7.9 billion)

  • 6. Boston Scientific (>$10.7 billion)

  • 7. Baxter International (>$11.3 billion)

  • 8. Stryker (>$14.8 billion)

  • 9. Becton Dickinson & Co. (>$17.2 billion)

  • 10. Danaher (>$20.5 billion)

  • 11. Abbott Laboratories (>$31.9 billion)

Ten largest medical products and equipment companies

We used the latest disposable income figures to rank the ten largest medical products and equipment companies. We only used Fortune 1000 companies for our list. Here are the ten largest medical products and equipment companies:

  • Dentsply Sirona (>$4 billion)
  • Founded in 1899 and based in Charlotte, North Carolina, this company designs, manufactures, sells and distributes professional dental products and technologies. Dentsply (NASDAQ: XRAY) has the following business segments: Technologies and Equipment and Consumables. Its shares are down more than 8% in the last three months and more than 6% in the last month. Dentsply Sirona reported a net loss of over $80 million in 2021 and a net profit of over $260 million in 2020.

  • Edwards Lifesciences (>$4.3 billion)
  • Founded in 1958 and based in Irvine, Calif., this company is dedicated to patient-focused medical innovations related to critical care monitoring and heart disease. Edwards Lifesciences Corp (NYSE: EW) products are classified into three categories: surgical structural heart, critical care and transcatheter heart valves. Its shares are down more than 9% in the last three months and more than 18% in the last month. Edwards Lifesciences reported net income of over $1.5 billion in 2021 and over $800 million in 2020.

  • Intuitive surgery (>$4.4 billion)
  • Founded in 1995 and based in Sunnyvale, California, this company develops, manufactures and markets da Vinci Surgical Systems and related instruments and accessories for invasive surgery. Intuitive Surgical, Inc. (NASDAQ: ISRG) products include da Vinci and Ion. Its shares are down more than 23% in the last three months and more than 24% in the last month. Intuitive Surgical reported net income of over $1.7 billion in 2021 and over $1 billion in 2020.

  • Zimmer Biomet Holdings (>$7.9 billion)
  • Founded in 1927 and based in Warsaw, Indiana, this company offers musculoskeletal health services. Zimmer Biomet Holdings Inc (NYSE: ZBH) has the following geographic segments: Americas and Global, EMEA and Asia Pacific. Its shares are down more than 17% in the last three months and more than 6% in the last month. Zimmer Biomet Holdings reported a net loss of over $130 million in 2021 and a net profit of over $1.10 billion in 2020.

  • Boston Scientific (>$10.7 billion)
  • Founded in 1979 and based in Marlborough, Mass., this company is an innovator of medical solutions that help improve patient health. Boston Scientific Corporation (NYSE: BSX) has the following business segments: Rhythm and Neuro, Cardiovascular and MedSurg. Its shares are down nearly 1% in the past three months, but up nearly 19% in the past year. Boston Scientific announced a net loss of more than $80 million in 2021 and a net profit of more than $4.70 billion in 2020.

  • Baxter International (>$11.3 billion)
  • Founded in 1931 and based in Deerfield, Illinois, this company markets kidney and hospital essential products, such as sterile intravenous solutions, infusion systems and devices, acute and chronic dialysis, etc. Shares of Baxter International Inc (NYSE: BAX) are up nearly 7% in the past three months, but down nearly 2% in the past month. Baxter International reported net income of over $1 billion in 2021.

  • Stryker (>$14.8 billion)
  • Founded in 1941 and based in Kalamazoo, Michigan, this company deals in technology products and services. Stryker Corporation (NYSE: SYK) has the following business segments: Orthopedics, MedSurg and Neurotechnology & Spine. Its shares are down more than 7% in the past three months. Stryker reported net income of over $1.90 billion in 2021 and over $1.50 billion in 2020.

  • Becton Dickinson & Co. (>$17.2 billion)
  • Founded in 1897 and based in Franklin Lakes, NJ, this company develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products. Becton Dickinson and Co (NYSE: BDX) has the following business segments: BD Medical, BD Life Sciences and BD Interventional. Its shares are up more than 5% in the past three months and nearly 1% in the past month. Becton Dickinson reported net income of over $2 billion in 2021 and over $800 million in 2020.

  • Danaher (>$20.5 billion)
  • Founded in 1969 and based in Washington, DC, this company designs, manufactures and markets medical, commercial, professional and industrial products and services. Danaher Corporation (NYSE: DHR) has the following business segments: life sciences, environmental and applied diagnostics and solutions. Its shares are down more than 9% in the past three months and nearly 11% in the past month. Danaher reported net income of over $6.30 billion in 2021 and over $3.60 billion in 2020.

  • Abbott Laboratories (>$31.9 billion)
  • Founded in 1888 and based in Abbott Park, Illinois, this company discovers, develops, manufactures and sells a line of health care products. Abbott Laboratories (NYSE:ABT) includes the following business segments: diagnostics, medical devices, established pharmaceuticals and nutritional products. Its shares are down nearly 3% in the past three months and nearly 10% in the past month. Abbott reported net income of over $7 billion in 2021 and over $4.40 billion in 2020.

    Updated January 31, 2022 at 10:22 a.m.

    MENAFN31012022005205011743ID1103620332


    Legal disclaimer: MENAFN provides the information “as is” without warranty of any kind. We assume no responsibility for the accuracy, content, images, videos, licensing, completeness, legality or reliability of any information in this article. If you have any complaints or copyright issues related to this article, please contact the provider above.

    read more
    Medical products

    COVID-19 Trade Policy Database: Food and Medical Products

    Many governments are using trade policy measures to increase the availability of medical and food products during the COVID-19 pandemic. It is important to monitor them to assess their impact, effectiveness and potential international spillovers, especially on countries that depend on imports of these essential products. This database is derived from official sources, media reports and other public sources and is updated monthly. the the underlying data can be found here.

    Medical sector


    Food sector

    Picture

    The data on this page is the result of a partnership between the Global Governance Program of the Robert Schuman Center for Advanced Study at the European University Institute, the Global Trade Alert initiative at the University of St. Gallen and the Trade and Regional Integration Unit of the World Bank Group. The project collects information on trade policy changes affecting medical and food products since the beginning of 2020. Its objective is to document the cumulative use of trade policies and changes between countries over time. A methodological note describing the specific products and types of policies covered by the monitoring exercise, and how the data is collected and processed, is available here.

    ⬇️Download Excel with underlying data

    ⬇️Download the zip file with additional digits

    read more
    Medical products

    BPL obtains a license from the National Medical Products Administration (NMPA) to market the product ALBUMINEX® 25% in China

    – This is the first-ever approval of a GLP product in China

    – The Chinese albumin market is the largest in the world

    – A distribution agreement has been signed and is in place

    – Expected launch mid-2022

    ELSTREE, United Kingdom, January 24, 2022 /PRNewswire/ — Organic Products Laboratory (BPL)a leading manufacturer of plasma-derived protein therapies, based in Elstree, UK, today announced that the National Medical Products Administration (NMPA) for China has granted BPL a license to market the product ALBUMINEX® 25% China. The Chinese albumin market is the largest in the world in terms of volume at over 600 million grams per year with >50% of volume imported and expectations are for continued growth.

    This is the first ever GLP product approval in China and constitutes a major milestone in the company’s history. The first product shipments are expected in the first half of 2022.

    BPL has a long history in manufacturing and supplying plasma protein therapies, including over 25 years of worldwide experience with albumin. For more information, please visit www.bplgroup.com.

    David GaoCEO and Vice President of BPL says, “ALBUMINEX® 25% is now approved in the two largest albumin markets in the world, the United States and China. Our US launch exceeded our expectations and we look forward to a very successful launch in China the middle of this year. Many thanks to all members of the company who collaborated and supported these efforts. We are truly grateful for all your hard work.”

    “We are delighted to be able to offer ALBUMINEX® 25% to the sick in China“, noted Bob Rossilli, US President and Chief Commercial Officer, Global Business. “Obtaining this important full license and distribution agreement in China strongly reflects our current plan for global expansion while underscoring our corporate mission of providing a continuous supply of high quality plasma-derived products worldwide, supporting both healthcare professionals and patients alike. day-to-day. »

    About the Organic Products Laboratory (BPL)
    Recognizing the importance of plasma and drawing on many years of industry experience, BPL provides high quality plasma-derived medicines to meet the needs of clinicians, patients and customers worldwide. Based in the UKwith US offices in Durham, North Carolinaand plasma collection centers across United States, we are dedicated to the production of drugs for the treatment of immune deficiencies, bleeding disorders and infectious diseases as well as for intensive care. BPL invests in the latest R&D, technology and manufacturing methods, and is constantly adapting to ensure that we continue to effectively serve all of our stakeholders. For more information, visit http://www.bplgroup.com Where https://www.bpl-us.com.

    BPL consists of two operating divisions – BPL Plasma and BPL Therapeutics. BPL Plasma, headquartered in Austin, TX and operating in the United Statescollects donor plasma At approximately 28 centers across the United States, BPL Plasma employs more than 900 people to meet donor needs and ensure high quality plasma collection at all of their centers. Plasma collection is regulated by the FDA and MHRA, and BPL Plasma follows industry guidelines. BPL Plasma operates clean and safe plasma facilities with trained staff dedicated to supporting donors throughout the process that leads to plasma donation. Plasma is shipped to BPL Therapeutics headquarters in Elstree, UK. Plasma is fractionated, purified and filled through the efforts of our more than 1,000 employees involved in production, quality, R&D, sales, customer service and administrative activities. GLP plasma-derived medicinal products are commercially available in the UK, United Statesand over 30 other countries around the world through our network of local affiliates and distribution partners.

    Contact:
    Katie Lynch
    APCO in the world
    [email protected]

    Quote

    Show original content:https://www.prnewswire.com/news-releases/bpl-granted-licence-from-the-national-medical-products-administration-nmpa-to-market-albuminex-25-product-to-china-301466153. html

    SOURCE Bio product laboratory

    read more
    Medical products

    150 million worth of fake COVID test kits and other medical products seized

    BDC

    Fake coronavirus antigen test kits, face masks, Chinese medicines and other counterfeit goods worth 150 million pesos were seized from a warehouse in Manila on Friday, the customs office reported. .

    Among the confiscated goods were “Clungene COVID-19 antigen test kits, counterfeit LianHua Chinese herbal medicines and fake 3M N95 face masks,” the office said in a statement on Monday.

    The brand of the test kit is not one of those approved by the Philippine Food and Drug Administration (FDA). A list of certified test kits is available at https://www.fda.gov.ph/fda-advisory-no-2021-2094-list-of-covid-19-test-kits-with-fda-special-certification-and-performance-validation-conducted- and-or-recommended-by-the-research-institute-in-tropical-medicine-ritm/.

    Other goods found in the warehouse were “goods infringing intellectual property rights, such as clothing from brands such as Nike, Fila, Converse, Adidas, as well as Louis Vuitton bags, wallets, phone accessories and Gucci and others”.

    The Bureau of Customs said the warehouse owner, a Chinese national, has been arrested and will face charges of violating the Customs Modernization and Tariffs Act as well as FDA rules.

    “It is certain that the owner of the warehouse will face the weight of the law. This is neither the first nor the last time that we will see these groups operating on our shores, ”said the deputy commissioner of customs at the Intelligence, Raniel T. Ramiro.

    “Our job here is to make sure these don’t make it to local markets.”

    read more
    Medical products

    Greenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH, Becomes Exclusive Distribution Partner for Selected Little Green Pharma Extracts in Germany

    AMP has entered into an exclusive three-year pharmaceutical distribution agreement for LGP Classic Full-Plant Cannabis Extract Oils. LGP medical cannabis products have been registered for sale with the relevant authorities in Germany and include 20:5 LGP Classic and 10:10 LGP Classic extract oils in 30 and 50 milliliter sizes. Doctors and pharmacists can find more information about the product or order on the AMP website: https://amp-eu.com/doccheck-login.

    LGP is a pioneer and leader in the production of medical cannabis extract oils with GMP cultivation facilities in Australia and Denmark, whose medical cannabis preparations provide various THC and CBD profiles available as LGP Classic medical cannabis oils. LGP medicinal cannabis oils are made from a whole plant (full spectrum) extracted with medium chain triglyceride (MCT) oil. LGP was among the first medical cannabis companies to produce and export medical cannabis oils to Germany and continues to build its reputation in Europe by being selected as the main supplier of medicinal cannabis extract oil in France two-year medical cannabis trials conducted by the National Agency for the Safety of Medicines and Health Products (ANSM).

    LGP medical cannabis extract oils will also be used in the clinical study of the Waldhausklinik Deuringen gGmbH (“Waldhausklinik”) on the therapeutic use of cannabis extracts focused on the treatment of pain in patients with chronic pain. multilocular. Waldhausklinik is a non-profit acute care hospital for internal medicine in the Free State of Bavaria and has entered into a research collaboration with AMP on the efficacy and safety of medical cannabis.

    dr. Stefan Feuerstein, President and Director of Greenrise Global and Managing Director of AMP, said, “We see the industry maturing with the growth of cannabis-based pharmaceuticals rather than flowers and we are excited to add medical cannabis extracts. LGP to our portfolio.

    M/s. Fleta Solomon, Managing Director of Little Green Pharma, said: “We have made it our strategic goal to be one of the leading producers and distributors of medical cannabis extracts in Europe, which means being a leader in Germany, the world’s largest medical cannabis market. Our partnership with Greenrise Global’s subsidiary, AMP Alternative Medical Products GmbH, puts us on the right path.”

    About Little Green Pharma
    Little Green Pharma is a vertically integrated and geographically diverse global medicinal cannabis and psychedelics company, with operations ranging from cultivation and production to manufacturing and distribution.

    The Company has two global production sites for the manufacture of its own brand and white label GMP grade medical cannabis product lines, being a 21,500m2 culture and 4000m2 GMP manufacturing facility capable of producing over 20 tons of medicinal cannabis biomass per year located in Denmark (EU) and an indoor cultivation and manufacturing facility located at Western Australia capable of producing ~3 tons of medicinal cannabis biomass per year. The Company is also licensed to supply psilocybin and is currently expanding its WA production facilities to produce psilocybin medicines.

    Little Green Pharma cannabis products comply with all requirements of the Danish Medicines Agency and Therapeutic Goods Administration (Australia) regulations and testing requirements. With a growing range of products containing different ratios of active ingredients, Little Green Pharma supplies medical grade cannabis products to the Australian, European and overseas markets.

    The company has a strong focus on providing patient access to the emerging global medicinal cannabis market and is actively engaged in promoting education and awareness programs, as well as participating in clinical surveys and projects. research to develop new innovative delivery systems.

    For more information about Little Green Pharma, visit: www.littlegreenpharma.com

    FOLLOW US ON:

    Twitter: https://twitter.com/LittleGreenPHAR
    LinkedIn: https://www.linkedin.com/company/little-green-pharma
    Facebook: https://www.facebook.com/littlegreenpharma

    About Greenrise Global Brands

    Greenrise Global helps people realize the beneficial properties of cannabis. Greenrise Global is a publicly traded Canadian company with two German operating subsidiaries: Greenrise GmbH (“Greenrise Wellbeing”) and AMP Alternative Medical Products GmbH (“AMP”). Greenrise Wellbeing is a CBD wellness company based in Hamburg, with brands such as Herbify and CANAVEX® in his wallet.

    AMP Alternative Medical Products GmbH is based in Erfurt and supplies medical cannabis products to pharmacies across Germany, including the medical cannabis brands of Aphria, Bedrocan, Little Green Pharma and the AMP branded product line and sold through its national sales team. AMP complies with the German Narcotics Act (BtMG) and the regulatory requirements of the Free State of Thuringia, ensuring that products imported from around the world and sold in Germany Meet the European Union Good Manufacturing Practice (EU-GMP) standard.

    For more information about Greenrise Global, please visit www.greenriseglobal.com

    FOLLOW US ON:

    Twitter: https://twitter.com/GreenriseGlobal
    LinkedIn: https://linkedin.com/company/greenriseglobal/
    Instagram: https://www.instagram.com/greenriseglobal/

    Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

    This press release contains forward-looking statements based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and their calendar. Although the Company believes that the expectations expressed in these forward-looking statements are based on reasonable assumptions, these statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Accordingly, actual results may differ materially from those expressed in such forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless the otherwise required by law.

    SOURCE Greenrise Global Brands Inc.

    For more information: GLOBAL GREENRISE CONTACT: Hendrik Knopp, Director, [email protected], +1 236-833-1602; CONTACT AMP ALTERNATIVE MEDICAL PRODUCTS: Dr. Stefan Feuerstein, Managing Director, [email protected], +49-172-6945663; Media inquiries: Valeria Bravo, Corporate Communications and Media, [email protected], +1 604-689-7533; LGP CONTACT: Alistair Warren, Company Secretary, [email protected], +61 8 6280 0050; Fleta Salomon, President and CEO, [email protected] +61 8 6280 0050

    read more
    Medical products

    FDA Suspends Non-Mission-Critical Domestic and Foreign Inspections – Medical Product Supply Chain Week in Review | Alston and bird

    Just before the New Year holidays, the FDA announced it was suspending non-mission-critical domestic and foreign inspection activities. The FDA amended the EUA of the Moderna COVID-19 vaccine recall. The Center for Drug Evaluation and Research has released its annual report. This week, the Senate HELP Committee approved the appointment of Dr. Robert Califf as Commissioner of the FDA. The senators introduced legislation that would require certain foreign establishments to register with the FDA. Please see details of these and other supply chain developments below:

    • On December 29, the FDA implemented changes to its inspection program due to record levels of COVID-19 infections. National mission-critical inspections will continue until January 19, while “some inspection activities” have been temporarily postponed. Mission-critical foreign inspections will continue; however, the agency will reassess feasibility if travel restrictions warrant. The program of priority surveillance foreign inspections which was to begin in February 2022 has been interrupted. It is likely that the FDA will not conduct any uncritical inspections, domestic or foreign, until the United States has passed the peak of the current omicron wave.
    • January 4, HHS amended its declaration under the Public Preparedness and Emergency Preparedness Act (PREP) to include pharmacists and certain pharmacy trainees as “qualified persons” who can administer flu vaccines in states where they are not not authorized or certified. The PREP Act allows the Secretary of HHS to issue a statement and grant immunity from liability to such individuals.
    • On January 5, White House Press Secretary Jen Psaki and Port Envoy to the White House Supply Chain Task Force John Porcari tenuous a briefing on the progress of supply chain improvements and new actions to come. Porcari reported that consumers received 97% to 99% of their packages on time or with minimal delays during the holiday season. Porcari added that the ports of Los Angeles and Long Beach are imposing a new tax on long-lived empty containers. Porcari stressed that procedures are in place to prioritize the distribution of medical supplies. One such procedure is to “bulk stow” medical supplies on ships for easy identification and retrieval. He also discussed the impact of the omicron variant on operations and the procedures in place to deal with any disruptions.
    • On January 7, the FDA amended the EUA of the Moderna COVID-19 vaccine recall. The agency authorized the administration of the booster dose five months (previously six months) after the primary vaccination of the vaccine.
    • On January 10, the FDA Posted draft guidance, “Notification to the FDA of a Permanently Discontinuing or Discontinuing Manufacture of a Device Under 506J of the FD&C Act”. These draft guidelines, authorized under the CARES Act of 2020, are intended to prevent shortages of medical devices before and during a public health emergency and to provide a mechanism by which manufacturers notify the FDA of their intention to cease or suspend production. The draft guidelines apply to “devices essential to public health during a public health emergency, including those that are essential to life, sustaining life or intended for use in the medical care of emergency or during surgery” or “devices for which the FDA determines information about possible significant supply disruptions are needed during or before a public health emergency. Comments are due no later than March 11, 2022.
    • On January 10, Senators Gary Peters (D-MI) and Susan Collins (R-ME) introduced S. 3449, a bill that would require foreign drug and device establishments to register with the FDA whether or not the drug or device undergoes further processing at a separate facility outside the United States. States before being imported into the United States. The goal is to give the FDA greater regulatory oversight authority to not only monitor products entering the supply chain and determine shortages, but also ensure that products are safe for the public. The Bill has been referred to the Health, Education, Labor and Pensions (HELP) Committee.
    • On January 13, the Senate HELP committee vote 13 to 8 to advance the President’s nominee for FDA Commissioner Dr. Robert Califf. His confirmation hearing took place on December 14, 2021. The nomination now goes to the Senate for a final vote and confirmation.
    • FDA Center for Drug Evaluation and Research (CDER) published its annual report, “Advancing Health Through Innovation: New Drug Therapy Approvals”. The report highlights CDER approvals of new therapies, biosimilars, and new indications for approved products. A post-marketing safety surveillance review is also included. The number of products approved (50) was above average despite the pandemic-related challenges, with more than half (27) being first-line drugs. CDER also met its action targets under the Prescription Drug User Fees Act for 49 of the 50 submissions.

    [View source.]

    read more
    Medical products

    Monetizing healthcare with disposable medical products – Hunter Women’s Chronicle

    Reading time:3 minutes, 13 seconds

    This report analyzes the single-use endoscope market, with the United States being the largest. The monetization of healthcare with disposable medical devices and recurring revenue from monitoring, a smaller and lighter product, creates new opportunities for broader consumer and commercial markets. Improving product quality, reducing costs and profitable growth are the keys to dominating this lucrative market. However, poor design and prototype design can be linked to several challenges. Technological innovation, integrated services and reduced R&D costs could significantly increase a company’s revenue.

    Click on the tab below to benefit from the sample copy of the report

    Sample request

    Introduction to Single Use Endoscopes Market

    Strict government regulations make it difficult for doctors, hospitals and large corporations to raise capital in the current economic climate. There has been a shift in the way pharmaceutical organizations have approached the development of disposable medical products. Pharmaceutical companies are now offering their services and expertise in this area to medical device manufacturers without costly milestone payments to third parties.

    Global Endoscope Explosion

    Slowing economic growth and rising import tariffs have led to a slowdown in global healthcare spending, which presents a unique opportunity for the disposable medical products market. This can be attributed in particular to the greatly increased use of endoscopes in recent years. According to Global Industry Analysts (GIA) Inc., one of the leading research companies, there were around 1 billion daisies installed globally across the globe in 2020 alone.

    Defining the key players in the single use endoscopes market

    The pharmaceutical industry is striving to develop and introduce more disposable products, which makes the single-use endoscope market an attractive area for new investment. A few years ago, only knives and needles were included in the disposable medical market as antibacterials. The discovery of a new way to use endoscopes, which includes test strips to determine the appropriate medications that could be prescribed without harming patients while they undergo medical tests, has increasingly served to increase the number of observers included in this market.

    An analysis of the low, medium, high and technological platform; their role in product development

    In March 2020, the American Society of Gastroenterology declared that endoscopes are writable and disposable. This means that with proper treatment and monitoring, these devices can last up to six months, providing a frictionless revenue stream with negligible cost to hospitals. For insights into a new market segment and the opportunities ahead, download the report Single-Use Endoscopes Market: Monetizing Healthcare with Disposable Medical Products today.

    Regulations and cost variables in the preparation of single-use endoscopes

    The use of disposable medical instruments, such as endoscopes, is increasing rapidly. This is due to government regulations and regulatory requirements that reduce costs for outsourced healthcare providers. Additionally, the demand for more flexible options in disposable medical devices is pushing manufacturers towards more specialized instruments with various functionalities.

    Click on the tab below for the instant purchase of the report with a flat rate discount of $500

    Instant Buy Request

    Supply chain approach for manufacturer pharmaceutical process for disposable medical products

    Due to stringent government regulations and increasing attention to patient safety and human factor issues, the healthcare industry is moving towards a system where the emphasis is on the quality life cycle. Patient safety issues leading to contaminated supply chains pose a major challenge to manufacturers. Reports show that healthcare interventions are highly dependent on the use of home medical products, but it has been difficult from a business perspective to effectively plan for a market with multiple users of these products. Manufacturers are required to closely monitor the demand for single-use endoscopes for the development of replacement products. A supply chain approach will be more effective in achieving affordability and meeting regulatory requirements unlike other methods that manufacturers have tried in the past.

    happy

    happy


    0 %

    Sad

    Sad


    0 %

    Excited

    Excited


    0 %

    Sleepy

    Sleepy


    0 %

    Angry

    Angry


    0 %

    Surprise

    Surprise


    0 %

    read more
    Medical products

    FDA suspends non-mission-critical domestic and foreign inspections – Medical Products Supply Chain Week in Review – Food, Drugs, Healthcare, Life Sciences

    United States: FDA suspends non-mission-critical domestic and foreign inspections – Medical Product Supply Chain Week in Review

    To print this article, all you need to do is be registered or log in to Mondaq.com.

    Just before the New Year holidays, the FDA announced it was suspending non-mission-critical domestic and foreign inspection activities. The FDA amended the EUA of the Moderna COVID-19 vaccine recall. The Center for Drug Evaluation and Research has released its annual report. This week, the Senate HELP Committee approved the appointment of Dr. Robert Califf as Commissioner of the FDA. The senators introduced legislation that would require certain foreign establishments to register with the FDA. Please see details of these and other supply chain developments below:

    • On December 29, the FDA implemented changes to its inspection program due to record levels of COVID-19 infections. National mission-critical inspections will continue until January 19, while “some inspection activities” have been temporarily postponed. Mission-critical foreign inspections will continue; however, the agency will reassess feasibility if travel restrictions warrant. The program of priority surveillance foreign inspections which was to begin in February 2022 has been interrupted. It is likely that the FDA will not perform any uncritical inspections, domestic or foreign, until the United States has passed the peak of the current omicron wave.
    • January 4, HHS amended its declaration under the Public Preparedness and Emergency Preparedness Act (PREP) to include pharmacists and certain pharmacy trainees as “qualified persons” who can administer flu vaccines in states where they are not not authorized or certified. The PREP Act allows the Secretary of HHS to issue a statement and grant immunity from liability to such individuals.
    • On January 5, White House Press Secretary Jen Psaki and Port Envoy to the White House Supply Chain Task Force John Porcari tenuous a briefing on the progress of supply chain improvements and new actions to come. Porcari reported that consumers received 97% to 99% of their packages on time or with minimal delays during the holiday season. Porcari added that the ports of Los Angeles and Long Beach are imposing a new tax on long-lived empty containers. Porcari stressed that procedures are in place to prioritize the distribution of medical supplies. One such procedure is to “bulk stow” medical supplies on ships for easy identification and removal. He also discussed the impact of the omicron variant on operations and the procedures in place to deal with any disruptions.
    • On January 7, the FDA amended the EUA of the Moderna COVID-19 vaccine recall. The agency authorized the administration of the booster dose five months (previously six months) after the primary vaccination of the vaccine.
    • On January 10, the FDA Posted draft guidance, “Notification to the FDA of a Permanently Discontinuing or Discontinuing Manufacture of a Device Under 506J of the FD&C Act.” These draft guidelines, authorized under the CARES Act of 2020, are intended to prevent shortages of medical devices before and during a public health emergency and to provide a mechanism by which manufacturers notify the FDA of their intention to cease or suspend production. The draft guidelines apply to “devices essential to public health during a public health emergency, including those that are essential to life, sustaining life or intended for use in the medical care of emergency or during surgery” or “devices for which the FDA determines information about possible significant supply disruptions are needed during or before a public health emergency.” Comments are due by March 11, 2022.
    • On January 10, Senators Gary Peters (D-MI) and Susan Collins (R-ME) introduced S. 3449, a bill that would require foreign drug and device establishments to register with the FDA whether or not the drug or device undergoes further processing at a separate facility outside the United States. States before being imported into the United States. The goal is to give the FDA greater regulatory oversight authority to not only monitor products entering the supply chain and determine shortages, but also ensure that products are safe for the public. The Bill has been referred to the Health, Education, Labor and Pensions (HELP) Committee.
    • On January 13, the Senate HELP committee vote 13 to 8 to advance the President’s nominee for FDA Commissioner Dr. Robert Califf. His confirmation hearing took place on December 14, 2021. The nomination now goes to the Senate for a final vote and confirmation.
    • FDA Center for Drug Evaluation and Research (CDER) published its annual report, “Advancing Health Through Innovation: Approvals of New Drug Therapies”. The report highlights CDER approvals of new therapies, biosimilars, and new indications for approved products. A post-marketing safety surveillance review is also included. The number of products approved (50) was above average despite pandemic-related challenges, with more than half (27) being first-line drugs. CDER also met its action targets under the Prescription Drug User Fees Act for 49 of the 50 submissions.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

    read more
    Medical products

    2022 Emergency Oxygen Kits Market Analysis by Major Key Players

    New Jersey, United States,-

    A new report titled “(Emergency Oxygen Kits Market)” by Market Research Intellect sheds light on the industry dynamics and current and future trends that play a key role in determining the expansion of the market. ‘business. The report also highlights the key driving factors and restraints affecting the growth. For a comprehensive understanding, experts reviewed regulatory scenarios, market entry strategies, industry best practices, pricing strategies, technology and consumer environment, sales and demand outlook . It also included growth estimates to provide users with accurate statistics and facts. The report will provide readers with a broader and more transparent picture of the overall scenario.

    Corona impact outlook 19

    This section of the report shows the impact of the global Corona outbreak on businesses. The report describes the impact on manufacturing activity, production, demand, supply chain, logistics management and distribution networks. The analysts have highlighted the measures or strategies taken by the company to combat the impact of Corona 19. In addition, they have identified a major opportunity to emerge after Corona 19. This will help players take advantage of the opportunity to recover losses and stabilize the activity.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=559836

    Additionally, market revenue based on region and country is provided in the Emergency Oxygen Kits report. The authors of the report also shed light on common business tactics adopted by players. Key players of the global Emergency Oxygen Kits market and their comprehensive profiles are included in the report. Additionally, investment opportunities, recommendations, and current trends in the global Emergency Oxygen Kits market are mapped by the report. Using this report, key players in the global Emergency Oxygen Kits Market will be able to make sound decisions and plan their strategies accordingly to stay ahead.

    The competitive landscape is an essential aspect that every key player must know. The report highlights the competitive scenario of the Global Emergency Oxygen Kits Market to know the competition at country and global level. Market experts have also provided an outline of each major player in the global Emergency Oxygen Kits market, considering key aspects such as business areas, production, and product portfolio. Additionally, the companies in the report are studied based on key factors such as company size, market share, market growth, revenue, production volume, and profit.

    Major Players Covered by Emergency Oxygen Kits Markets:

    • Mada Medical Products
    • Inc.
    • Marine Medical Antibes
    • Corporate Life
    • FERNO
    • Allied Health Care
    • Mega medical

    Emergency Oxygen Kits Market Split By Type:

    Emergency Oxygen Kits Market Split By Application:

    • Hospitals and Clinics
    • Industrial and factories
    • Public facilities

    The Emergency Oxygen Kits Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Emergency Oxygen Kits Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Emergency Oxygen Kits market and its growth potential in the years future.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=559836

    Scope of the Emergency Oxygen Kits Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Analysis of the Emergency Oxygen Kits Market can be represented as follows:

    Each regional Emergency Oxygen Kits industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global emergency oxygen kit market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Answers to key questions in the report:

    • What is the growth potential of the Emergency Oxygen Kits markets?
    • Which product segment will take the lion’s share?
    • Which regional market will impose itself as a precursor in the years to come?
    • Which application segment will grow at a rapid pace?
    • What are the growth opportunities that may emerge in the Lock Washers industry in the coming years?
    • What are the major challenges that the global emergency oxygen kit markets may face in the future?
    • Who are the leading companies in the Global Emergency Oxygen Kits Market?
    • What are the key trends that are positively impacting market growth?
    • What are the growth strategies considered by the players to maintain their hold in the global emergency oxygen kits market?

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-emergency-oxygen-kits-market-size-forecast/

    The study thoroughly explores the profiles of major market players and their major financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the Emergency Oxygen Kits market production, revenue, market share and growth rate for each key company, and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical failure data of emergency oxygen kits from 2016 to 2020 and forecast to 2021-2029.

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical products

    Alimed, Bioseal, Cypress Medical Products, Deroyal, Dukal Corporation, Dynarex Corporation – Industrial Computing

    The global tourniquet market 2021 The report is a collection of details related to each market related parameter. Each aspect is studied in detail in the analysis report. The market analysis report provides a comprehensive analysis of all financial topics associated with the Tourniquet industry. The growth pattern observed in the Turnstile industry performance over time is studied in the market report. The study helps provide an in-depth understanding of fundamental changes in the state of the market over time. The analysis report also provides an in-depth discussion about all the aspects that are likely to impact on the performance of the Tourniquet market.

    The report profiles the following companies, which include

    • Alimed
    • Bioseal
    • Cypress Medical Products
    • Deroyal
    • Dukal Corporation
    • Dynarex Company
    • Graham-Field Inc
    • Integrated Life Sciences
    • Medline
    • Cardinal Health
    • Patterson Medical
    • Stryker
    • Tetra Medical Supply Corp
    • VBM
    • Zimmer
    • Longtai
    • Lantian

    The industry report analyzes the set of deliberate movements in the Tourniquet industry on a global level. The research includes an in-depth study of the growth and development activities taking place in the Tourniquet industry. The research based on the global Turnstiles market provides details associated with fundamental events and investments made in the market. The research provides details related to popular trends widely accepted by entities in the Tourniquet market. The industry analysis report includes an in-depth discussion of several industry analysis strategies used by researchers while documenting the research.

    Download a free sample at: https://courant.biz/report/global-tourniquet-market/61152/

    Global Tourniquets Market: Product Segment Analysis

    • Non-inflatable tourniquets (electronic tourniquet systems connected to inflatable armbands.)
    • Pneumatic tourniquets, the cuffs of which are inflated by compressed gas.

    Global Tourniquets Market: Application Segment Analysis

    • Surgical framework
    • Emergency use

    Global Tourniquet Market: Regional Segment Analysis

    • United States
    • Europe
    • Japan
    • China
    • India
    • South East Asia

    Research includes the analysis of all deliberate movements, policies, technological developments, discoveries, trends, tools, products, development plans, news, etc. The analysis of the global Tourniquet market covers detailed data about the anticipated growth rate for the anticipated era. In addition, a detailed discussion about the future scope of the Turnstile market is also included in the study report. The report on the global Tourniquet industry focuses on the expansion of the market in the coming times. It offers readers detailed data on several strategies and development plans implemented by market entities across the world. The report aims to provide a 360 degree view of the tourniquet industry.

    The content of the study topics includes a total of 10 chapters:

    1. About Tourniquet Industry (Industry Definition, Types, Main Market Activities)
    2. Global Market Competition Landscape (Markets by Regions, Market Revenue (M USD), Market Sales and Growth Rate 2016-2021, Major Players Revenue by Regions)
    3. Global Tourniquet Market Share (Production and Revenue Market Share by Regions and Players)
    4. Supply chain (raw material analysis, raw material market analysis, cost of production, manufacturing equipment and end user analysis)
    5. Company Profiles (Company Details, Product Info, Revenue, Profit Analysis)
    6. Globalization and commerce (business locations, supply channels, marketing strategy, etc.)
    7. Distributors and customers (Information on the main distributors and customers by region)
    8. Import, export, consumption and consumption value by major countries
    9. Global Tourniquet Market Forecast to 2026 (Demand, Price Revenue, Regions, Types, Applications)
    10. Key success factors and market overview

    Access the full report here:https://courant.biz/report/global-tourniquet-market/61152/

    Customization of the report:

    This report can be customized to meet customer requirements. Please connect with our sales team ([email protected]), which will make sure you get a report that’s right for you. You can also contact our leaders at +1 (210) 807 3402 to share your research needs.

    Contact us:
    Nancy smith
    Business sales specialist
    [email protected]
    Phone number: United States: +1 (210) 807 3402
    current.biz

    read more
    Medical products

    Greenrise Global’s medical cannabis subsidiary, AMP Alternative Medical Products GmbH, announces the start of dronabinol sales in Germany

    Dronabinol is pure tetrahydrocannabinol (THC) and is registered as an active pharmaceutical ingredient (API) and has been registered for sale with the competent authorities in Germany. Doctors and pharmacists can find more information about the product or order on the AMP website: https://amp-eu.com/doccheck-login/

    AMP and Eurox have entered into a non-exclusive agreement for the marketing and distribution of Dronabinol for sale in pharmacies from February 2022. In preparation for the launch of pharmacy sales, AMP trained its national sales team on the benefits of Dronabinol for patients to physicians and preparation methods for pharmacists.

    Eurox was one of the first medical cannabis companies to produce Dronabinol made in Germany to one of Europe largest GMP facilities located in Hesse, Germany and controls the entire supply chain, from cultivation, production to distribution, ensuring a stable and efficient supply to its customers.

    Neil Smith, the President of Eurox commented: “If you believe in ‘Made in Germany‘, it means Eurox. AMP’s focus on serving German patients and its national sales coverage make it an ideal partner for us.”

    dr. Stefan Feuerstein, President and Director of Greenrise Global and Managing Director of AMP, “The German market is gravitating towards pharmaceuticals as health authorities tighten their regulatory oversight to ensure patient safety. Dronabinol is a well-established product in the Germany, and we expect it to be one of our best-selling products this year.”

    About Eurox Pharma

    Eurox Pharma is one of Europe leading medical cannabis companies. Eurox is vertically integrated, with:

    • Fully owned German subsidiaries responsible for product development and intellectual property.
    • Manufactured to EU GMP in Germany with a German pharmaceutical partner.
    • A cultivation facility at Portugal ensure vertical integration and independence of supply.
    • A significant minority stake in Integro Medical Clinics, a UK-registered medical cannabis clinic.
    • Various high caliber distribution partnerships in Germany and other European countries and its own sales team.

    For more information on Eurox, please visit www.eurox-pharma.com

    About Greenrise Global Brands

    Greenrise Global helps people realize the beneficial properties of cannabis. Greenrise Global is a publicly traded Canadian company with two German operating subsidiaries: Greenrise GmbH (“Greenrise Wellbeing”) and AMP Alternative Medical Products GmbH (“AMP”). Greenrise Wellbeing is a CBD wellness company based in Hamburg, with brands such as Herbify and CANAVEX® in his wallet.

    AMP is based in Erfurt and supplies medical cannabis products to pharmacies across Germany, including the medical cannabis brands of Aphria, Bedrocan, Small green pharmacy and GPAof the branded product line and sold through its national sales team. AMP complies with the German Narcotics Act (BtMG) and the regulatory requirements of the Free State of Thuringia, ensuring that products imported from around the world and sold in Germany Meet the European Union Good Manufacturing Practice (EU-GMP) standard.

    For more information about Greenrise Global, please visit https://greenriseglobal.com/

    FOLLOW US ON:

    Twitter: https://twitter.com/GreenriseGlobal
    LinkedIn: https://linkedin.com/company/greenriseglobal/
    Instagram: https://www.instagram.com/greenriseglobal/

    Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

    This press release contains forward-looking statements based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and their calendar. Although the Company believes that the expectations expressed in these forward-looking statements are based on reasonable assumptions, these statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Accordingly, actual results may differ materially from those expressed in such forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless the otherwise required by law.

    SOURCE Greenrise Global Brands Inc.

    For further information: GREENRISE CONTACT: Hendrik Knopp, Director, [email protected], +1 236-833-1602; Media inquiries: Valeria Bravo, Corporate Communications and Media, [email protected], +1 604-689-7533; AMP CONTACT: Dr. Stefan Feuerstein, President, Greenrise Global Inc., Managing Director, AMP Alternative Medical Products GmbH, [email protected], +49 151 7284 4643; EUROX CONTACT: Jessica Smith, International Director of Public Relations and Marketing, [email protected]

    read more
    Medical products

    FDA Approves Booster Dose for Teens – Medical Products Supply Chain Weekly Review | Alston & Bird

    During the holidays, the CDC updated its recommendations for quarantine and post-exposure masking. The FDA has cleared the booster dose of Pfizer vaccine for adolescents 12 to 15 years old and for immunocompromised children 5 to 11 years old. The FDA has released draft guidelines for manufacturers of medical devices marketed under EUA or enforcement discretion policies to help them transition to traditional approvals at the end of the health emergency. public. The Administration has convened the Supply Chain Disruption Working Group for an update on its progress. The FDA has issued guidance for lab staff and manufacturers on technical considerations for new strains in developing COVID-19 tests and reading current test results. Please see details of these and other supply chain developments below:

    • On December 22, the President convened a meeting of the Supply Chain Disruption Task Force with stakeholders from the business sector. The implementation of the recommendations of the Working Group has led to drastic improvements in the flow of goods in the main ports. Dwell times in the ports of Long Beach and Los Angeles have been reduced from 12 to 5 days and from 9 to 4 days, respectively. The Port of Savannah with the Georgia Ports Authority has set up inland pop-up container sites that are accessible by truck and train, speeding up the movement of containers to these locations. The involvement of commercial carriers has also accelerated the movement of goods through the supply chain. The ports of Long Beach and Los Angeles are still operating towards 24/7 operation.
    • On December 22, administration officials met with EU officials on COVID-19 and global health security to assess each country’s progress towards the goal of the partnership cemented in September to defeat the global pandemic . Increasing the global production of vaccines and supplies is a major component of the initiative. The meeting also focused on developing strategies for future actions, including establishing a source of funding for such efforts.
    • On December 22, the FDA Center for Device and Radiological Health (CDRH) released a draft guidance document “Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUA) During Coronavirus Disease 2019 (COVID-19) Public health emergency ”and“ Transition plan for medical devices that fall under enforcement policies during the public health emergency of coronavirus disease 2019 (COVID-19). These proposed transition plans are guided by the principles of ensuring continued access of patients, providers and consumers to quality products; adequately prepare manufacturers and other stakeholders for the transition; and avoid supply chain disruptions. The plans would provide guidance on the requirements and timelines for marketing presentations. Assessment methods would include a risk-based approach that takes into account the intended uses, regulatory history and the level of risk of the device. A notice will be published for manufacturers 180 days before the expiration date of the EUA declaration. An EUA declaration is separate from a public health emergency declaration. Once an EUA declaration is terminated, all EUAs authorized under the EUA declaration are also terminated. Manufacturers must notify the FDA if they intend to continue marketing their products. The FDA intends to apply a phased approach to products marketed under discretionary enforcement policies that allow manufacturers to prepare for new requirements to avoid disruption. Comments on these draft guidelines are expected by March 23, 2022. We recommend that stakeholders carefully review the documents, submit comments if necessary, and start preparing for transitions early.
    • On December 22, the FDA released a draft guideline, “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations,” to provide sponsors and other stakeholders with guidance on how to assess digital health technology (DHT) used in their clinical investigations. The draft guidance includes how to assess a DHT as suitable for use. When evaluating a product, sponsors and stakeholders should consider the rationale for using the product and its descriptions. Sponsors and stakeholders should also consider whether the product can offer verification, validation and usability information. In addition, investigators should determine whether DHT would provide data permitting an appropriate assessment of clinical parameters from the data from any statistical analysis. The draft guidance also emphasizes that risk considerations regarding clinical risks, confidentiality and informed consent should be considered. Comments are due by March 22, 2022.
    • On December 23, the FDA released a revised guideline, “SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests,” which contains specific information regarding the omicron variant. The agency asks labs to be aware that some molecular tests fail to detect omicron and that there are other tests that detect modified omicron. Tests that do not detect omicron should not be used. Laboratories that use tests with multiple genetic targets should be aware that omicron demonstrates genetic abandonment in the results. Although this result may indicate the presence of omicron, it is not definitive. In light of this, the FDA advises labs to consider genetic sequencing if available.
    • On December 27, the CDC announced that it was recommending a five-day window for isolation and the use of masks for asymptomatic people with positive COVID-19 results. The CDC has also changed its recommendations for people exposed to someone with COVID-19 in isolation with strict mask use for five days after exposure for those exposed who are not vaccinated or have been vaccinated more. six months previously (two months for Johnson & Johnson). For those who have received a booster, isolation is not required; however, the use of a mask for five days followed by a test on the fifth day is recommended.
    • On December 29, the Center for Devices and Radiological Health (CDRH) issued an EUA for CLINITEST, a rapid self-test of the COVID-19 antigen from Siemens. This EUA is particularly important because the validation data was collected through the FDA’s collaboration with the National Institutes of Health (ITAP) Independent Testing Assessment Program. SD Biosensor Inc. has also been granted EUA for its home COVID-19 test.
    • On January 3, the FDA announced changes to the EUA for the Pfizer vaccine. The agency decided to allow a booster dose for adolescents 12 to 15 years old and to shorten the recommended time between the primary vaccination and the booster dose to five months, instead of six months. The decision was made on the basis of actual data from Israel which showed no additional security concerns. The decision to reduce the time between the primary series and the booster is taken in response to the prevalence of the more transmissible omicron variant and the need to strengthen the immune response of the population. The FDA has also cleared a third dose of Pfizer vaccine for immunocompromised children 5 to 11 years old. The agency defines immunocompromised as those who have undergone a solid organ transplant or similar conditions that compromise their immune system. The aim is to strengthen their immune response to “enable these children to obtain the maximum potential benefit from the vaccination”.

    [View source.]

    read more
    Medical products

    FDA Cleared Booster Dose for Teens – Medical Products Supply Chain Weekly Review – Food, Drugs, Healthcare, Life Sciences

    United States: FDA Approves Booster Dose for Teens – Medical Products Supply Chain Weekly Review

    To print this article, simply register or connect to Mondaq.com.

    During the holidays, the CDC updated its recommendations for quarantine and post-exposure masking. The FDA has cleared the booster dose of Pfizer vaccine for adolescents 12 to 15 years old and for immunocompromised children 5 to 11 years old. The FDA has released draft guidelines for manufacturers of medical devices marketed under EUA or enforcement discretion policies to help them transition to traditional approvals at the end of the health emergency. public. The Administration has convened the Supply Chain Disruption Working Group for an update on its progress. The FDA has issued guidance for lab staff and manufacturers on technical considerations for new strains in developing COVID-19 tests and reading current test results. Please see details of these and other supply chain developments below:

    • On December 22, the President convened a meeting of the Supply Chain Disruption Task Force with stakeholders from the business sector. The implementation of the recommendations of the Working Group has led to drastic improvements in the flow of goods in the main ports. Dwell times in the ports of Long Beach and Los Angeles have been reduced from 12 to 5 days and from 9 to 4 days, respectively. The Port of Savannah with the Georgia Ports Authority has set up inland pop-up container sites that are accessible by truck and train, speeding up the movement of containers to these locations. The involvement of commercial carriers has also accelerated the movement of goods through the supply chain. The ports of Long Beach and Los Angeles are still operating towards 24/7 operation.
    • On December 22, administration officials met with EU officials on COVID-19 and global health security to assess each country’s progress towards the goal of the partnership cemented in September to defeat the global pandemic . Increasing the global production of vaccines and supplies is a major component of the initiative. The meeting also focused on developing strategies for future actions, including establishing a source of funding for such efforts.
    • On December 22, the FDA Center for Device and Radiological Health (CDRH) released a draft guidance document “Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUA) During Coronavirus Disease 2019 (COVID-19) Public health emergency ”and“ Transition plan for medical devices that fall under enforcement policies during the public health emergency of coronavirus disease 2019 (COVID-19). These proposed transition plans are guided by the principles of ensuring continued access of patients, providers and consumers to quality products; adequately prepare manufacturers and other stakeholders for the transition; and avoid supply chain disruptions. The plans would provide guidance on the requirements and timelines for marketing presentations. Assessment methods would include a risk-based approach that takes into account the intended uses, regulatory history and the level of risk of the device. A notice will be published for manufacturers 180 days before the expiration date of the EUA declaration. An EUA declaration is separate from a public health emergency declaration. Once an EUA declaration is terminated, all EUAs authorized under the EUA declaration are also terminated. Manufacturers must notify the FDA if they intend to continue marketing their products. The FDA intends to apply a phased approach to products marketed under discretionary enforcement policies that allow manufacturers to prepare for new requirements to avoid disruption. Comments on these draft guidelines are expected by March 23, 2022. We recommend that stakeholders carefully review the documents, submit comments if necessary, and start preparing for transitions early.
    • On December 22, the FDA released a draft guideline, “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations,” to provide sponsors and other stakeholders with guidance on how to assess digital health technology (DHT) used in their clinical investigations. The draft guidance includes how to assess a DHT as suitable for use. When evaluating a product, sponsors and stakeholders should consider the rationale for using the product and its descriptions. Sponsors and stakeholders should also consider whether the product can offer verification, validation and usability information. In addition, investigators should determine whether DHT would provide data permitting an appropriate assessment of clinical parameters from the data from any statistical analysis. The draft guidance also emphasizes that risk considerations regarding clinical risks, confidentiality and informed consent should be considered. Comments are due by March 22, 2022.
    • On December 23, the FDA released a revised guideline, “SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests,” which contains specific information regarding the omicron variant. The agency asks labs to be aware that some molecular tests fail to detect omicron and that there are other tests that detect modified omicron. Tests that do not detect omicron should not be used. Laboratories that use tests with multiple genetic targets should be aware that omicron demonstrates genetic abandonment in the results. Although this result may indicate the presence of omicron, it is not definitive. In light of this, the FDA advises labs to consider genetic sequencing if available.
    • On December 27, the CDC announced that it was recommending a five-day window for isolation and the use of masks for asymptomatic people with positive COVID-19 results. The CDC has also changed its recommendations for people exposed to someone with COVID-19 in isolation with strict mask use for five days after exposure for those exposed who are not vaccinated or have been vaccinated more. six months previously (two months for Johnson & Johnson). For those who have received a booster, isolation is not required; however, the use of a mask for five days followed by a test on the fifth day is recommended.
    • On December 29, the Center for Devices and Radiological Health (CDRH) issued an EUA for CLINITEST, a rapid self-test of the COVID-19 antigen from Siemens. This EUA is particularly important because the validation data was collected through the FDA’s collaboration with the National Institutes of Health (ITAP) Independent Testing Assessment Program. SD Biosensor Inc. has also been granted EUA for its home COVID-19 test.
    • On January 3, the FDA announced changes to the EUA for the Pfizer vaccine. The agency decided to allow a booster dose for adolescents 12 to 15 years old and to shorten the recommended time between the primary vaccination and the booster dose to five months, instead of six months. The decision was made on the basis of actual data from Israel which showed no additional security concerns. The decision to reduce the time between the primary series and the booster is taken in response to the prevalence of the more transmissible omicron variant and the need to strengthen the immune response of the population. The FDA has also cleared a third dose of Pfizer vaccine for immunocompromised children 5 to 11 years old. The agency defines immunocompromised as those who have undergone a solid organ transplant or similar conditions that compromise their immune system. The aim is to strengthen their immune response to “enable these children to obtain the maximum potential benefit from the vaccination”.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: Food, Medicines, Health Care, Life Sciences of the United States

    Alston and Birds Health Care Week in Review, December 17, 2021

    Alston & Bird

    Below is Alston & Bird’s Healthcare Week review, which provides a summary of the latest healthcare regulatory news, advice and guidance; federal legislation and the work of congressional committees; reports, studies and analyzes; and other health policy news.

    read more
    Medical products

    FDA clears two oral drugs for COVID-19 – Medical Products Supply Chain Weekly Review – Food, Drugs, Healthcare, Life Sciences

    United States: FDA clears two oral drugs for COVID-19 – Medical products supply chain review of the week

    To print this article, simply register or connect to Mondaq.com.

    Last week, the FDA cleared oral antivirals from Pfizer and Merck for the treatment of COVID-19. The Biden-Harris administration released the trucking action plan. The CDC approved the ACIP preference recommendation for the Pfizer-BioNTech and Moderna vaccine boosts. The new recommended Tris vaccine buffer leads to greater stability and does not require dilution. Please see details of these and other supply chain developments below:

    • On December 15, the FDA approved Eagle Pharmaceuticals’ Abbreviated New Drug Application (ANDA) for injection of vasopressin (20 units / ml in multidose vials), a product that has grown in demand during the COVID-pandemic. 19. The FDA said that this approval, the first approval from an ANDA for this product, represents the agency’s commitment “to facilitate access to medical products to help meet the critical needs of the American public.”
    • On December 16, the Authority released its Trucking Action Plan to help reduce supply chain disruption as part of initiatives promoted by the Chain Disruption Task Force. supply. Globally, the plan aims to implement measures to reduce barriers to the issuance of commercial driver’s licenses (CDLs); accelerate the learning of trucking; recruit veterans, especially those with previous trucking experience, into the industry; and schedule listening sessions with the current workforce to implement improvement strategies. In order to promote immediate implementation, the plan also includes specific actions for 30, 60 and 90 days to implement the objectives of the plan.
    • On December 16, the FDA approved the use of Tris buffer for the manufacture of Pfizer-BioNTech’s Comirnaty COVID-19 vaccine. This new formulation offers two key advantages to vaccinators: (1) it increases the stability of the vaccine longer at refrigerated temperatures; and (2) it does not require dilution by the supplier before use.
    • On December 16, the CDC approved the Advisory Committee on Immunization Practices (ACIP) recommendations that the Pfizer-BioNTech and Moderna vaccines are preferred for booster use over the Johnson & Johnson vaccine. ACIP met earlier today and based its decision on data including a review of efficacy and adverse events.
    • On December 17, the FDA announced that it was considering a program that would impose sterilization changes to the master file pilot program for 510 (k) approved medical devices. The change applies to the established Category B or to new sterilization methods. In addition to manufacturers in the innovation challenge, current 510 (k) holders can also participate in two previous programs where the FDA (1) has challenged manufacturers to develop new ways to develop alternatives to the ethylene oxide; and (2) reduce emissions of ethylene oxide. If changes are made to sterilization methods when ethylene oxide is used, participants can now refer to their master files instead of submitting a new 510 (k).
    • On December 20, Moderna announced that it was continuing to advance clinical trials to develop an omicron-specific vaccine for use as a booster. He also noted that the antibodies from his 50mcg and 100mcg booster doses demonstrated a 37- and 83-fold increase in antibody levels. Clinical trials of vaccines targeting both omicron and delta are underway.
    • On December 21, the Center for Devices and Radiological Health (CDRH) released a plan for how the CDRH intends to manage reviewer workload in 2022 based on the increase in the total number of submissions. In 2021, the CDRH saw an increase in medical device submissions for approval through the traditional processes, namely the PMA, 510 (k) and Q-sub processes, which it addressed through the implementation of new approaches to review, including triage of cases, reallocation of staff and resources to COVID-19 products, use of contractors and overtime. Despite these approaches, some issues related to meeting review deadlines still need to be addressed. For devices other than in vitro diagnostics, the CDRH expects to be able to comply with the review deadlines of the Medical Device User Fee Agreement (MDUFA) in 2022 despite the influx of medical products subject to review. For in vitro diagnostic products, the CDRH will also try to meet the deadlines promised by the MDUFA. Non-COVID products that were not prioritized during the pandemic will require extended review times. In addition, the pre-submission request program will be reinstated as of January 1, 2022.
    • On December 22, the FDA cleared Pfizer’s oral antiviral drug, Paxlovid, for the treatment of mild to moderate COVID-19 in adults and children 12 years of age or older (weighing 40 kg or more). This is the first oral antiviral treatment for COVID-19 to receive emergency use authorization. The clearance was based on data from the EPIC-HR trial, which demonstrated that Paxlovid significantly reduced hospitalizations and deaths from all causes in the study population compared to those randomized to receive a placebo. Paxlovid is a combination of nirmatrelvir and ritonavir – the former inhibits the replication of SARS-CoV-2 and the latter slows down the breakdown of nirmatrelvir in the body. The FDA will continue to monitor clinical trial data for the safety and effectiveness of the drug.
    • On December 23, the FDA cleared Merck’s oral antiviral drug, molnupiravir, for the treatment of mild to moderate COVID-19 in adults at high risk of progression to severe COVID-19 and for whom options for Alternative treatment to COVID-19 is not available. accessible or clinically appropriate.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: Food, Medicines, Health Care, Life Sciences of the United States

    read more
    Medical products

    FDA Approves Two Oral COVID-19 Drugs – Medical Products Supply Chain Weekly Review | Alston & Bird

    Last week, the FDA cleared oral antivirals from Pfizer and Merck for the treatment of COVID-19. The Biden-Harris administration released the trucking action plan. The CDC approved the ACIP preference recommendation for the Pfizer-BioNTech and Moderna vaccine boosts. The new recommended Tris vaccine buffer leads to greater stability and does not require dilution. Please see details of these and other supply chain developments below:

    • On December 15, the FDA approved Eagle Pharmaceuticals’ Abbreviated New Drug Application (ANDA) for injection of vasopressin (20 units / ml in multidose vials), a product that has grown in demand during the COVID-pandemic. 19. The FDA said that this approval – the first approval from an ANDA for this product – represents the agency’s commitment “to facilitate access to medical products to help meet the critical needs of the American public.”
    • On December 16, the Authority released its Trucking Action Plan to help reduce supply chain disruption as part of initiatives encouraged by the Chain Disruption Task Force. supply. Globally, the plan aims to implement measures to reduce barriers to the issuance of commercial driver’s licenses (CDLs); accelerate the learning of trucking; recruit veterans, especially those with previous trucking experience, into the industry; and schedule listening sessions with the current workforce to implement improvement strategies. In order to promote immediate implementation, the plan also includes specific actions for 30, 60 and 90 days to implement the objectives of the plan.
    • On December 16, the FDA approved the use of Tris buffer for the manufacture of Pfizer-BioNTech’s Comirnaty COVID-19 vaccine. This new formulation offers two key advantages to vaccinators: (1) it increases the stability of the vaccine longer at refrigerated temperatures; and (2) it does not require dilution by the supplier before use.
    • On December 16, the CDC approved the Advisory Committee on Immunization Practices (ACIP) recommendations that the Pfizer-BioNTech and Moderna vaccines are preferred for booster use over the Johnson & Johnson vaccine. ACIP met earlier today and based its decision on data including a review of efficacy and adverse events.
    • On December 17, the FDA announced that it was considering a program that would impose sterilization changes to the master file pilot program for 510 (k) approved medical devices. The change applies to the established Category B or to new sterilization methods. In addition to manufacturers in the innovation challenge, current 510 (k) holders can also participate in two previous programs where the FDA (1) has challenged manufacturers to develop new ways to develop alternatives to it. ethylene oxide; and (2) reduce emissions of ethylene oxide. If changes are made to sterilization methods when ethylene oxide is used, participants can now refer to their master files instead of submitting a new 510 (k).
    • On December 20, Moderna announced that it was continuing to advance clinical trials to develop an omicron-specific vaccine for use as a booster. He also noted that the antibodies from his 50mcg and 100mcg booster doses demonstrated a 37- and 83-fold increase in antibody levels. Clinical trials of vaccines targeting both omicron and delta are underway.
    • On December 21, the Center for Devices and Radiological Health (CDRH) released a plan for how the CDRH intends to manage reviewer workload in 2022 based on the increase in the total number of submissions. In 2021, the CDRH saw an increase in medical device submissions for approval through the traditional processes, namely the PMA, 510 (k) and Q-sub processes, which it addressed through the implementation of new approaches to review, including triage of cases, reallocation of staff and resources to COVID-19 products, use of contractors and overtime. Despite these approaches, some issues related to meeting review deadlines still need to be resolved. For devices other than in vitro diagnostics, the CDRH expects to be able to meet the review deadlines of the Medical Device User Fee Agreement (MDUFA) in 2022 despite the influx of medical products subject to review. For in vitro diagnostic products, the CDRH will also try to meet the deadlines promised by the MDUFA. Non-COVID products that were not prioritized during the pandemic will require extended review times. In addition, the pre-submission request program will be reinstated as of January 1, 2022.
    • On December 22, the FDA cleared Pfizer’s oral antiviral drug, Paxlovid, for the treatment of mild to moderate COVID-19 in adults and children 12 years of age or older (weighing 40 kg or more). This is the first oral antiviral treatment for COVID-19 to receive emergency use authorization. The clearance was based on data from the EPIC-HR trial, which demonstrated that Paxlovid significantly reduced hospitalizations and deaths from any cause in the study population compared to those randomized to receive a placebo. Paxlovid is a combination of nirmatrelvir and ritonavir – the former inhibits the replication of SARS-CoV-2 and the latter slows down the breakdown of nirmatrelvir in the body. The FDA will continue to monitor clinical trial data for the safety and effectiveness of the drug.
    • On December 23, the FDA cleared Merck’s oral antiviral drug, molnupiravir, for the treatment of mild to moderate COVID-19 in adults at high risk of progression to severe COVID-19 and for whom options for Alternative treatment to COVID-19 is not available. accessible or clinically appropriate.

    [View source.]

    read more
    Medical products

    Which medical products are at the top of Amazon’s listings?

    What medical products are hot on Amazon this season? As expected, as the pandemic continues, thermometers and masks are on buyers’ lists, but so are perennial products such as relaxation and fitness items. Many articles are digital health products, demonstrating the trend of deepening consumption. And you may even see some similarities to articles from our previous look at Amazon buying trends.

    On December 21, the top 10 gift ideas in home medical supplies and equipment were:

    • Fitbit Inspire 2 Health & Fitness Tracker with 1-Year Free Fitbit Premium Trial, 24/7 Heart Rate, Black / Black, One Size (S and L Bands Included)
    • Fitbit Charge 5 Advanced Fitness & Health Tracker with Built-in GPS, Stress Management Tools, Sleep Tracker, 24 Hour Heart Rate & Up, Black / Graphite, One Size (S and L Bands Included)
    • AncestryDNA: genetic ethnicity test, ethnicity estimate, AncestryDNA test kit
    • 23andMe Ancestry + Traits Service: Personal genetic DNA testing with over 2000 geographic regions, family tree, relative DNA research, and trait reports
    • Fitbit Luxe Fitness and Wellness Tracker with Stress Management, 24/7 Sleep and Heart Rate Tracker, Black / Graphite, One Size (S and L Bands Included)
    • AncestryDNA + Traits: Genetic Ethnicity Test + Traits, AncestryDNA Test Kit with 35+ Traits, DNA Ancestry Test Kit, Genetic Test Kit
    • Black Disposable Masks 50PCS 3 Ply Breathable Filter Protection
    • KardiaMobile Single Lead Personal ECG Monitor | FDA Approved | Detects AFib
    • IHealth No-Touch forehead thermometer, digital infrared thermometer for adults and children, non-contact baby thermometer with 3 ultra-sensitive sensors, large LED display and soft vibration alert (PT3)
    • RENPHO Body Fat Scale Smart BMI Scale Wireless Digital Bathroom Weight Scale Body Composition Analyzer with Sync Smartphone App with Bluetooth 396 lbs – Black

    Also on December 21, the top 10 most wanted home medical supplies and equipment were:

    • IHealth No-Touch forehead thermometer, digital infrared thermometer for adults and children, non-contact baby thermometer with 3 ultra-sensitive sensors, large LED display and soft vibration alert (PT3)
    • FYY Daily Pill Organizer, 7 Compartment Portable Travel Pill Organizer, [Folding Design] Pocket Purse Pill Box Holds Vitamins, Cod Liver Oil, Supplements & Medication – Blue
    • Elviros Memory Foam Neck Pillow, Contour Pillows for Neck and Shoulder Pain, Ergonomic Orthopedic Neck Support Pillow for Side, Back and Tummy Sleep (Blue-S)
    • Avana Kind Bed Orthopedic Support Wedge Pillow Comfort System, Blue / Gray
    • FridaBaby Fast Read Digital Rectal Thermometer
    • Neck and Shoulder Relaxer, Cervical Traction Device for TMJ Pain Relief and Cervical Spine Alignment, Chiropractic Neck Stretcher (Blue)
    • RENPHO Body Fat Scale Smart BMI Scale Wireless Digital Bathroom Weight Scale Body Composition Analyzer with Sync Smartphone App with Bluetooth 396 lbs – Black
    • Fitbit Inspire 2 Health & Fitness Tracker with 1-Year Free Fitbit Premium Trial, 24/7 Heart Rate, Black / Black, One Size (S and L Bands Included)
    • 23andMe Health + Ancestry Service: Personal genetic DNA testing, including health predispositions, carrier status, well-being, and trait reports (before purchasing, see important test information below below)
    • Non-contact forehead thermometer for adults and children, home digital infrared thermometer with fever indicator, instant accurate reading

    And the top 10 sellers in home medical supplies and equipment on December 21 were:

    • Black Disposable Masks 50PCS 3 Ply Breathable Filter Protection
    • Zacurate Pro Series 500DL Fingertip Pulse Oximeter Blood Oxygen Saturation Monitor with Silicone Cover, Batteries and Lanyard (Royal Black)
    • Disposable face mask, black masks, 3-ply disposable face mask (200 pieces, black)
    • ApePal KN95 5-Layer Disposable Face Masks, Wide Elastic Earrings, Safety Face Mask, Black, 50 Pieces / Pack
    • Non-contact forehead thermometer for adults and children, home digital infrared thermometer with fever indicator, instant accurate reading
    • 100pcs Black Disposable Masks For Adults 3 Layer Non Woven Masks With Soft Elastic Earring
    • Wecolor 50 Disposable 3-Ply Earring Masks, Suitable for Home, School, Office and Outdoor (Black)
    • Black Face Mask 100pcs Disposable Masks Breathable 3-Layer Masks Mouth Cover for Adult Men and Women
    • 100pcs Black Disposable Face Mask 3 Ply Filter Protection Non-medical Face Masks Face Cover
    • Black disposable face masks, 3 ply face masks of 50 disposable masks

    The listings above are only a snapshot taken on December 21, so be sure to click on the links for up-to-date rankings.

    read more
    Medical products

    FTC to Survey Big Business Supply Chain Problems – Medical Products Supply Chain Weekly Review | Alston & Bird

    Over the past two weeks, the Federal Trade Commission (FTC) has ordered major U.S. companies to provide information on problems and solutions in their supply chain. The FDA has issued an Emergency Use Clearance (EUA) for monoclonal therapy to include all children. An independent survey of pharmacies indicates that they still face supply chain issues. Please see details of these and other supply chain developments below:

    • On November 29, the FTC ordered nine major U.S. companies to provide the government with information about their supply chain operations. Specifically, the FTC is conducting an investigation to determine the reason for the delays. The FTC has asked companies to provide information on the main drivers of disruption in their supply chain and what they have done to address the issues. Companies have 45 days to respond.
    • On November 30, the FDA released a statement that discusses its omicron variant surveillance plan. The plan includes ongoing reporting by stakeholders of the impact of the variant on testing, vaccines and treatments. Currently, the FDA expects the variant to have a low impact on testing capabilities and infrastructure. The information will be released to the public as soon as it becomes available.
    • On December 3, the FDA expanded the EUA for two monoclonal antibodies – bamlanivimab and etesevimab (used in combination) – to include treatment of all pediatric patients, including newborns, who test positive for the COVID test -19 and are at high risk of progression to severe COVID-19. The combination drug is now also authorized for post-exposure prophylaxis for the prevention of COVID-19 in all pediatric patients, including newborns, at high risk of progression to severe COVID-19. The move comes after the FDA evaluated the results of clinical trials that showed the therapy to be safe and effective.
    • On December 3, the Federal Reserve released a note based on a textual analysis of earnings calls to account for the effects of the supply chain bottleneck on prices. Call SMS messages won from the S&P Global Market Intelligence database were searched for certain terms and were classified as positive impact or negative impact. Additionally, the authors used a regression model to analyze the impact of supply bottlenecks on concerns. The authors’ findings suggest that the global container shortage is the primary concern of most industries, and that the automotive sector suffers the most negative impacts. In an analysis of companies facing large supply chain disruptions versus low disruptions, those that experienced large disruption experienced statistically significant price increases. Overall, stronger global demand, supply bottlenecks and chip shortages had the biggest effect on prices. It is important to note that capacity issues and shipping bottlenecks have not resulted in price increases due to the increase in mentions in calls.
    • On December 8, the FDA issued an EUA for AstraZeneca’s Evusheld, an injectable drug combined with monoclonal antibodies. The authorization is for use in adults and adolescents 12 years of age and older who also have moderately to severely compromised immune systems or whose vaccination is not recommended due to serious side effects. Data from a clinical trial have shown a 77% reduction in the risk of contracting COVID-19 after treatment, with efficacy lasting up to six months.
    • On December 8, the FDA released a draft guideline titled “Considerations for Using Real Data and Evidence to Support Regulatory Decision Making for Drugs and Biologics”. The goal of the guidance, which would meet a mandate under the 21st Century Cures Act of 2016, is to facilitate increased efficiency in the approval of new indications for legally marketed drugs. Sponsors are encouraged to contact the FDA to discuss their draft study protocol and statistical analysis plan for review and comment before finalizing the documents. Additionally, sponsors need to consider and address data privacy concerns using real world data.
    • On December 9, the Treasury Department’s Office of Foreign Assets Control (OFAC) imposed sanctions on foreign government officials and entities on the International Anti-Corruption Day. The initiative targets, among others, heads of state and entities that have participated in acts of corruption in the context of “COVID-19 purchases”. Specifically, officials who have engaged in bribery programs, inflation in the prices of medical devices and PPE, and improper awarding of contracts are subject to sanctions. Government officials and their families have also faced sanctions for US visas.
    • On December 9, at the Food and Drug Law Institute’s Enforcement, Litigation and Compliance conference, Elizabeth Miller of the FDA, deputy commissioner for medical products and tobacco operations in the Office of Regulatory Affairs, spoke revealed that the agency is planning a pilot program to conduct unannounced inspections in India and expand the program to China.
    • On December 10, the Department of Transportation announced that the agency had awarded $ 12.6 million in America’s Marine Highway (AMHP) grants to nine maritime highways to help deal with disruption in the water supply chain. supply and movement of goods. AMHP, which operates as a public-private partnership, seeks to reduce land congestion, support transport options and improve the performance of the transport system. Some specific projects mentioned include funding for a New York / New Jersey barge project to increase trailer transportation, increasing the operational capacity of the Richmond, Virginia marine terminal, and upgrading ship equipment. a marine terminal in North Carolina.
    • On December 10, the Center for Devices and Radiological Health released a discussion paper titled “Point-of-Care 3D Printing of Medical Devices.” The paper provides background, an overview of how these devices might be approved for point-of-care use, and the challenges of this approach. The authors also ask 16 questions on which they would like to receive comments. Public comments are expected on February 8, 2022.
    • On December 16, the FDA released a draft guideline, “Inspection of Injectables for Visible Particles: Draft Guidance for Industry.” The guidelines aim to provide industry with risk-based procedures to “assess, correct and prevent the risk of visible particulate contamination”. Serious adverse events have been observed following injectables contaminated with visible particles. Manufacturers performing risk assessments and implementing mitigation strategies for injectables containing visible particles should consider the type of particles, container components and closure systems, and quality assurance procedures, among other factors. Comments are due by February 14, 2022.
    • The International Coalition of Drug Regulators has published an article from its COVID-19 Working Group, “Remote PCB and GMP Regulatory Oversight Inspections”. The document provides an assessment of how regulators provided remote monitoring during the pandemic, the challenges of implementation, and the success of the programs. The Working Group noted that while the possibilities offered by remote monitoring facilitate new monitoring methods, they should not replace traditional inspections. However, there is room for supplementation with these new tools.
    • The National Community Pharmacists Association has released the results of a survey showing that supply chain issues continue to plague 60% of independent pharmacies. In addition to these disruptions, independent pharmacies continue to flag staff, low reimbursement rates and market forces as reasons for their concern. Supply chain disruptions have increased consumer wait times for prescriptions. Overall, 41% of respondents felt that the state of the industry can be classified from bad to very bad.
    • Amazon has invested in a private supply chain network that has helped the company bypass supply chain issues. The company uses charter freighters, its own shipping containers, ships that bypass the busiest ports of Los Angeles and Long Beach, and planes that bypass ports completely. By serving as its own shipping provider, Amazon can use less busy ports for deliveries and is not dependent on container availability and access by third-party shipping companies. Amazon is now estimated to ship 72% of its merchandise. In addition, Amazon has increased the number of vacation rentals by 50% and increased the number of new installations.

    [View source.]

    read more
    Medical products

    Museveni supports planned medical products factory

    President Yoweri Museveni welcomes the initiative being considered by a local company Microhaem Scientific and Medical Supplies Limited and its partners to establish a medical diagnostics and pharmaceutical factory in the country.

    During his meeting with a delegation from Microhaem Scientifics (MHS) and its business partners on Thursday, December 9 at State House Nakasero, the president assured the group that he was ready to support initiatives to produce diagnostic tools. and human medicines locally in the country. He said such facilities would also benefit regional and continental demand for medicines for human use.

    “I should support the partnership. I tell you that there is a huge demand for human drugs in the country, the region and beyond. The demand is not just in Uganda, the issue affects the entire East African region and the continent. It is not only a question of manufacturing but also of answering the question of the strong demand ”, declared President Museveni.

    The president observed that the government spends large sums of money to buy human drugs and diagnostic tools abroad. He further noted that by looking at the annual imports into the country, the import of drugs is very large and continues to expand.

    Mr Museveni suggested to investors in the planned partnership that if they chose to manufacture drugs in the country, they would be supported by the indigenous raw materials available to master the manufacturing process. He cited the presence of cinchona which was originally found in South America and which is used in the manufacture of quinine, an antimalarial drug.

    “Here in Uganda we have many such products which can be obtained from the local green vegetation. If the pharmaceutical manufacturers have the diverse knowledge to manufacture a variety of medical products, it would be much better for the country and for them. [investors] being insured with the market, ” he added.

    MHS Head of Delegation and Managing Director Cedric Akwesigye, who led the discussion, pointed out that Microhaem Scientifics Supplies Ltd (MHS), a Ugandan company founded in 2012, is a huge investment aimed at solving the problem. problem of lack of technical support. on medical equipment and the quality of medical supplies in the country.

    “In record time, MHS has partnered with government to set up well-established medical laboratories for the Uganda Virus Research Institute (UVRI) and Central Public Health Laboratories (CPHL) at border points from Malaba, Elegu, Mutukula. These labs have dramatically reduced the turnaround time for COVID-19 test results, especially for truck drivers. So far, the company’s medical facilitation capacity has supported 500,000 Covid-19 tests, ”he said.

    Mr. Akwesigye also noted that the president’s stewardship has championed the growth of local businesses like MHS to achieve partnership milestones with reputable global companies. He pledged MHS ‘continued strategic investment in addressing the medical and diagnostic needs of the company.

    MHS is partnering with Desert Laboratories Inc in the United States to set up a factory to manufacture medical laboratory molecular tests for Covid-19, HIV, and tuberculosis, among others.

    read more
    Medical products

    3 actions to capitalize on the dynamism of the medical products industry

    This story originally appeared on Zacks

    The COVID-19 pandemic, which has proven to be a biological crisis of an unprecedented nature, has changed the very nature and dynamics of the healthcare industry. Zacks’ medical products industry has also not been immune to the pandemic, and has been hit hard by widespread supply chain disruptions and postponement of elective proceedings. However, the medical products space has seen a substantial recovery, mainly due to the easing of previous restrictions and the acceleration of vaccinations. Apart from this, the slow resumption of elective procedures, the growing demand for in vitro diagnostics (IVD) and the growing reliance on artificial intelligence (AI) and robotics are expected to favor industry participants. in the coming days. Despite a pandemic-induced disruption triggered by the Delta variant, particularly during August and September, industry players have yet to show signs of slowing down. Industry participants love Abbott Laboratories ABT, Bio-Rad Laboratories, Inc. BIO and Hill Rom Holdings, Inc. HRC are likely to take advantage of the factors mentioned above.

    – Zack

    5 actions in the process of doubling

    Each has been handpicked by a Zacks expert as the # 1 favorite stock to earn + 100% or more in 2021. Previous recommendations have climbed + 143.0%, + 175.9%, +498 , 3% and + 673.0%.

    Most of the stock in this report is flying under Wall Street’s radar, which provides a great opportunity to get into the ground floor.

    Today, discover these 5 potential circuits >>

    Want the latest recommendations from Zacks Investment Research? Today you can download 7 best stocks for the next 30 days. Click to get this free report

    Abbott Laboratories (ABT): Free Stock Analysis Report

    BioRad Laboratories, Inc. (BIO): Free Inventory Analysis Report

    HillRom Holdings, Inc. (HRC): Free Stock Analysis Report

    To read this article on Zacks.com, click here.

    Zacks investment research

    read more
    Medical products

    Intensify actions to fight substandard and falsified medical products. Urgent appeal to “false breakers”

    “Health is not a hoax – Fight the fakes” is the slogan for this year’s Fight the Fakes week. The aim is to highlight how substandard and falsified medicines pose serious risks to human health and have disastrous consequences for the well-being of communities and the socio-economic stability of each country. They deserve much more attention in international fora.

    Fight the Fakes Alliance invites organizations and individuals around the world to become fake busters for this year’s Fight the Fakes week, December 6-12, and to help raise awareness of the dangers involved.

    Sometimes substandard and falsified drugs can have tragic consequences. They are contributing to the development of the second global health emergency after COVID-19: antimicrobial resistance and drug-resistant infections. They create mistrust in drugs, health professionals and health systems and block the socio-economic development of a country. The problem is most acute in low- and middle-income countries, with estimates suggesting that up to 1 in 10 medical products are either substandard or falsified.

    Since the start of the COVID-19 pandemic, diagnostic tests, personal protective equipment (PPE), potential therapies and vaccines have been found to be falsified across the world. The World Health Organization (WHO) has issued several medical product alerts related to COVID-19 vaccines and treatments over the past two years, while the Infectious Disease Data Observatory collects hundreds of reports from the field public on substandard and falsified COVID-19 medical products. and COVID-19 vaccines.

    As the rollout of COVID-19 vaccination accelerates, criminals are capitalizing on shortages or barriers to access, but also waves of vaccine hesitation. It may also accelerate the spread of counterfeit products that are unrelated to COVID-19, proving a flourishing global business of substandard and falsified medical products, without regard for the health impacts.

    About Fight the Fake Alliance

    The Fight the Fakes Alliance (aka “Fight the Fakes”) is a non-profit, multi-party association that aims to raise awareness of the dangers of falsified and substandard medicines. He gives voice to those who have been personally affected and shares the stories of those working to end this threat to public health. He seeks to build a global movement of organizations and individuals who will shed light on the threat these so-called drugs pose to patient safety and health systems and to achieving universal health coverage. The diverse members of Fight the Fakes share the belief that coordination among all stakeholders working along the medical supply chain is essential if we are to tackle this threat to global health.




    read more
    Medical products

    Medical Products Supply Chain Weekly Review – FDA Approves Pfizer and Moderna Booster for All Adults | Alston & Bird

    Over the past week, the FDA cleared the Pfizer and Moderna booster injections for all adult age groups, while the CDC’s Advisory Committee on Immunization Practices (ACIP) also recommended the Moderna vaccine booster. for all adults. Pfizer has submitted an Emergency Use Authorization (EUA) application for its oral treatment with COVID-19. President Biden signed the Infrastructure Investments and Jobs Act and the Executive Order for its implementation. The FDA has issued updated guidelines for manufacturers of SARS-CoV-2 tests. Please see details of these and other supply chain developments below:

    • On November 15, the President signed the Law on Investment in Infrastructure and Employment (IIJA) and a decree to facilitate its implementation. IIJA Amends Homeland Security Act 2002 to Allow Secretaries of Homeland Security, Health and Human Services (HHS) Departments, and Veterans to Transfer Personal Protective Equipment (PPE) and Equipment medically necessary for the national stock under a production contract during a public health emergency declared by the secretary of the HHS. In general, the Secretary of Homeland Security, at the request of the Secretary of HHS, is authorized to transfer to HHS, for reimbursement, excess PPE or medically necessary equipment possessed by the Department of Homeland Security (DHS). The DHS Secretary must determine whether the requested personal or medically necessary protective equipment is surplus equipment and certify that the transfer of such equipment will not have a negative impact on the health or safety of officers, employees or subordinates. treating DHS. The IIJA is also amending the Public Health Services Act to allow the Secretary of HHS, in coordination with the Secretary of DHS, to sell drugs, vaccines (and other biologicals), medical devices, or supplies. within the national stock to a federal agency, nonprofit, state, or local, tribal, or territorial entity. Products sold must be within one year of expiration or determined to be no longer needed in inventory due to advances in medical or technical capacity. The IIJA also includes a subtitle “Make PPE in America Act” which requires the development of a short-term (three-year) and long-term strategy for the national production of PPE. An Infrastructure Implementation Working Group has been established to oversee the implementation of the law. The working group will be co-chaired by Mitch Landrieu, White House Infrastructure Implementation Coordinator, and Brian Deese, Director of the National Economic Council.
    • On November 15, the FDA updated its policies regarding COVID-19 test review expectations and released several policies that provide guidance to manufacturers. The FDA’s goal is to ensure that the tests are reliable and accurate. The update included the following:
      • The FDA has re-issued the “Policy for Testing for Coronavirus-2019 Disease During Public Health Emergency (Revised),” which applies to tests that use diagnostic and serological methodology. Manufacturers can submit EUA requests for home and point-of-care testing, high-volume laboratory molecular diagnostic testing, high-volume laboratory and point-of-care antibody testing, and funded testing by the US government agency. All other types must use traditional pre-market channels.
      • The FDA has published the “Umbrella EUA for SARS-CoV-2 Molecular Diagnostic Tests for Serial Testing”. This EUA applies to certain SARS-CoV-2 serial use nasal swab tests, which are used in testing programs by schools, workplaces or community groups. Testing should be performed in a single CLIA certified laboratory.
      • The FDA reissued the EUA, “Laboratories that have developed a molecular test (LDT) for coronavirus disease 2019 (COVID-19)”. In its review of current policies and the changing needs of the pandemic, the agency is prioritizing serial use testing and has updated its conditions for authorizing molecular-based laboratory-developed tests. Additional tests may be permitted.
      • The FDA has issued guidance on its “Viral Transport Media Enforcement Policy During Coronavirus Disease 2019 (COVID-19) Public Health Emergency.” Due to the increase in serial testing, there is a need to increase the availability of transport media for clinical specimens. The FDA created this guide to support this effort and provide a standard for media manufacturers. The guide specifically provides criteria for commercial manufacturers on validation, agency notification and labeling expectations. Additional guidance and expectations are included for manufacturers of alternative media types and saline transport media.
    • On November 16, Pfizer announced the submission of an EUA application for its COVID-19 oral antiviral drug, Paxlovid (ritonavir). The medicine is intended for home use in high-risk patients to prevent hospitalization and death. According to an interim review from the Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients (EPIC-HR) trial, a phase 2/3 study, Paxlovid demonstrated a relative risk reduction of 89% (risk reduction absolute 6.2%) of hospitalization and death in participants 18 years and older at high risk for disease progression. Recruitment for the trial was discontinued upon recommendation of the Data Oversight Committee based on interim analysis data. Trials for standard risk patients and post-exposure prophylaxis are still ongoing. On the same day, Pfizer agreed to license Paxlovid to the Medicines Patent Pool, a United Nations-backed entity, to provide access to the drug to low- and middle-income countries. On November 18, Pfizer announced an agreement with the US government to supply 10 million courses of Paxlovid, subject to regulatory clearance from the FDA.
    • On November 16, the Center for Devices and Radiological Health (CDRH) updated the Medical Device Development Tools program documents landing page. The program is voluntary and supports sponsors in the development and evaluation of their medical devices with the aim of facilitating the review of CDRH. The program’s tools are evaluated and approved by the FDA and must be capable of producing scientifically plausible results.
    • On November 17, the White House COVID-19 response team announced that the administration was planning to provide funding to increase vaccine production. The Department of Health and Human Services is in contact with manufacturing companies that can increase their vaccine production. The goal is to add at least one billion doses to the national supply through investments in infrastructure and training.
    • On November 19, the FDA cleared the Pfizer and Moderna vaccines for use as a booster dose in all age groups 18 years and older. The agency based its decision on data from ongoing clinical trials and real-time results from vaccine use. The authorizations relate to a booster dose at least six months after the end of the initial series. The CDC ACIP then met and unanimously recommended that the Moderna vaccine be allowed for people 18 years of age and older. The committee’s decision has been forwarded for approval to CDC director Dr. Walensky and the FDA.

    [View source.]

    read more
    Medical products

    Precision Medical Products Launches Most Durable Portable Compression Device on the Market

    ROCKLIN, Calif., November 19, 2021 / PRNewswire / – Today, Precision Medical Products (PMP) announced the release of the latest version of its Circul8 Pro® device, a powerful and portable on-the-go deep vein thrombosis (DVT) prevention product. Now with over 20 hours of battery life, the Circul8 Pro® is the most durable portable battery-operated compression device on the market.

    “Our company continues to innovate and raise the bar of standards of care as we position ourselves as the clear leader in DVT prevention,” said the CEO of Precision Medical Products. Jeremy Perkins.

    The device from Precision Medical Products exceeds guidelines recommended by industry experts for the prevention of perioperative DVT, such as the Association of Perioperative Registered Nurses (AORN). The AORN recommendations are based on a study by the American College of Chest Physicians, whose guidelines recommend 18 hours of use of DVT prevention devices. Patients using the Circul8 Pro® will be equipped with a device that allows ease of movement without the need for constant recharging.

    “Our 20+ hour battery makes patient compliance easy, paving the way for the best possible outcome,” Perkins concluded.

    In addition to the latest version of Circul8 Pro®, Precision Medical Products’ existing range of offerings include the CIRCUL8® brand and VenaOne®, a mobile DVT prevention system for hospital use. The Circul8 Pro® and VenaOne® are self-contained and wireless, allowing maximum mobility. PMP also offers PreVent®, the only remote DVT prevention and monitoring solution available.

    About precision medical products: Since launching as a self-funded startup in 2010, Precision Medical Products has been helping patients recover from surgery, using its innovative DVT prevention products, programs and offerings. Precision Medical Products was recognized on Inc. 5000’s list of America’s fastest growing companies and received a variety of innovation awards for its patented products.

    SOURCE Precision Medical Products

    read more
    Medical products

    Recbio Receives Pharmaceutical Production License From Jiangsu Medical Products Administration For Production Of COVID-19 Vaccine

    TAIZHOU, China, November 16, 2021 / PRNewswire / – Jiangsu Recbio Technology Co., Ltd. (“Recbio”), a biopharmaceutical company specializing in the research, development and commercialization of innovative vaccines capable of combating widespread diseases with significant burdens, recently announced that the company has received the Pharmaceutical Production License (scope: COVID-19 recombinant two-component vaccine [CHO cell]) issued by the Jiangsu Medical Products Administration (JSMPA). It indicates that the Recbio production plant in Taizhou, Jiangsu Province, China (Taizhou facility) qualified to manufacture COVID-19 two-component recombinant vaccine [CHO cell] (ReCOV), which means that Recbio has taken another important step towards a vaccine business with a full industry chain spanning research, production and commercialization.

    The newly constructed state-of-the-art production facility has been designed in accordance with current Good Manufacturing Practices (cGMP) standards. With a total GFA of over 17,000 m², the Taizhou factory has an annual production capacity of over 100 million doses, which can quickly be expanded to 300 million doses per year.

    Over the past 10 years, new adjuvants have been gradually applied in the vaccine industry and have brought about profound changes to the industry. Recbio is one of the few companies with commercial production capacity for new adjuvants that have been approved by the FDA for human use. As a result, the vaccines developed by the company not only have peak performance, but also do not depend on any particular adjuvant supplier. Equipped with a novel adjuvant BFA03 developed in-house and AS03 benchmarking, ReCOV demonstrated excellent immunogenicity, safety and tolerability in the phase I clinical study in New Zealand. In particular, the titer of neutralizing antibodies induced by ReCOV was not lower than that induced by international general public mRNA vaccines. ReCOV is expected to apply for an EUA (Emergency Use Authorization) in the first half of 2022.

    About the two-component COVID-19 recombinant vaccine (ReCOV)

    In May 2020, Recbio, in collaboration with the Jiangsu Provincial Center for Disease Control and Prevention (“Jiangsu CDC”) and Taizhou Medical New & High-tech Industrial Development Zone, jointly developed a two-component recombinant COVID-19 vaccine (ReCOV). Under the leadership of Professor Fengcai Zhu from Jiangsu CDC, the R&D team thoroughly optimized the vaccine using protein engineering and new adjuvant technologies so that ReCOV shows promising safety and strong immunogenicity against SARS. -CoV-2 and variants of concern such as Delta. A series of comprehensive advantages such as better cross-protection against emerging variants, easy production scale-up, cost advantages, global accessibility, good preparation stability, as well as a storage and transport at room temperature is becoming a new, very competitive second-generation COVID-19 vaccine.

    About Recbio

    Recbio is an innovative vaccine company founded in 2012. With the vision of “Becoming the leader in innovative vaccines in the future”, Recbio’s mission is to “Protect human health with the best vaccines in its class”. It has established three major cutting-edge technology platforms, including a platform for novel adjuvants, a protein engineering platform and an immunoassessment platform. Recbio has a high-value vaccine portfolio comprising HPV vaccine candidates, COVID-19 vaccine candidates, shingles vaccine candidates, influenza vaccine candidates, adult tuberculosis vaccine candidates, and more. The core scientific team has more than 20 years of experience in the development and commercialization of innovative vaccines. For more information, please visit https://www.recbio.cn/.

    Forward-looking statements

    This press release may contain certain forward-looking statements which are, by their nature, subject to important risks and uncertainties. The words “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, with respect to Recbio, are intended to identify certain of these forward-looking statements. Recbio does not intend to regularly update these forward-looking statements.

    These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of Recbio regarding future events at the time these statements are made. These statements do not constitute a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond Recbio’s control and are difficult to predict. Therefore, actual results may differ materially from information contained in forward-looking statements due to future changes or developments in our business, Recbio’s competitive environment and political, economic, legal and social conditions.

    Jiangsu Recbio Technology Co., Ltd.

    Investor survey:
    E-mail: [email protected]
    Phone. : + 86-0523-86818860

    Media investigation:
    E-mail: [email protected]
    Phone. : + 86-0523-86818860

    SOURCE Jiangsu Recbio Technology Co., Ltd.

    read more
    Medical products

    Medical Products Supply Chain Week Review – November 2021 # 2 | Alston & Bird

    Last week, the president chose Dr. Robert Califf to be the commissioner of the FDA. Congress passed the Infrastructure Investment and Jobs Act. New vaccination requirements have been issued by OSHA and CMS for some employers. In addition, the State Department has updated its rules for passengers entering the United States. Please see details of these and other supply chain developments below:

    • On November 4, the Department of Labor’s Occupational Safety and Health Administration (OSHA) announced a new Temporary Emergency Standard (ETS) that requires companies with 100 or more employees to develop a vaccination policy. against COVID-19. Requirements include that companies check the immunization status of each employee, require proof of vaccination, and keep records. Additionally, unvaccinated employees would be subject to weekly testing, early notification of a positive COVID-19 diagnosis, and a quarantine strategy. Employers have 60 days to comply with all of the requirements. In the meantime, lawsuits have been filed with the United States’ Courts of Appeals for the Fifth, Sixth, Seventh, Eighth, Eleventh and DC Circuits to review the legality of the order. While the Fifth Circuit has granted an emergency motion to suspend the OSHA HTA, cases will be consolidated and transferred to one circuit through a lottery system. The complainants argue that OSHA does not have the specific legislative authority to establish this rule and is in violation of the doctrine of non-delegation. For more information, see Alston & Bird’s Labor and Employment / Healthcare advisory, “What You Need to Know About OSHA’s ETS for Employee Vaccination Requirements” .
    • On November 4, the Centers for Medicare & Medicaid Services (CMS) issued emergency regulations requiring the full immunization of some health facility staff by January 4, 2022. The agency’s data collection determined that these requirements have not led to a critical shortage of personnel from the widespread resignation of essential personnel. For any non-compliant entity, CMS has committed to use its executing authority to take further action.
    • On November 6, Congress passed the Infrastructure Investment and Jobs Act. The law will provide funding for large infrastructure projects to “strengthen our supply chains and avoid the disruptions that have caused inflation.” The 10-year plan provides for $ 17 billion in funding for the modernization of port infrastructure and $ 25 billion in funding for US airports. The bill awaits the president’s signature.
    • On November 9, Pfizer and BioNTech submitted a request to change their Emergency Use Authorization (EUA) for the booster dose of the COVID-19 vaccine. The amendment would allow the booster dose to be authorized for all persons 18 years of age and over. The claim is based on data from a Phase 3 clinical trial which demonstrated the booster to be 95% safe and effective.
    • On November 10, the Administration announced action plans to improve the flow of goods through the supply chain and the progress made so far. The amount of cargo that passed through the ports of Los Angeles and Long Beach reached an all-time high. The Administration plans to facilitate the movement of goods by working with key stakeholders to operate the ports 24/7, including removing fees for truckers who collect cargo overnight and on weekends. , reducing rail rates for shipping to ports on weekends and encouraging retailers to use off-peak weekend hours for supply chain activities.
    • On November 12, President Biden will appoint Dr. Robert Califf as FDA commissioner. Califf previously served as commissioner during the Obama administration and is expected to receive bipartisan support. The announcement is expected today.
    • The FDA has issued “Product Specific, Interim and Revised Guidelines” to help manufacturers develop bioequivalence studies to use in their Abbreviated New Drug Application (ANDA) submissions. The guidelines and draft guidelines will apply to the products explicitly listed. The deadline for submitting comments is January 2, 2022.

    [View source.]

    read more
    Medical products

    Medical Products Supply Chain Weekly Review – November 2021 # 1 | Alston & Bird

    Last week, the FDA granted EUA for the Pfizer-BioNTech vaccine for children aged 5 to 11. The agency also participated in the launch of the Bespoke Gene Therapy Consortium. The administration organized a global supply chain summit to strengthen cooperation and advocate for the diversification of supply chains. Please see details of these and other supply chain developments below:

    • On October 27, the FDA, the National Institutes of Health, 10 pharmaceutical companies and five nonprofits launched the Bespoke Gene Therapy Consortium (BGTC) to optimize and streamline the gene therapy development process. In particular, the BGTC will streamline regulatory requirements and processes for FDA approval of gene therapies, including the development of standardized approaches for preclinical testing (eg, toxicology studies).
    • On October 29, the FDA cleared the emergency use of the Pfizer-BioNTech vaccine for children aged 5 to 11. The authorization is for a two-dose regimen, and each dose is less than the prescribed dose for persons 12 years of age and older. The vaccine has been shown to be 90.7% effective in preventing COVID-19 in children 5 to 11 years old. Following the decision, the CDC approved the vaccine for use in this population.
    • On October 31, President Biden convened a summit with the European Union and 14 other countries to discuss transnational cooperation to strengthen supply chains. The conversation focused specifically on the diversification of the supply chain ecosystem, covering raw materials, manufacturing of intermediate and finished products, shipping, logistics, warehousing and distribution. President Biden also announced initiatives to address supply chain disruptions, including releasing stocks, funding technical assistance in Mexico and Central America, and a commitment to host future summits on the Supply Chain.
    • On November 3, the administration announced it would release a dashboard to show metrics that track progress and activity at the ports of Los Angeles and Long Beach. The dashboard will provide data on ships at berth awaiting docking, import volume in port and retail stocks. The Administration’s goal is to use the data to help stakeholders assess the health of the supply chain and foster future collaborations.
    • On November 4, the FDA released a draft guideline for industry, Content of Premarket Submissions for Device Software Functions. The guide aims to provide industry with the required information that should be included in a pre-market submission that will help the FDA assess the safety and effectiveness of software functions included in a medical device (SiMD), as well as software that functions as a medical device (SaMD). The guidelines will apply to all types of pre-market submissions, including PMA, 510 (k) and De Novo classification requests. Comments are due in 90 days.
    • The Center for Devices and Radiological Health has released its proposed list of guidance documents to be released in fiscal year 2022. The list includes its priorities (A-List) and guidance documents to be released if resources require it. allow (B-List). The CDRH will also carry out a retrospective review of the guidance documents for the years 1982, 1992, 2002 and 2012.

    [View source.]

    read more
    Medical products

    Medical Product Supply Chain Week in Review – November 4, 2021 – Food, Drugs, Healthcare, Life Sciences

    United States: Medical Product Supply Chain Week in Review – November 4, 2021

    To print this article, all you need to do is be registered or log in to Mondaq.com.

    Last week, the FDA granted an EUA for the Pfizer-BioNTech vaccine for use in children ages 5 to 11. The agency also participated in the launch of the Bespoke Gene Therapy Consortium. The Administration hosted a global supply chain summit to strengthen cooperation and advocate for the diversification of supply chains. Please see details of these and other supply chain developments below:

    • On October 27, the FDA, the National Institutes of Health, 10 pharmaceutical companies and five nonprofit organizations spear the Bespoke Gene Therapy Consortium (BGTC) to optimize and streamline the gene therapy development process. In particular, the BGTC will streamline regulatory requirements and FDA approval processes for gene therapies, including the development of standardized approaches for preclinical testing (eg, toxicology studies).
    • On October 29, the FDA